Final Program

Transcription

Final Program

www.lorenzinifoundation.org
Future Activities
Boston, MA, USA, June 14-18, 2009
XV International Symposium on ATHEROSCLEROSIS
Co-chairs: A.M. Gotto, Jr. (New York, NY, USA) and E.J. Schaefer (Boston, MA, USA)
For more information, please contact: [email protected]
For further information, please check the website: www.isa2009.org
www.athero.org
Scientific Committees
Co-Chairs:
A.M. Gotto, Jr. (New York, NY, USA) - S.M. Grundy (Dallas, TX, USA) - R. Paoletti (Milan, Italy)
Scientific Program Committee:
A.L. Catapano (Milan, Italy) - A. Corsini (Milan, Italy) - G. Franceschini (Milan, Italy) - C. Galli
(Milan, Italy) - A.M. Gotto, Jr. (New York, NY, USA) - S.M. Grundy (Dallas, TX, USA) - R. Paoletti
(Milan, Italy) - A. Peracino (Milan, Italy) - C.R. Sirtori (Milan, Italy) - E. Tremoli (Milan, Italy)
Scientific Secretaries:
S. Bellosta (Milan, Italy) - L. Calabresi (Milan, Italy)
Scientific-Organizing Secretariats:
Main Office
FONDAZIONE GIOVANNI LORENZINI
MEDICAL SCIENCE FOUNDATION
MRF 2008
Via A. Appiani 7
20121 MILAN (ITALY)
Phone: (+39) 02 29006267
Fax: (+39) 02 29007018
Email: [email protected]
Branch Office
GIOVANNI LORENZINI
MEDICAL FOUNDATION
MRF 2008
6535 Fannin, M.S. A-601
HOUSTON, TEXAS 77030 (USA)
Phone: (+1) 713 797 0401
Fax: (+1) 713 796 8853
Technical-Organizing Secretariat:
AIM GROUP – AIM CONGRESS S.R.L.
MRF 2008
Via G. Ripamonti, 129
20141 MILAN (ITALY)
Phone: (+39) 02 566011
Fax: (+39) 02 70048584
Please visit the website for further information:
www.lorenzinifoundation.org/mrf2008.html
I
International Advisory Board
Abbracchio M.P. (Italy)
Agabiti Rosei E. (Italy)
Ardissino D. (Italy)
Ballantyne C.M. (USA)
Barter P.J. (Australia)
Bernini F. (Italy)
Betteridge D.J. (UK)
Brewer H.B., Jr. (USA)
Brown W.V. (USA)
Calabresi L. (Italy)
Calvo G. (Spain)
Carmena R. (Spain)
Catapano A.L. (Italy)
Chait A. (USA)
Chapman M.J. (France)
Chiariello M. (Italy)
Corsini A. (Italy)
Cortellaro M. (Italy)
Crea F. (Italy)
Crepaldi G. (Italy)
Davidson M. (USA)
Davignon J. (Canada)
De Feo P. (Italy)
Del Prato S. (Italy)
Després J.-P. (Canada)
Dietz R. (Germany)
Di Minno G. (Italy)
Di Pasquale G. (Italy)
Eckel R. (USA)
Fargion S. (Italy)
Fedele F. (Italy)
Fellin R. (Italy)
Ferrari R. (Italy)
Fiorentini C. (Italy)
Franceschini G. (Italy)
Franconi F. (Italy)
Fruchart J.-C. (France)
Fuster V. (USA)
Galli C. (Italy)
Giampaoli S. (Italy)
Ginsberg H.N. (USA)
Greten H. (Germany)
Hamsten A. (Sweden)
Jönsson B. (Sweden)
Katan M.B. (The Netherlands)
Kita T. (Japan)
Landmesser U. (Switzerland)
Lanzavecchia A. (Switzerland)
LaRosa J.C. (USA)
La Vecchia C. (Italy)
Leitersdorf E. (Israel)
Libby P. (USA)
Locatelli F. (Italy)
II
Lüscher T.F. (Switzerland)
Maggi A. (Italy)
Maisch B. (Germany)
Mancia G. (Italy)
Mancini M. (Italy)
Mannarino E. (Italy)
Marañhao M. (Brazil)
Marcovina S.M. (USA)
Martin J.F. (UK)
Maseri A. (Italy)
Matsuzawa Y. (Japan)
McGuire A.J. (UK)
Modena M.G. (Italy)
Möckel M. (Germany)
Naruszewicz M. (Poland)
Nissen S.E. (USA)
Notarbartolo A. (Italy)
Novo S. (Italy)
Olsson A.G. (Sweden)
Packard C.J. (UK)
Patsch J.R. (Austria)
Pedersen T.R. (Norway)
Peracino A. (Italy)
Perk J. (Sweden)
Plebani M. (Italy)
Poli A. (Italy)
Poole-Wilson P.A. (UK)
Remuzzi G. (Italy)
Sadikot S.M. (India)
Sans S. (Spain)
Schaefer E.J. (USA)
Schenck-Gustafsson K. (Sweden)
Sirtori C.R. (Italy)
Sjöström L. (Sweden)
Sleight P. (UK)
Sobesky J. (Germany)
Stangl V. (Germany)
Stein Y. (Israel)
Tardif J.-C. (Canada)
Taskinen M.-R. (Finland)
Tavazzi L. (Italy)
Tokgözoǧlu L. (Turkey)
Tremoli E. (Italy)
Utermann G. (Germany)
Vella S. (Italy)
Volpe M. (Italy)
Wenger N.K. (USA)
Wood D.A. (UK)
Wu A. (USA)
Yusuf S. (Canada)
Zampelas A. (Greece)
Zanchetti A. (Italy)
Scientific Sponsorship
Jointly Sponsored by
Fondazione Giovanni Lorenzini Medical Science Foundation (FGL)
Giovanni Lorenzini Medical Foundation (GLMF)
International Atherosclerosis Society (IAS)
and
European Society of Gender Health and Medicine (ESGHM)
Italian Heart Foundation (FIpC)
Italian Society of Gender Health and Medicine (SISMG)
Under the Auspices of
American Heart Association:
Council on Arteriosclerosis, Thrombosis, and Vascular Biology
Council on Basic Cardiovascular Sciences
Council on Cardiovascular Disease in the Young
Council on Clinical Cardiology
Council on Epidemiology and Prevention
Council on High Blood Pressure Research
Council on the Kidney in Cardiovascular Disease
Council on Nutrition, Physical Activity, and Metabolism
Council on Stroke
Asian Pacific Society of Atherosclerosis and Vascular Disease (APSAVD)
Association of Black Cardiologists
European Association for the Study of Diabetes (EASD)
European Atherosclerosis Society (EAS)
European Federation for Internal Medicine (EFIM)
European Federation for Pharmaceutical Sciences (EUFEPS)
European Lipoprotein Club (ELC)
European Society for Clinical Investigation (ESCI)
European Society of Hypertension (ESH)
International Association of Gerontology and Geriatrics (IAGG)
International Conference on the Bioscience of Lipids (ICBL)
International Menopause Society (IMS)
International Society for the Study of Fatty Acids and Lipids (ISSFAL)
International Society on Thrombosis and Haemostasis (ISTH)
International Task Force for Prevention of Coronary Heart Disease
International Union of Angiology (IUA)
Italian Association of Hospital Cardiologists (ANMCO)
Italian Diabetologists Association (AMD)
Italian Federation of Cardiology (FIC)
Italian Federation of Internal Medicine (FADOI)
Italian Out-Patient Cardiologists Association (ANCE)
Italian Society for Cardiovascular Prevention (SIPREC)
III
Italian Society for the Study of Atherosclerosis (S.I.S.A.)
Italian Society for the Study of Diabetes (S.I.D.)
Italian Society for the Study of Haemostasis and Thrombosis (SISET)
Italian Society of Arterial Hypertension (SIIA)
Italian Society of Cardiology (SIC)
Italian Society of Experimental and Clinical Therapy (S.I.Te.C.S.)
Italian Society of Gerontology and Geriatrics (SIGG)
Italian Society of Internal Medicine (SIMI)
Italian Society of Nephrocardiology (SINCAR)
Italian Society of Obesity (SIO)
Italian Society of Pharmacology (SIF)
Mediterranean Society of Atherosclerosis
National Lipid Association (NLA)
The American Geriatrics Society
The American Society of Hypertension (ASH)
The Federation of European Pharmacological Societies (EPHAR)
The Scandinavian Society for Atherosclerosis Research (SSAR)
Vascular - Independent Research and Education - European Organisation (VAS)
Weill Cornell Medical College
World Heart Federation (WHF)
World Hypertension League (WHL)
IV
General Information
LOCATION AND DATE OF THE SYMPOSIUM
The Symposium will take place in Venice Lido (Italy) at the Venice Convention Center, Lungomare
Marconi, 30 - Phone: +39 041 2720030 on October 22-25, 2008.
SECRETARIAT AND REGISTRATION DESK
The following services are available at the Secretariat and
Registration Desk:
• registration (pre-registered participants and on-site registrations)
• secretariat
• information
• incoming mail and messages
• lost and found
Opening Hours
Tuesday, October 21:
Wednesday, October 22:
Thursday, October 23:
Friday, October 24:
Saturday, October 25:
15.00 – 19.00
7.30 – 19.00
7.30 – 19.00
7.30 – 19.00
7.30 – 13.00
REGISTRATION
Only registered participants may attend the scientific sessions and the social events offered by the
Symposium. The late enrollment fee (from October 11 and on site) will be charged even if the registration
form was received without payment before that date.
The registration fees for the Symposium are as follows (all amounts given in EUROS):
from October 11 and on site
Participants
€ 710
Students/Nurses*
€ 270
Accompanying Persons
€ 120
(V.A.T. included)
(*) Student/nurse rate registrations will be granted only to those who demonstrate their student/nurse position by presenting an official statement
from the Head of their Department or Institute or a copy of their nursing license.
V
All participants, students, and nurses, are entitled to:
• attend all Scientific Sessions
• attend the Opening Ceremony of the Symposium and the Welcome Reception (Buffet Dinner)
• receive Final Program and Abstract Book
• Coffee Breaks
• receive tickets for Light Lunches
• round-trip bus service from the MRF 2008 Symposium Hotel in Venice Lido (booked through the
Congress) and from the S.M. Elisabetta Pier in Venice Lido to the Symposium Venue.
All accompanying persons regularly enrolled are entitled to:
• attend the Welcome Reception (Buffet Dinner)
• receive ticket for the Tour of the “Gallerie dell’Accademia”
• round-trip bus service from the MRF 2008 Symposium Hotel in Venice Lido (booked through the
FOR ITALIAN PARTICIPANTS ONLY
All the Italian participants with the VAT/IVA number must indicate this number (and the corresponding
address) in the registration form (DPR 633/72).
The regular invoice for the registration will be sent only to those who have indicated the fiscal
code and/or the IVA number (compulsory if available) of the actual payer.
PRIVACY LAW
The personal data will be handled exclusively by MRF 2008 Committee according to the law 675/96 and
the law decree 196/2003.
BADGES
The official name badge must be worn for admission to all sessions and other activities of the Symposium.
Accompanying Persons may not attend the scientific sessions.
Badges will show different colours:
BLUE Organizers
RED Invited Speakers and Chairpersons
WHITE Participants
GREEN Students
YELLOW Accompanying Persons
Lost badges will be replaced for a fee of € 35,00 (VAT 20% included) with proof of the original registration.
COFFEE BREAKS
Coffee Breaks will be offered at the Palazzo del Casinò from Wednesday morning until Saturday morning
to registered participants.
BAR
Cash-bar are located at the Palazzo del Casinò.
LUNCHES
Light lunches will be offered at the Palazzo del Casinò from Wednesday until Friday to registered
participants.
CELLULAR PHONES
In consideration of fellow attendees, it is requested that all cellular phones, pagers, and other electronic
devices be turned off or set to the silent mode during all scientific and plenary sessions to avoid disruption.
CERTIFICATE OF ATTENDANCE
Certificates of Attendance will be available on request at the end of the Symposium at the Registration
Desk. The request form is enclosed in the Symposium envelope.
VI
ITALIAN CME CREDITS/CREDITI ECM (for Italian participants only)
CME Credits (Crediti ECM) have been applied for from the Italian Ministry of Health for selected sessions.
The following credits have been awarded on a daily basis:
I educational pathway: 3 credits
II educational pathway: 3 credits
Friday, October 24:
III educational pathway: 4 credits
IV educational pathway: 2 credits
Participants will find all the necessary forms and questionnaires in the ECM envelope (please request it
at the Registration Desk).
To obtain credits, Italian participants must:
• Return the evaluation form, duly filled in, to the Registration Desk;
• Return the multiple choice questionnaires. The anagraphical data must be compulsorily indicated since
required by the Italian Ministry of Health.
EBAC ACCREDITATION & UEMS/EACCME (for European and USA citizens)
The Fondazione Giovanni Lorenzini Medical Science Foundation is accredited by the European Board for
Accreditation in Cardiology (EBAC) and by the European Accreditation Council for Continuing Medical
Education (EACCME) to provide the following CME activity for medical specialists. EBAC works in
cooperation with the European Accreditation Council for Continuing Medical Education (EACCME), which
is an institution of the European Union of Medical Specialists (UEMS).
The Fondazione Giovanni Lorenzini Medical Science Foundation is designated for a maximum of 21 hours
of European external CME credits. Each participant should claim only those hours of credit that he/she
actually spent in the educational activity.
EBAC and EACCME credits are recognized by the American Medical Association towards the Physician’s
Recognition Award (PRA). To convert EBAC/EACCME credit to AMA PRA category 1 credit, contact the
AMA.
SLIDE LIBRARY
A slide library of key selected presentations will be available after the Symposium at
www.lorenzinifoundation.org
POST OFFICE
The post office is located in Piazza S.M. Elisabetta - Venice Lido.
Opening hours: 8.30 - 18.30 (from Monday to Friday); 8.30 - 12.30 (Saturday); Sunday closed.
BANK
Banking hours in Venice Lido and in Venice Downtown are between 8.30 - 13.30 and 14.40 - 16.10, from
Monday to Friday.
Please remember that usually banks are closed on Saturday and Sunday.
ELECTRICITY
Voltage in Italy is 220 volts - 50 Hz. Foreign appliances may require an adapter.
USEFUL NUMBERS
Ambulance: dial 118
Police:
dial 113
Fire Brigade: dial 115
PERSONAL INSURANCE COVERAGE
Registration for the Symposium implies that the participant agrees that neither the Scientific Organizing
Committee nor the Fondazione Giovanni Lorenzini assume any liability or responsibility whatsoever.
The Symposium participants are requested to make their own arrangements for medical, travel, and
personal insurance. The Scientific Organizing Committee cannot assume liability for changes in the
program due to external circumstances.
VII
SYMPOSIUM WEBSITE
Home page for the MRF 2008 Symposium is located at: http://www.lorenzinifoundation.org/mrf2008.html
OFFICIAL LANGUAGE
The official language of the Symposium is English. No simultaneous translation is provided.
PRESS REGISTRATION
Working press from newspapers, magazines, radio and television stations, and medical publications will
receive complimentary registration, provided that they can officially demonstrate their position.
SCIENTIFIC EXHIBITION
During the Symposium an exhibition of pharmaceutical and biomedical instruments and products is held
in the Meeting area Palazzo del Casinò.
E-MAIL SERVICE
E-mail service will be available in the Exhibition Area at the Palazzo del Casinò to allow the attendants to
send and receive messages during the Symposium. The address is: [email protected]
To receive e-mail during the Symposium, the sender of the message must fill in the subject/object field
with the complete name of the recipient (Symposium participant).
MESSAGES, MAIL, AND FAX
During the Symposium, mail may be addressed to the participants as follows:
MRF 2008 – FONDAZIONE GIOVANNI LORENZINI MEDICAL SCIENCE FOUNDATION
c/o Venice Convention Center - Lungomare Marconi, 30 - Venice Lido (Italy) - Telefax: +39 041 2720031.
CLOAKROOM
A cloakroom will be at the disposal of all participants in the Symposium Venue in the Secretariat Area, free
of charge. Delegates will be kindly requested not to leave their personal belongings after closing time.
HOW TO REACH VENICE AND VENICE LIDO
• By Plane – Venice Marco Polo Airport
Located 12 km by road and 10 km by water from the city, this airport is connected to Venice Lido by the
Public ACTV watertaxi service: it is a private watertaxi service which uses public transport stops. Please
take Alilaguna Red Line and get off at Lido stop (it takes around 55 minutes). A shuttle bus will take you
to Hotel Excelsior.
• By Plane – Treviso Antonio Canova Airport (especially for low-cost airlines)
Located 20 km by road from Venice, this airport is especially used by low-cost airline companies. Venice
Lido is reachable by bus service from Airport to Piazzale Roma and then by water to the Lido.
• By Train
Santa Lucia is the Venice Train Station. It is connected to the rest of Italy with Eurostar trains, Intercities
and Interregional, and local trains. From here, frequent boat connections to Venice Lido are available.
• By Car
Venice can be reached with the following motorway and road connections: A4 from Trieste and from Turin,
A27 from Belluno, A13 from Bologna, and the state roads SS.309 Romea from the Adriatic Coast, SS.14
from Trieste, SS.13 from Treviso, SS.11 from Padua. Once you arrive near the lagoon, get on to the Ponte
della Libertà - a long bridge with two lanes linking Venice to the mainland - follow the signs for Venice and
you will arrive at Piazzale Roma, where the Railway Station is located.
Here you have to leave your car.
Parking areas at Piazzale Roma: the Autorimessa Comunale, the Garage S. Marco and the small
open air car park S. Andrea. One alternative is the large car park on the Tronchetto island.
VIII
• By Public Transportation (once in Venice)
Public transportation to Venice Lido (S.M. Elisabetta) will be available from every water-bus stop in
Venice.
Traveling time by water-bus from San Marco Square to Venice Lido: approximately 15 minutes.
• Shuttle bus (on the Lido)
A round-trip bus service from the MRF 2008 Symposium Hotel in Venice Lido (booked through the
HOTEL INFORMATION
AIM GROUP desk is located in the Secretariat area. The staff will be happy to make reservations.
The opening hours are:
Tuesday, October 21:
15.00 – 19.00
7.30 – 19.00
7.30 – 19.00
Friday, October 24:
7.30 – 19.00
7.30 – 13.00
IX
Scientific Program Information
The Scientific Program will include Plenary Sessions, Special Lectures, Workshops, Symposia, Round
Tables and Poster Sessions for contributed papers.
RULES FOR CHAIRPERSONS
Every effort must be made to adhere to the time-table of the scientific sessions.
Chairpersons are asked to interrupt speakers if they exceed their allocated time.
NOTICE TO ALL SPEAKERS (Slide Centers, Projection Facilities,...)
Presentations and discussions must be given in English.
Power Point Presentations: Power Point presentations will be accommodated with an LCD-panel
projection system. Speakers are kindly requested to bring 2 copies (one as back up) of the electronic
media containing their slides. They may scan for viruses and preview check the slide files in the slide
center at least 1 hour before the start of the session or during the breaks. If speakers use their own
computers, they must be given to the room technician at least one hour before the start of the session or
during the breaks. For any other service please contact the Secretariat desk directly.
POSTER PRESENTATION
POSTER NUMBER:
the poster number assigned to your abstract may be found at the top of the
board. The authors must use the board with this number.
MOUNTING AND
the mounting and the removal of the posters must be done by the authors
REMOVAL POSTERS: according to the following schedule:
GROUP A Mounting: Tuesday, October 21
from 16.00 to 18.00
Wednesday, October 22 from 8.00 to 9.00
GROUP A Removal: Thursday, October 23
from 14.00 to 16.30
GROUP B Mounting: Thursday, October 23
from 17.00 to 18.30
Friday, October 24
from 8.00 to 9.00
GROUP A Removal: Saturday, October 25
from 13.30 to 14.30
The organizers are not responsible for any item, including posters, left in the room.
POSTER DISPLAY: is for the duration of 11/2 days for each of the two groups:
GROUP A
Wednesday, October 22 from
Thursday, October 23
from
GROUP B
Friday, October 24
from
Saturday, October 25
from
POSTER DISCUSSION: one of the authors will be available at the poster
GROUP A
Wednesday, October 22
Wednesday, October 22
Thursday, October 23
GROUP B
Friday, October 24
Friday, October 24
Saturday, October 25
9.00
8.30
9.00
8.30
to
to
to
to
18.30
14.00
18.30
13.00
site as follows:
from 12.30 to 14.00
from 15.45 to 16.30
from 12.30 to 14.00
from 13.00 to 14.00
from 16.00 to 16.30
from 10.45 to 11.15
Note:
- “Poster assistants” will be available to assist the authors if needed.
- Facilities for slide projection are not available at the site of poster presentation.
- Photocopies made from a reduction of your poster and any additional material may be distributed by
the author(s) during the poster discussion.
X
LAST-MINUTE COMMUNICATIONS
A notice-board will be placed in the Symposium area, where any last-minute program changes and
other essential information will be posted. Participants are kindly asked to check this board frequently.
YOUNG INVESTIGATOR AWARDS
Friday, October 24, 12.30 – 13.00 – Room A
Research awards will be made to recognize scientific merit and outstanding research
achievements in a poster presentation by an investigator, 35 years old or less, who submits
an abstract in the competition. Selection is based on originality, importance of work, work
accomplished, quality of experimental design and methodology, strength and reliability of data,
and means of expression.
These posters will be reviewed each day of the Symposium by the Awards Committee for the
selection to up to 5 winners and the names of the semi-finalists will be posted each day in the
Registration Area. Each Each winner will receive a certificate and an award of $1,000.
The Poster Awards for Young Investigators will be announced and presented on Friday,
October 24 at 12.30 in Room A. The poster presenter must be present at the Ceremony to win
the award as no awards may be accepted in absentia.
XI
Social Program
SOCIAL EVENTS (for registered participants and accompanying persons)
•
Wednesday, October 22, 2008 (evening)
h. 19.00 WELCOME RECEPTION (Buffet Dinner) at the PALAZZO DEL CASINO’
(Lungomare Marconi, 30) - (complimentary)
The Symposium badge is requested.
SOCIAL EVENTS (for registered accompanying persons)
•
Thursday, October 23, 2008 (morning – half day)
TOUR OF THE “GALLERIE DELL’ACCADEMIA” - (complimentary) - Lunch not included.
The Tour ticket is requested.
The greatest existing collection of Venetian art is housed in the three buildings of the Gallerie
dell’Accademia and features five centuries of masterpieces. Founded by Giambattista Piazzetta in
the 18th century, the collection was greatly enlarged by Napoleon, who transferred a large number
of works from the convents and churches he himself had suppressed.
Among the numberless works of art, you should not miss the Legend of St. Ursula, by Vittore
Carpaccio, a cycle of eight magnificent paintings dating from the late 16th c., the Coronation of the
Virgin, a bright polyptych painted in 1325 by Paolo Veneziano, considered the very founder of the
Venetian school, and the enigmatic Tempest by Giorgione, a painting in which the innovative use of
the landscape influenced all the art of the following centuries.
Many other paintings are worth a stop: you will view works by the three Bellinis (Jacopo, Gentile,
and Giovanni), Andrea Mantegna, Lorenzo Lotto, Paolo Veronese, Jacopo Tintoretto, and Tiepolo.
Departure time: 9.00
Meeting point: Registration Desk in the Secretariat Area.
XII
In Grateful Appreciation
The Organizing Committee gratefully acknowledges the generous
support in the form of unrestricted educational grants from the
following:
KOWA COMPANY Ltd. (Tokyo, Japan)
PFIZER Inc (New York, NY, USA)
MERCK / SCHERING-PLOUGH PHARMACEUTICALS
(Whitehouse Station, NJ, USA and Kenilworth, NJ, USA)
SOLVAY PHARMACEUTICALS (Hannover, Germany)
and
ASTRA ZENECA S.p.A. (Milan, Italy)
BRAHMS AKTIENGESELLSCHAFT (Hennigsdorf, Germany)
BRAHMS ITALIA S.r.l. (Milan, Italy)
DLD Gesellschaft für Diagnostika und Medizinische Geräte mbH (Hamburg, Germany)
F. HOFFMANN - LA ROCHE LTD. (Basel, Switzerland)
GALBUSERA S.p.A. (Cosio Valtellino, Italy)
ITAMAR MEDICAL Ltd. (Caesarea, Israel)
MERCK SHARP & DOHME ITALIA S.p.A. (Rome, Italy)
NUTRITION FOUNDATION OF ITALY (Milan, Italy)
RECORDATI S.p.A. (Milan, Italy)
SERVIER S.p.A. (Milan, Italy)
SIGMA-TAU S.p.A. (Rome, Italy)
SOCIETÀ PRODOTTI ANTIBIOTICI S.p.A. (Milan, Italy)
SOLVAY PHARMA S.p.A. (Grugliasco, Italy)
XIII
7th International Symposium on
MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASES
Prevention and Intervention - Health Policy
Venice (Lido), October 22-25, 2008
Program at Glance
XV
LECTURES, SYMPOSIA, WORKSHOPS
MORNING
Wednesday,
October 22
Opening Remarks
9.00 - 9.30
pg. 1
ROOM A
Plenary Session
MULTIPLE RISK
ASSESSMENT
9.30 - 12.00
pg. 1
Special Lecture
THE USE OF A DIETARY
PORTFOLIO APPROACH IN
HYPERLIPIDEMIA
12.00 - 12.30
pg. 2
Special Lecture
XXXIV LORENZINI ANNUAL
LECTURE
HYPERTENSION AND
STROKE
12.30 - 13.00
pg. 2
Thursday,
October 23
Plenary Session
CLINICAL ASSESSMENT
OF MULTIPLE RISKS
8.30 - 10.35
pg. 8
Special Lecture
SPOTLIGHT ON NICOTINIC
ACID: NEW INSIGHTS
11.00 - 11.30
pg. 9
Special Lecture
OMEGA 3
11.30 - 12.00
pg. 9
ROOM B
ROOM C
Plenary Session
PREVENTION AND
TREATMENT OF MULTIPLE
RISK FACTORS
8.30 - 10.35
pg. 17
Symposium
MEDICAL APPROACHES TO
SMOKING CESSATION
11.00 - 12.30
pg. 18
Young Investigator Awards
Ceremony
12.30 - 13.00
pg. 18
Special Lecture
Video Presentation
CARDIOVASCULAR RISK
FACTORS IN THE 21st
CENTURY: THE OLD, THE
NEW, AND THE FUTURE
12.30 - 13.00
pg. 9
Workshop
HEART AND
INFLAMMATION
11.00 - 13.00
pg. 10
XVI
Friday,
October 24
Saturday,
October 25
Plenary Session
BRIDGING SCIENCE AND
HEALTH POLICY IN CVD:
FOCUS ON LIPID
MANAGEMENT THE FACTS
8.30 - 9.25
pg. 24
Plenary Session
FOCUS ON LIPID
MANAGEMENT THE BARRIERS
9.25 - 10.45
pg. 24
Plenary Session
FOCUS ON LIPID
MANAGEMENT THE POLICY
11.15 - 13.00
pg. 25
Workshop
GENDER PERSPECTIVES
11.00 - 13.00
pg. 19
LECTURES, SYMPOSIA, WORKSHOPS
ROOM A
AFTERNOON
Wednesday,
October 22
Thursday,
October 23
Friday,
October 24
Symposium
MACRO-AND
MICROVASCULAR
COMPLICATIONS OF
METABOLIC DISEASES:
OPTIMIZING THERAPEUTIC
APPROACHES TO
REDUCING RESIDUAL RISK
14.00 - 15.30
pg. 3
Symposium
MANAGEMENT OF
PATIENTS WITH MULTIPLE
LIPID RISK FACTORS
14.00 - 15.30
pg. 11
Symposium
FROM HOSPITAL TO HOME:
CONTINUITY OF CARE IN
INTERNAL MEDICINE
14.00 - 16.00
pg. 20
Round Table
BEAUTIFUL:
FROM RATIONALE TO
IMPLICATIONS IN
CORONARY ARTERY
DISEASE (CAD)
16.00 - 17.00
pg. 5
Workshop
OBESITY AND DIABETES
16.00 - 18.15
pg. 14
Round Table
HEALTH POLICY
STRATEGIES
16.30 - 18.30
pg. 22
Workshop
PREVENTION AND
TREATMENT OF MULTIPLE
RISK FACTORS
14.00 - 16.05
pg. 4
Workshop
SPECIAL POPULATIONS
14.00 - 15.45
pg. 12
Symposium
HEALTHY FOOD AND
HEALTHY CHOICES:
A NEW EUROPEAN PROFILE
APPROACH
14.00 - 16.00
pg. 21
Workshop
METABOLIC SYNDROME
16.30 - 18.25
pg. 7
Workshop
NON-PHARMACOLOGICAL
APPROACHES AND
INTERVENTION
16.30 - 18.25
pg. 15
Symposium
OMEGA 3 FATTY ACIDS
16.30 - 17.50
pg. 23
Saturday,
October 25
ROOM C
ROOM B
Workshop
ESTABLISHED AND NEW
EMERGING RISK FACTORS
17.15 - 18.30
pg. 6
Workshop
SMOKING AND MULTIPLE
RISKS
14.00 - 15.00
pg. 13
Workshop
CRITICAL AREAS IN
ATHEROSCLEROSIS
16.00 - 18.05
pg. 16
XVII
POSTER SESSIONS
GROUP A
POSTER DISPLAY:
for the duration of 11/2 days
WEDNESDAY, OCTOBER 22
from 9.00 to 18.30
and
THURSDAY, OCTOBER 23
from 8.30 to 14.00
PALAZZO DEL CASINÒ
POSTER DISCUSSION:
one of the authors will be
available at the poster site as
follows:
Poster Session
EPIDEMIOLOGY OF CARDIOVASCULAR RISK
FACTORS
Posters (1 - 15)
pp. 26 - 27
WEDNESDAY, OCTOBER 22:
from 12.30 to 14.00
WEDNESDAY, OCTOBER 22:
from 15.45 to 16.30
Poster Session
ESTABLISHED AND NEW EMERGING RISK
FACTORS
Posters (16 - 32)
pp. 28 - 29
and
THURSDAY, OCTOBER 23:
from 12.30 to 14.00
Poster Session
MULTIPLE RISK FACTORS AND
BIOMARKERS
Posters (33 - 53)
pp. 30 - 31
Poster Session
DYSLIPIDEMIA
Posters (54 - 84)
pp. 32 - 34
Poster Session
ATHEROSCLEROSIS AND THROMBOSIS
Posters (85 - 119)
pp. 35 - 37
Poster Session
METABOLIC SYNDROME AND
CARDIOMETABOLIC RISK
Posters (120 - 145)
pp. 38 - 40
Poster Session
PREVENTION OF MULTIPLE RISK FACTORS
Posters (146 - 153)
pg. 41
Poster Session
ANTIATHEROSCLEROTIC DRUGS
Posters (154 -155)
pg. 42
Poster Session
TREATMENT OF MULTIPLE RISK FACTORS
Posters (156 - 163)
pg. 43
XVIII
POSTER SESSIONS
GROUP B
POSTER DISPLAY:
for the duration of 11/2 days
FRIDAY, OCTOBER 24
from 9.00 to 18.30
and
SATURDAY, OCTOBER 25
from 8.30 to 13.00
PALAZZO DEL CASINÒ
POSTER DISCUSSION:
one of the authors will be
available at the poster site as
follows:
FRIDAY, OCTOBER 24:
from 13.00 to 14.00
FRIDAY, OCTOBER 24:
from 16.00 to 16.30
and
SATURDAY, OCTOBER 25:
from 10.45 to 11.15
Poster Session
OBESITY
Posters (1 - 9) - pg. 44
Poster Session
DIABETES
Posters (10 - 45) - pp. 45 - 48
Poster Session
HYPERTENSION
Posters (46 - 62) - pp. 49 - 50
Poster Session
HEART AND INFLAMMATION
Posters (63 - 67) - pg. 51
Poster Session
HEART AND OTHER ORGANS
Posters (68 - 70) - pg. 52
Poster Session
STROKE
Posters (71 - 76) - pg. 53
Poster Session
RENAL DISEASES
Posters (77 - 86) - pp. 54 - 55
Poster Session
PERIPHERAL VASCULAR DISEASE
Posters (87 - 93) - pg. 56
Poster Session
RHEUMATIC DISEASE
Posters (94 - 97) - pg. 57
Poster Session
HIV AND CARDIOVASCULAR RISK
Posters (98 - 100) - pg. 58
Poster Session
GENETICS
Posters (101 - 114) - pp. 59 - 60
Poster Session
SPECIAL POPULATIONS
Posters (115 - 124) - pp. 61 - 62
Poster Session
GENDER PERSPECTIVES IN
CARDIOVASCULAR RISK FACTORS
Posters (125 - 131) - pg. 63
Poster Session
SMOKING AND MULTIPLE RISKS
Posters (132 - 136) - pg. 64
Poster Session
ATHEROSCLEROSIS AND NUTRITION
Posters (137 - 151) - pp. 65 - 66
Poster Session
NON-PHARMACOLOGICAL APPROACHES
AND INTERVENTION
Posters (152 - 162) - pp. 67 - 68
Poster Session
HEALTH ECONOMICS
Posters (163 - 168) - pg. 69
Poster Session
GUIDELINES FOR PRACTICE
Posters (169 - 170) - pg. 70
XIX
7th International Symposium on
MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASES
Prevention and Intervention - Health Policy
Venice (Lido), October 22-25, 2008
Scientific Program
(THE AUTHOR IN BOLD FACE IS THE PRESENTING AUTHOR)
XXI
PARTICIPANTS ARE REQUESTED TO REFRAIN
FROM SMOKING IN THE MEETING AREA
ADMISSION TO THE SCIENTIFIC SESSIONS RESERVED
ONLY FOR PARTICIPANTS WEARING THE MEETING BADGE
XXII
Wednesday, OCTOBER 22, 2008
9.00 - 12.00
ROOM A
WEDNESDAY
OPENING REMARKS
9.00 - 9.30
W.V. Brown (Atlanta, GA, USA)
J.-C. Fruchart (Lille, France)
R. Ferrari (Ferrara, Italy)
R. Paoletti (Milan, Italy)
Plenary Session
MULTIPLE RISK ASSESSMENT
Chairs: W.V. Brown (Atlanta, GA, USA)
R. Ferrari (Ferrara, Italy)
Hour:
Abstract
Number Ref.:
9.30 - 9.55
ESTABLISHED RISK FACTORS AND RISK SCORES
P.A. Wolf (Boston, MA, USA)
1
9.55 - 10.20
NEW AND EMERGING RISK FACTORS: ROLE OF HDL-RELATED
PROTEINS
R.P.F. Dullaart (Groningen, The Netherlands)
2
10.20 - 10.45
A NEW TARGET FOR PREVENTION: INFLUENZA AS A TRIGGER
OF ACUTE CORONARY SYNDROMES
M. Madjid, S.W. Casscells (Houston, TX, USA)
3
10.45 - 11.10
Coffee Break
11.10 - 11.35
WHAT IS CHANGING - THE EUROPEAN VIEW
D.A. Wood (London, UK)
11.35 - 12.00
USING BIOMARKERS IN THE CLINIC
W.V. Brown (Atlanta, GA, USA)
12.00
End of the Session
430
Addendum
1
12.00 - 13.00
ROOM A
SPECIAL LECTURES
Chair: J. Davignon (Montreal, QC, Canada)
Hour:
12.00 - 12.30
Abstract
Number Ref.:
THE USE OF A DIETARY PORTFOLIO APPROACH IN
HYPERLIPIDEMIA
D.J.A. Jenkins, T.H. Nguyen, C.W.C. Kendall, J.M.W. Wong, A.R. Josse,
N. Fozdar, A. Marchie, R.G. Josse, L.A. Leiter, W. Singer (Toronto, ON, Canada)
6
Chair: R. Paoletti (Milan, Italy)
12.30 - 13.00
13.00
2
XXXIV LORENZINI ANNUAL LECTURE
HYPERTENSION AND STROKE
G. Mancia (Milan, Italy)
End of the Session
5
14.00 - 15.30
ROOM A
Symposium
WEDNESDAY
MACRO-AND MICROVASCULAR COMPLICATIONS
OF METABOLIC DISEASES: OPTIMIZING THERAPEUTIC
APPROACHES TO REDUCING RESIDUAL RISK
Chair: J.-C. Fruchart (Lille, France)
Hour:
Abstract
Number Ref.:
14.00 - 14.25
CONTRIBUTION OF LIPOPROTEIN ABNORMALITIES TO
MACRO- AND MICROVASCULAR RESIDUAL RISK
A. Zambon (Padua, Italy)
431
14.25 - 14.50
TARGETING LIPOPROTEIN SUBCLASSES: NEW OPPORTUNITIES
FOR CARDIOVASCULAR RISK REDUCTION IN THE METABOLIC
SYNDROME
R.S. Rosenson (Ann Arbor, MI, USA)
433
14.50 - 15.15
PPAR-α IN THE TREATMENT OF MACRO-AND MICROVASCULAR
COMPLICATIONS IN TYPE 2 DIABETES
J.-C. Fruchart (Lille, France)
439
15.15 - 15.30
General Discussion
15.30
End of the Session
15.30 -16.00
Coffee Break
Supported in part by an unrestricted educational grant from Solvay Pharmaceuticals
3
14.00 - 16.05
ROOM B
Workshop
PREVENTION AND TREATMENT OF MULTIPLE RISK FACTORS
Chairs: M. Madjid (Houston, TX, USA)
A. Corsini (Milan, Italy)
Hour:
4
Abstract
Number Ref.:
14.00 - 14.20
PREVENTION IN LOWER RISK POPULATIONS
S. Giampaoli (Rome, Italy)
7
14.20 - 14.40
LOWER IS BETTER AND BEYOND IN THE CONTROL OF
HYPERLIPOPROTEINEMIAS
A.L. Catapano (Milan, Italy)
8
14.40 - 15.10
CURRENT APPROACHES TO MODULATE REVERSE
CHOLESTEROL TRANSPORT AND HDL
R. Lawn (Palo Alto, CA, USA)
9
15.10 - 15.20
POLYPHARMACY
A. Corsini (Milan, Italy)
10
15.20 - 15.35
THE SANDS TRIAL: DOES AGGRESSIVE LOWERING OF LDL-C
AND NON-HDL-C IN DIABETES DECREASE THE PLASMA APO-B
AND LDL PARTICLE NUMBER?
W.J. Howard, J.L. Fleg, M. Mete, J.D. Otvos, R.E. Ratner, M.J. Roman,
M. Russell, J.G. Umans, N.J. Weissman, B.V. Howard (Washington, DC,
Bethesda, MD, Hyattsville, MD, Raleigh, NY, New York, NY and Phoenix, AZ, USA)
11
15.35 - 15.50
NIACIN THERAPY RAISES HOMOCYSTEINE LEVELS: REVERSAL
BY FOLIC ACID AND B VITAMIN SUPPLEMENTATION
S. Gundry, W. Ehrman (Palm Springs, CA, USA)
12
15.50 - 16.05
A PRACTICAL AND SOCIO-CULTURAL APPROACH IN GLOBAL
CARDIOVASCULAR RISK ASSESSMENT AND PREVENTIVE
SELF-MANAGEMENT BY PATIENTS
X. Debussche, M. Balcou-Debussche, M. Roddier (Saint Denis, Reunion
Island and Amiens, France)
13
16.05
End of the Session
16.05 -16.30
Coffee Break
16.00 - 17.00
ROOM A
Round Table
WEDNESDAY
BEAUTIFUL: FROM RATIONALE TO IMPLICATIONS IN
CORONARY ARTERY DISEASE (CAD)
Chairs: R. Paoletti (Milan, Italy)
L. Tavazzi (Cotignola, Italy)
Hour:
Abstract
Number Ref.:
16.00 - 16.20
“FUNNY” CHANNELS DISCOVERY: THE FIRST STEP OF A
BEAUTIƒUL JOURNEY
D. Di Francesco (Milan, Italy)
16.20 - 16.40
BEAUTIFUL: CLINICAL AND PHYSIOPATHOLOGICAL
IMPLICATIONS IN CORONARY ARTERY DISEASE (CAD)
L. Tavazzi (Cotignola, Italy)
16.40 - 17.00
General Discussion
17.00
End of the Session
Addendum
438
–
Supported in part by an unrestricted educational grant from Servier S.p.A.
5
17.15 - 18.30
ROOM A
Workshop
ESTABLISHED AND NEW EMERGING RISK FACTORS
Chairs: M. Cuchel (Philadelphia, PA, USA)
G.D. Norata (Milan, Italy)
Hour:
6
Abstract
Number Ref.:
17.15 - 17.30
ATHEROPROTECTIVE FUNCTIONS OF THE LONG PENTRAXIN 3
G.D. Norata, C. Garlanda, P. Marchesi, A. Mantovani, A. Catapano
(Milan, Cinisello Balsamo and Rozzano, Italy)
14
17.30 - 17.45
CHOLESTEROL EFFLUX CAPACITY OF SERUM IS BETTER
CORRELATED WITH CONCENTRATIONS OF APOA-I THAN HDL-C
M. Cuchel, M. de la Llera-Moya, J.A. Phillips, M.L. Wolfe,
G.H. Rothblat, D.J. Rader (Philadlephia, PA and New Brunswick, NJ, USA)
15
17.45 - 18.00
MARKERS OF ATHEROSCLEROSIS AND OF INFLAMMATION
FOR PREDICTION OF CORONARY HEART DISEASE IN OLDER
ADULTS
N. Rodondi, P. Marques-Vidal, J. Butler, J. Cornuz, K. Sutton-Tyrrell,
S. Satterfield, T. Harris, D. Bauer, E. Vittinghoff, A. Newman (Lausanne,
Switzerland, Atlanta, GA, Pittsburgh, PA, Memphis, TN, Bethesda, MD
and San Francisco, CA, USA)
16
18.00 - 18.15
FIBRINOGEN, CD40L, CRP AND SUBCLINICAL ATHEROSCLEROSIS
A. Panayiotou, M. Griffin, T. Tyllis, D. Bond, N. Georgiou, A. Nicolaides
(Nicosia, Cyprus and London, UK)
17
18.15 - 18.30
HIGH LEVELS OF PLASMA FIBRINOGEN AT ADMISSION AND
DURING HOSPITALIZATION ARE PREDICTIVE OF TARGET
VESSEL REVASCULARIZATION FOLLOWING PRIMARY PTCA
A. Lupi, S. Ferraro, L. Rossi, M. Santagostino, M. Sansa, R. Rosso,
A.S. Bongo (Novara, Italy)
18
18.30
End of the Session
16.30 - 18.25
ROOM B
Workshop
WEDNESDAY
METABOLIC SYNDROME
Chairs: N. Marx (Ulm, Germany)
G. Crepaldi (Padua, Italy)
Hour:
Abstract
Number Ref.:
16.30 - 16.50
THE ROLE OF INFLAMMATION IN DIABETES AND VASCULAR
DISEASE
N. Marx, D. Walcher, K. Hess, M. Burgmaier (Ulm, Germany)
19
16.50 - 17.10
METABOLIC SYNDROME AND CARDIOMETABOLIC RISK
A. Zambon (Padua, Italy)
432
17.10 - 17.25
KEY ROLE OF LOW HDL CHOLESTEROL FOR THE ASSOCIATION OF
THE METABOLIC SYNDROME WITH INFLAMMATION IN CORONARY
PATIENTS
P. Rein, C.H. Saely, S. Beer, A. Vonbank, C. Boehnel, V. Jankovic, H. Drexel
(Feldkirch, Austria, and Triesen, Liechtenstein)
20
17.25 - 17.40
CENTRAL OBESITY IS INDEPENDENT OF CONVENTIONAL
MULTIVARIABLE RISK IN PREDICTING 15 YEAR CORONARY
HEART (CHD) AND CARDIOVASCULAR (CVD) DEATHS
T. Welborn, S. Dhaliwal (Nedlands and Bentley, Australia)
21
17.40 - 17.55
OBESITY IS ASSOCIATED WITH CORONARY HEART DISEASE
THROUGH ITS INTERRELATIONSHIP WITH OTHER METABOLIC
SYNDROME COMPONENTS-ARIC STUDY
D. Liao, Y. Duan, J. Liu, S. Rodriguez-Colon, C. Wu, P. Cheriyath
(Hershey, PA, USA)
22
17.55 - 18.10
THE EFFECT OF ABT-335 (FENOFIBRIC ACID) ON THE PREVALENCE
OF METABOLIC SYNDROME IN PATIENTS WITH MIXED DYSLIPIDEMIA
H. Bays, C. Setze, M. Kelly, K. Gustafson, D. Sleep, J. Stolzenbach
(Louisville, KY and Abbott Park, IL, USA)
23
18.10 - 18.25
ASSOCIATION OF NITRIC OXIDE WITH COMPONENTS OF
METABOLIC SYNDROME AMONG OUTPATIENT CARDIOVASCULAR
PATIENTS IN GEORGIA
N. Dolidze, D. Enquobahrie, B. Gelaye, G. Chapidze, M. Williams
(Tbilisi, Georgia, Seattle, WA and Boston, MA, USA)
24
18.25
End of the Session
7
8.30 - 10.35
Thursday, OCTOBER 23, 2008
ROOM A
Plenary Session
CLINICAL ASSESSMENT OF MULTIPLE RISKS
Chairs: D.P. Hajjar (New York, NY, USA)
E. Tremoli (Milan, Italy)
Hour:
8
Abstract
Number Ref.:
8.30 - 8.55
BENEFITS AND RISKS OF WEIGHT LOSS MEDICATIONS: EVIDENCE
FROM META-ANALYSES
R. Christensen, H. Bliddal (Frederiksberg, Denmark)
25
8.55 - 9.20
FATTY ACIDS, INSULIN RESISTANCE, AND ER STRESS IN THE
DEVELOPMENT OF HEPATIC STEATOSIS AND
HYPERTRIGLYCERIDEMIA
H.N. Ginsberg, A. Hernandez-Ono, B. Moon, C. Gayet,
T. Ota (New York, NY, USA)
26
9.20 - 9.45
HOW TO MANAGE THE CARDIOVASCULAR RISK IN
HYPERTENSION: THE ROLE OF COMBINATION TREATMENT
C. Borghi (Bologna, Italy)
425
9.45 - 10.10
RENAL FUNCTION AS A MAJOR RISK FACTOR FOR CARDIOVASCULAR
DISEASE
G. Remuzzi (Bergamo, Italy)
27
10.10 - 10.35
PLATELET INHIBITION IN ATHEROTHROMBOSIS
C. Patrono (Rome, Italy)
28
10.35
End of the Session
10.35 - 11.00
Coffee Break
11.00 - 13.00
ROOM A
SPECIAL LECTURES
Chairs: D.P. Hajjar (New York, NY, USA)
Abstract
Number Ref.:
11.00 - 11.30
SPOTLIGHT ON NICOTINIC ACID: NEW INSIGHTS
M.J. Chapman (Paris, France)
441
11.30 - 12.00
OMEGA 3
L. Tavazzi, on behalf of the GISSI-HF Investigators
(Cotignola, Florence, Milan and Santa Maria Imbaro, Italy)
437
12.00 - 12.30
CARDIOVASCULAR RISK FACTORS IN THE 21st CENTURY: THE
OLD, THE NEW, AND THE FUTURE - Video Presentation
A.M. Gotto, Jr. (New York, NY, USA)
12.30
End of the Session
Addendum
THURSDAY
Hour:
9
11.00 - 13.00
ROOM B
Workshop
Chairs: P. Libby (Boston, MA, USA)
F. Crea (Rome, Italy)
Hour:
10
Abstract
Number Ref.:
11.00 - 11.20
FUNDAMENTAL AND APPLIED ASPECTS OF INFLAMMATION IN
ATHEROSCLEROSIS
P. Libby (Boston, MA, USA)
422
11.20 - 11.40
BIOMARKERS IN CARDIOMYOPATHIES AND PERIMYOCARDITIS
B. Maisch, S. Pankuweit, P. Alter (Marburg, Germany)
29
11.40 - 12.00
NEW CARDIAC BIOMARKERS MR-PROANP AND PROADM IN
440
THE DIAGNOSIS AND PROGNOSIS OF ACUTE AND CHRONICAL
HEART FAILURE
M. Möckel, C. Müller, R. Nowak, W.F. Peacock, I. Anand, R. Christenson,
L.B. Daniels, S. Di Somma, G. Filippatos, C. Hogan, S.-X. Neath, L. Ng,
P. Ponikowski, A.M. Richards, A.H.B. Wu, P. Clopton, J. Landsberg, S.D. Anker,
A. Maisel (Berlin, Germany, Basel, Switzerland, Detroit, MI, Cleveland, OH,
Minneapolis, MN, Baltimore, MD, San Diego, CA, USA, Rome, Italy, Athens, Greece,
Richmond, VA, USA, Leicester, UK, Wroclaw, Poland, Otago, New Zaeland,
San Francisco, CA and San Diego, CA, USA)
12.00 - 12.15
HIGH DENSITY LIPOPROTEIN REDUCES THE HUMAN MONOCYTE
INFLAMMATORY RESPONSE THROUGH ATP-BINDING CASSETTE
TRANSPORTER A1
D. Sviridov, A. Murphy, K. Woolard, A. Hoang, N. Mukhamedova,
R. Stizaker, S. McCormick, A. Remaley, J. Chin-Dusting (Melbourne,
Australia, Dunedin, New Zealand and Bethesda, MD, USA)
30
12.15 - 12.30
C-REACTIVE PROTEIN PREDICTS FUNCTIONAL STATUS AND
CORRELATES WITH LEFT VENTRICULAR EJECTION FRACTION IN
PATIENTS WITH CHRONIC STABLE ANGINA
P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J.C. Kaski (Oviedo, Guadalajara,
Alicante, Spain and London, UK)
31
12.30 - 12.45
ENDOTHELIN LEVELS CORRELATES WITH CARDIO-PULMONARY
DYSFUNCTION IN CIRRHOSIS
G.I. Pandele, L.C. Dima-Cozma, C. Dascalu, C. Lupusoru, C. Ghiciuc,
D. Radulescu (Iasi, Romania)
32
12.45 - 13.00
ROSUVASTATIN+PIOGLITAZONE DECREASE INTERFERON-GAMMA,
TNF-ALPHA, IL-6, MCP-1, MYELOPEROXIDASE, CRP, AND INCREASE
IL-4 IN DIABETICS WITH ATHEROSCLEROSIS
L.G. Tan, S.A. Tan, L.S. Berk (Yucaipa, CA, USA)
33
13.00
End of the Session
14.00 - 15.30
ROOM A
Symposium
MANAGEMENT OF PATIENTS WITH MULTIPLE
LIPID RISK FACTORS
Chair: M.J. Chapman (Paris, France)
Abstract
Number Ref.:
14.00 - 14.05
WELCOME & INTRODUCTION
M.J. Chapman (Paris, France)
–
14.05 - 14.25
HDL-C AS A MARKER FOR CORONARY EVENTS AND THE
RELATIONSHIP BETWEEN CV EVENTS AND HDL-C IN SPECIAL
SUB-GROUPS
B.V. Howard (Washington, DC, USA)
429
14.25 - 14.50
RISK FACTORS OF CVD BEYOND LDL-C, SECONDARY MARKER
DATA FROM THE PITAVASTATIN PHASE 3 STUDIES
M. Farnier (Dijon, France)
428
14.50 - 15.15
JAPAN ASSESSMENT OF PITAVASTATIN AND ATORVASTATIN IN
ACUTE CORONARY SYNDROME: JAPAN-ACS STUDY
H. Daida, K. Miyauchi, T. Kimura, T. Morimoto, I. Miki, S. Minematsu, T. Hiro,
Y. Nakagawa, Y. Ozaki, M. Yamagishi, T. Yamaguchi, S. Saito, K. Kimura,
M. Matsuzaki on behalf of the JAPAN-ACS Investigators (Tokyo, Kyoto, Ube,
Tenri, Toyoake, Kanazawa and Yokohama, Japan)
426
15.15 - 15.30
General Discussion
15.30
End of the Session
15.30 -16.00
Coffee Break
THURSDAY
Hour:
–
Supported in part by an unrestricted educational grant from Kowa Company Ltd.
11
14.00 - 15.45
ROOM B
Workshop
SPECIAL POPULATIONS
Chairs: P. Schwandt (Munchen, Germany)
J. Shepherd (Glasgow, UK)
Hour:
12
Abstract
Number Ref.:
14.00 - 14.20
GENDER AND CVD RISK FACTORS
L. Ose (Oslo, Norway)
34
14.20 - 14.40
INTENSIVE STATIN THERAPY: GENDER AND AGE CONSIDERATIONS
J. Shepherd (Glasgow, UK)
35
14.40 - 15.00
EVALUATION OF RISK FACTORS FOR CARDIOVASCULAR
DISEASE IN YOUTH WITH TYPE 2 DIABETES
S.M. Marcovina (Seattle, WA, USA)
423
15.00 - 15.15
INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS IN
CHILDREN AND ADOLESCENTS: THE PEP FAMILY HEART STUDY
P. Schwandt, T. Bertsch, E. Liepold, G.M. Haas (München and Nürnberg,
Germany)
36
15.15 - 15.30
KIF6 TRP719ARG POLYMORPHISM AND EFFECT OF STATIN
THERAPY IN THE ELDERLY: RESULTS FROM THE PROSPER TRIAL
O. Iakoubova, I. Ford, M. Robertson, C. Tong, C. Rowland, J. Jukema,
G. Blauw, M. Murphy, J. Devlin, J. Shepherd (Alameda, CA, USA, Glasgow,
UK, Leiden, The Netherlands and Cork, Ireland)
37
15.30 - 15.45
CARDIOVASCULAR RISK FACTORS (CVDRF) AND LIFESTYLE IN
TURKISH AND GERMAN FAMILIES LIVING IN NUREMBERG:
THE PEP FAMILY HEART STUDY
G. Haas, E. Liepold, P. Schwandt (München, Germany)
38
15.45
End of the Session
15.45 -16.30
Coffee Break
14.00 - 15.00
ROOM C
Workshop
Chair: A. Peracino (Milan, Italy)
Abstract
Number Ref.:
14.00 - 14.15
ANGIOGRAPHIC EVIDENCE OF EARLY CORONARY ARTERY
DISEASE AND INCREASED RISK OF MORTALITY IN SMOKERS WITH
NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
J. Robertson, R. Ebrahimi, A. Lansky, R. Mehran, G. Stone, A. Lincoff
(Cleveland, OH, Los Angeles, CA and New York, NY, USA)
39
14.15 - 14.30
SMOKING INDUCES LONG-LASTING MODIFICATIONS OF PLATELET
SEROTONIN CATABOLISM THROUGH DEMETHYLATION OF THE
MONOAMINE OXIDASE GENE PROMOTER
F. Rendu, M. Del Pino, G. Chironi, J. Callebert, K. Peoc’h, A. Simon,
J.-M. Launay (Paris, France)
40
14.30 - 14.45
CIGARETTE SMOKE UP-REGULATES CYCLOOXYGENASE-2
EXPRESSION IN ENDOTHELIAL CELLS VIA NADPH OXIDASE
ACTIVATION
S.S. Barbieri, E. Zacchi, B.B. Weksler, E. Tremoli (Milan, Italy and New York,
NY, USA)
41
14.45 - 15.00
NICOTINE IMPAIRES GLUT4 TRANSLOCATION IN SKELETAL MUSCLE
CELLS THROUGH MECHANISMS INVOLVING OXIDATIVE
STRESS/PKC THETA/NUCLEAR FACTOR-KB/AKT PATHWAY
T. Morita, E. Terada, J. Tatebe, G. Yoshino, T. Saji, J. Yamazaki (Tokyo, Japan)
42
15.00
End of the Session
15.30 -16.00
Coffee Break
THURSDAY
Hour:
13
16.00 - 18.15
ROOM A
Workshop
Chairs: R.H. Eckel (Aurora, CO, USA)
R. Fellin (Ferrara, Italy)
Hour:
14
Abstract
Number Ref.:
16.00 - 16.15
IMPACT OF HYPERGLYCEMIA ON CLINICAL OUTCOME IN PATIENTS
UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
A. De Monte, A. Perkan, G. Vitrella, L. Cattin, G. Sinagra (Trieste, Italy)
43
16.15 - 16.30
HIGH TRIGLYCERIDES, LOW HDL CHOLESTEROL, AND SMALL LDL
PARTICLES PREDICT INCIDENT TYPE 2 DIABETES IN NON-DIABETIC
CORONARY PATIENTS
C.H. Saely, P. Rein, A. Vonbank, S. Beer, S. Aczel, T. Marte, H. Drexel
(Feldkirch, Austria and Triesen, Liechtenstein)
44
16.30 - 16.45
ABT-335 (FENOFIBRIC ACID) + ROSUVASTATIN COMBINATION
THERAPY IN MIXED DYSLIPIDEMIC PATIENTS WITH OR WITHOUT
TYPE 2 DIABETES MELLITUS
P. Jones, N. Fraser, E. Roth, M. Kelly, K. Gustafson, C. Setze, D. Sleep
(Houston, TX, Troy, OH, Cincinnati, OH and Abbott Park, IL, USA)
45
16.45 - 17.00
EFFECT OF EZETIMIBE/SIMVASTATIN (E/S) VS ATORVASTATIN (A)
ON LIPOPROTEIN SUBCLASSES IN TYPE 2 DIABETES (T2DM)
PATIENTS WITH HYPERCHOLESTEROLEMIA (HC)
T. Mazzone, R. Goldberg, J. Guyton, R. Weinstock, A. Polis, J. Tomassini,
A. Tershakovec (Chicago, IL, Miami, FL, Durham, NC, Syracuse, NY and
New Wales, PA, USA)
46
17.00 - 17.15
EFFICACY OF RIMONABANT IN IMPROVING LIPID PROFILE AND
GLUCOSE TOLERANCE IN OVERWEIGHT/OBESE NON-DIABETIC
PATIENTS: POOLED DATA FROM RIO STUDIES
A. Scheen, L.F. Van Gaal, F.X. Pi-Sunyer, J.-P. Despres (Liege and Antwerp,
Belgium, New York, NY, USA and Laval, QC, Canada)
47
17.15 - 17.30
SUBCLINICAL DISEASE (SD) IN OVERWEIGHT AND OBESE
INDIVIDUALS AT INTERMEDIATE CARDIOVASCULAR (CV) RISK
F. Perego, B. Porta, E. Renesto, M. Arquati, L. Zocchi, G. Casazza, P.G.
Duca, M. Cortellaro (Milan, Italy)
48
17.30 - 17.45
EFFECT OF DIFFERENT EXERCISE INTENSITIES ON LONG-TERM
WEIGHT LOSS IN OBESITY
A. Schoeneberger, K. Schmidt (Königstein, Germany)
49
17.45 - 18.00
THE EFFECT OF ACUTE EXERCISE UPON ADIPONECTIN AND
LEPTIN IN OVERWEIGHT SUBJECTS
D. Pop, D. Zdrenghea, L. Procopciuc, M. Cebanu, A. Sitar-Taut
(Cluj-Napoca, Romania)
50
18.00 - 18.15
FAT DISTRIBUTION AND LIPOPROTEIN ASSOCIATED
PHOSPHOLIPASE A2 ACTIVITY IN HEALTHY ADULTS
P. Detopoulou, T. Nomikos, E. Fragopoulou, D. Panagiotakos, C. Pitsavos,
S. Antonopoulou (Athens, Greece)
51
18.15
End of the Session
16.30- 18.25
Thursday OCTOBER 23, 2008
ROOM B
Workshop
NON-PHARMACOLOGICAL APPROACHES AND INTERVENTION
Chairs: A.H. Lichtenstein (Boston, MA, USA)
L. Calabresi (Milan, Italy)
Abstract
Number Ref.:
16.30 - 16.50
PHYSICAL ACTIVITY TO THE TREATMENT AND PREVENTION OF
THE METABOLIC SYNDROME
P. De Feo (Perugia, Italy)
52
16.50 - 17.10
DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
A.H. Lichtenstein (Boston, MA, USA)
424
17.10 - 17.25
REGULATION OF HUMAN STEAROYL-COA DESATURASE BY
OMEGA-3 FATTY ACIDS: IMPLICATIONS FOR THE DIETARY
MANAGEMENT OF METABOLIC SYNDROME
P. Gillies, R.A. Velliquette, J.P. Vanden Heuvel, J.W. Green, G. Zhao,
P.M. Kris-Etherton (Wilmington, DE and University Park, PA, USA)
53
17.25 - 17.40
EFFECT OF FISH OIL SUPPLEMENTATION ON SECONDARY
PREVENTION OF MYOCARDIAL INFARCTION AND MAJOR
ADVERSE CARDIAC EVENTS; A META ANALYSIS
G. Nam, S. Vasan, A. Shah (Torrance, CA, USA)
54
17.40 - 17.55
TRANS10, CIS12 CONJUGATED LINOLEIC ACID INCREASES
INFLAMMATION AND LIPID OXIDATION MARKERS COMPARED
TO CIS 9, TRANS11 CONJUGATED LINOLEIC ACID
T. Tholstrup, M. Raff, E. Straarup, P. Lund, S. Basu, J. Bruun
(Frederiksberg, Lyngby, Denmark, Uppsala, Sweden and Aarhus, Denmark)
55
17.55 - 18.10
ALDOSTERONE RESPONSIVENESS TO LOW SODIUM INTAKE AND
BLOOD PRESSURE REACTIVITY TO ANGIOTENSIN-II INFUSION
ARE UNRELATED TO PLASMA CETP MASS
J.A. Krikken, G.M. Dallinga-Thie, G.J. Navis, R.P.F. Dullaart (Groningen and
Amsterdam, The Netherlands)
56
18.10 - 18.25
ATHEROSCLEROSIS PREVENTION IN POSTMENOPAUSAL WOMEN
WITH THE ISOFLAVONOID-RICH DIETARY SUPPLEMENT KARINAT
I. Sobenin, V. Myasoedova, A. Orekhov (Moscow, Russia)
57
18.25
End of the Session
THURSDAY
Hour:
15
16.00 - 18.05
ROOM C
Workshop
CRITICAL AREAS IN ATHEROSCLEROSIS
Chairs: C. Ehnholm (Helsinki, Finland)
S. Bellosta (Milan, Italy)
Hour:
16
Abstract
Number Ref.:
16.00 - 16.20
SERUM APOLIPOPROTEIN M LEVELS ARE NOT ASSOCIATED WITH
RISK OF CORONARY HEART DISEASE IN TWO INDEPENDENT
PROSPECTIVE CASE-CONTROL STUDIES
C. Ehnholm, J. Ahnhström, O. Axler, M. Jauhiainen, V. Salomaa,
A. Havulinna, R. Frikke-Schmidt, A. Tybjaerg-Hanssen, B. Dahlbäck
(Helsinki, Finland, Malmö, Sweden and Copenhagen, Denmark)
58
16.20 - 16.35
PROTEOMIC OF HUMAN LOW DENSITY LIPOPROTEIN
C. Banfi, M. Brioschi, S. Barcella, R. Wait, E. Tremoli
(Milan, Italy and London, UK)
59
16.35 - 16.50
CHOLESTEROL LOADING INDUCES SMOOTH MUSCLE CELLS
TRANSDIFFERENTIATION TO MACROPHAGES
S. Bellosta, M. Canavesi, A. De Francesco, A. Corsini (Milan, Italy)
60
16.50 - 17.05
REGULATION OF NOTCH SIGNALING IN VASCULAR SMOOTH
MUSCLE CELLS BY ALCOHOL
D. Morrow, W. Liu, J. Cullen, P. Cahill, E. Redmond (Rochester, NY,
USA and Dublin, Ireland)
61
17.05 - 17.20
INCREASED DEGRADATION OF CHOLESTEROL VIA THE ALTERNATE
PATHWAY OF BILE ACID BIOSYNTHESIS IN PRIMARY
HYPERCHOLESTEROLEMIA
M. Bertolotti, M. Del Puppo, C. Gabbi, C. Anzivino, L. Carulli, M. Galli Kienle,
N. Carulli (Modena and Monza, Italy)
62
17.20 - 17.35
DOES THE EFFICACY OF EZETIMIBE/SIMVASTATIN 10/40 MG
DIFFER FROM DOSE-DOUBLING OF DIFFERENT POTENCY STATINS
IN PATIENTS WITH A RECENT CORONARY EVENT?
P. Brudi, J.P.D. Reckless, P. Henry, T. Pomykaj, S.T. Lim, R. Massaad,
K. Vandormael, A.O. Johnson-Levonas (Whitehouse Station, NJ, USA,
Bath, UK, Paris, France, Braunschweig, Germany, Singapore,
Singapore, Brussels, Belgium and Rahway, NJ, USA)
63
17.35 - 17.50
NITRIC OXIDE DONOR AND ANTIOXIDANT HYBRIDS INHIBIT IN
VITRO SMOOTH MUSCLE CELL GROWTH
L. Arnaboldi, V. Nicolini, E. Volpi, A. Tanna, L. Lazzarato, M. Crosetti,
R. Fruttero, A. Gasco, A. Corsini (Milan and Turin, Italy)
64
17.50 - 18.05
DETECTION OF ATHEROSCLEROTIC PLAQUES IN THE APOE
DEFICIENT MOUSE USING NANO TECHNOLOGY AND NEW
IMAGING METHODS - PROJECT NANO-PLAQUE
H. Mangge, S. Haj-Yahya, A. Kratzer, R. Prassl, F. Sinner,
A. Zimmer (Graz, Austria)
65
18.05
End of the Session
8.30 - 10.35
Friday, OCTOBER 24, 2008
ROOM A
Plenary Session
PREVENTION AND TREATMENT OF MULTIPLE RISK FACTORS
Chairs: J.-C. Fruchart (Lille, France)
G. Bittolo Bon (Venice, Italy)
Abstract
Number Ref.:
8.30 - 8.55
A PRACTICAL APPROACH TO THE PATIENT WITH MULTIPLE RISK
FACTORS
F. Crea (Rome, Italy)
66
8.55 - 9.20
PREVENTION OF CARDIOVASCULAR DISEASE WITH A HEALTHY
LIFESTYLE
R.H. Eckel (Aurora, CO, USA)
67
9.20 - 9.45
DIABETES AND OTHER RISK FACTORS
A. Chait (Seattle, WA, USA)
68
9.45 - 10.10
LONG-TERM COMBINATION THERAPY: EFFICACY AND SAFETY
M. Davidson (Chicago, IL, USA)
69
10.10 - 10.35
NEW THERAPEUTIC APPROACHES TO THE INCREASED
MULTIFACTORIAL RISK
C.R. Sirtori (Milan, Italy)
70
10.35
End of the Session
10.35 - 11.00
Coffee Break
FRIDAY
Hour:
17
11.00 - 12.30
ROOM A
Symposium
MEDICAL APPROACHES TO SMOKING CESSATION
Chairs: G. De Backer (Ghent, Belgium)
C. La Vecchia (Milan, Italy)
Hour:
Abstract
Number Ref.:
11.00 - 11.20
SMOKING AND OTHER RISK FACTORS FOR CARDIOVASCULAR
DISEASE: A QUANTIFICATION
C. La Vecchia (Milan, Italy)
11.20 - 11.40
THE HEALTH AND ECONOMIC BENEFITS OF INCREASED SMOKING
CESSATION ACTIVITY BY GENERAL PRACTITIONERS IN EUROPE
D. Cohen, M.F. Alam, S. Groves, P. Jarvis, M. Stead, J. Barendregt
(Pontypridd, Stirling, UK and Brisbane, Australia)
11.40 - 12.10
WHAT HAVE WE LEARNED ABOUT SMOKING CESSATION?
G. De Backer (Ghent, Belgium)
12.10 - 12.30
General Discussion
12.30
End of the Session
71
Addendum
421
–
YOUNG INVESTIGATOR AWARDS
Best Poster Awards
Chair: R. Paoletti (Milan, Italy)
12.30 - 13.00
18
YOUNG INVESTIGATOR AWARDS CEREMONY
The 5 awards will be presented to the winners
–
11.00 - 13.00
ROOM B
Workshop
GENDER PERSPECTIVES
Chairs: A. Pines (Tel Aviv, Israel)
M.G. Modena (Modena, Italy)
Abstract
Number Ref.:
11.00 - 11.20
THE CHALLENGE OF GLOBAL RISK REDUCTION
J.A. Foody (Boston, MA, USA)
72
11.20 - 11.40
FROM ENDOTHELIAL DYSFUNCTION TO SPECIFIC RISK FACTORS:
THE GENDER PERSPECTIVE
M.G. Modena (Modena, Italy)
73
11.40 - 12.00
THE IMPORTANCE OF THE WINDOW OF OPPORTUNITY FOR THE
CARDIOVASCULAR RISK WITH HRT
A. Pines (Tel Aviv, Israel)
74
12.00 - 12.15
MEASUREMENT OF RENAL FUNCTION IN ASYMPTOMATIC
WOMEN: DOES IT ADD INFORMATION BEYOND THE FRAMINGHAM
RISK SCORE AS A PREDICTOR OF RISK OF DEATH?
M. Gulati, H. Black, M. Arnsdorf, A. Al-Hani, G. Bakris (Chicago, IL,
New York, NY, Chicago, IL and Chicago Heights, IL, USA)
75
12.15 - 12.30
THE FAO CORONARY HEART DISEASE (CHD) PREVENTION
PROGRAM: THE GENDER DIFFERENCE IN CALCULATED VERSUS
ESTIMATED RISK
R. Volpe, J. Pille (Rome, Italy)
76
12.30 - 12.45
IMPACT OF GENDER IN PRIMARY PREVENTION OF CORONARY
HEART DISEASE WITH STATIN THERAPY: A META-ANALYSIS
P. Costanzo, M. Petretta, C. Marciano, P. Perrone-Filardi, M. Chiariello
(Naples, Italy)
77
12.45 - 13.00
SQUALENE IN A SEX-DEPENDENT MANNER MODULATES
ATHEROSCLEROTIC LESION WHICH CORRELATES WITH HEPATIC
FAT CONTENT IN APOE- KNOCKOUT MALE MICE
J. Osada, N. Guillen, S. Acin, M.A. Navarro, J.M. Arbones-Mainar, C. Arnal,
I. Orman, J.C. Segovia, V. Ruiz-Gutiérrez (Zaragoza, Madrid and Seville, Spain)
78
13.00
End of the Session
FRIDAY
Hour:
Organized in collaboration with the International Menopause Society (IMS)
19
14.00 - 16.00
ROOM A
Symposium
CONTINUITY OF CARE IN INTERNAL MEDICINE
Chairs: B. Maisch (Marburg, Germany)
G. Vescovo (Vicenza, Italy)
Hour:
Abstract
Number Ref.:
14.00 -14.20
CONTINUITY OF CARE IN THE MULTIPLE RISK DISEASES:
INTRODUCTION
C. Cricelli (Florence, Italy)
–
14.20 -14.40
METABOLIC SYNDROME AND DISEASE MANAGEMENT
R. Nardi (Bologna, Italy)
–
14.40 -15.00
A MODEL OF CONTINUITY OF CARE FOR THE POLYPATHOLOGICAL
FRAIL OLD PEOPLE
G. Baggio, C. Destro, M. Bussolotto, M.C. Corti (Padua, Italy)
–
15.00 -15.20
CARE FOR HEART FAILURE PATIENTS USING NOVEL
CARDIOVASCULAR BIOMARKERS
S.D. Anker (Berlin, Germany)
–
15.20 -15.40
CONTINUITY OF CARE: DISCHARGE CONFERENCE; A
TRANSFERABLE TOOL?
A. Rosenberg (Uppsala, Sweden)
–
15.40 -16.00
General Discussion
–
16.00
End of the Session
16.00 -16.30
Coffee Break
Organized in collaboration with the Italian Federation of Internal Medicine (FADOI)
20
14.00 - 16.00
ROOM B
Symposium
HEALTHY FOOD AND HEALTHY CHOICES:
A NEW EUROPEAN PROFILE APPROACH
Chairs: C. Vögele (London, UK)
S. Borrello (Rome, Italy)
Abstract
Number Ref.:
14.00 -14.05
OPENING REMARKS
S. Borrello (Rome, Italy)
–
14.05 -14.20
HEALTH FOODS AND HEALTHY CHOICES: HOW ARE THE
FRENCH DEALING WITH THIS?
V. Azaïs-Braesco (Ceyrat, France)
14.20 -14.35
UNDERSTANDING THE DECISION MAKING PROCESS IN FOOD
CHOICE: REASON, DRIVE OR LEARNED BEHAVIOUR?
C. Vögele, T. Elbrott (London, UK and Göttingen, Germany)
14.35 -14.50
THE IMPACT OF HEALTHIER FOOD LABELLING IN THE UK - Audio Presentation
P. Scarborough (Oxford, UK)
14.50 -15.05
ASSESSMENT OF NUTRITIONAL PROFILES: BEYOND DICHOTOMY
F. Visioli (Paris, France)
80
15.05 - 15.55
General Discussion
–
15.55 -16.00
CONCLUDING REMARKS
C. Vögele (London, UK)
–
16.00
End of the Session
16.00 -16.30
Coffee Break
Addendum
79
Addendum
FRIDAY
Hour:
21
16.30 - 18.30
ROOM A
Round Table
HEALTH POLICY STRATEGIES
Chairs: L. Bresciani (Milan, Italy)
Hour:
Abstract
Number Ref.:
16.30 - 16.35
OPENING REMARKS
–
16.35 - 16.50
PRIMARY AND SECONDARY CARE: SCENARIO AND NUMBERS:
PATHWAYS, PERFORMANCES, OUTCOMES, ECONOMIC BURDEN
P. Lindgren (Stockholm, Sweden)
–
16.50 - 17.05
PRIMARY AND SECONDARY CARE: STRATEGY OF INTEGRATION OF
COMPETENCES: SYSTEM DEVELOPMENT, QUALITY ASSURANCE,
OBJECTIVES, ACTORS, PROCEDURES, TOOLS AND MONITORING
L. Bresciani (Milan, Italy)
–
17.05 - 17.20
ALLIANCES, PROGRAMMES, AND PROJECTS
• THE PARTNERSHIP FOR THE HEART - ALLIANCES, PROGRAMMES,
AND PROJECTS - INTERDISCIPLINARY ALLIANCES IN CV CONTINUITY
OF CARE
S.D. Anker (Berlin, Germany)
17.20 - 17.35
• THE EXPERIENCE OF ANDALUSIA: AN INTEGRATED APPROACH
FOR CARDIOVASCULAR DISEASES
J.L. Rocha Castilla (Seville, Spain)
–
17.35 - 17.50
• THE EXPERIENCE CALLED “HEARTY PEOPLE”
D. Vanuzzo (Udine, Italy)
–
17.50 - 18.05
• THE CARDIAC CARE CYCLE STRATEGY IN THE VENETO REGION
L. Bertinato (Venice, Italy)
–
18.05 - 18.25
General Discussion
–
18.25 - 18.30
CONCLUDING REMARKS
L. Bresciani (Milan, Italy)
–
18.30
End of the Session
Organized in collaboration with the Health Council of the Lombardia Region
22
–
16.30 - 17.50
ROOM B
Symposium
OMEGA 3 FATTY ACIDS
Chairs: P.C. Calder (Southampton, UK)
C. Galli (Milan, Italy)
Hour:
Abstract
Number Ref.:
16.30 - 16.50
THE LONG CHAIN OMEGA 3 FATTY ACIDS: FROM THE APPEARANCE
IN NATURE TO THE RELEVANCE FOR HUMAN HEALTH
81
16.50 - 17.10
OMEGA-3 FATTY ACIDS, ATHEROSCLEROSIS AND CVD OUTCOME
P.C. Calder (Southampton, UK)
82
17.10 - 17.30
SELECTED MECHANISMS OF THE PROTECTIVE EFFECTS OF OMEGA 3
FATTY ACIDS ON VASCULAR FUNCTIONS
R. De Caterina (Chieti and Pisa, Italy)
420
17.30 - 17.45
General Discussion
–
17.45 - 17.50
CONCLUSIONS AND RECOMMENDATIONS
–
17.50
End of the Session
FRIDAY
Supported in part by an unrestricted educational grant from
Sigma-Tau S.p.A. and Societaʼ Prodotti Antibiotici S.p.A.
23
8.30 - 13.00
Saturday, OCTOBER 25, 2008
ROOM A
Plenary Session
BRIDGING SCIENCE AND HEALTH POLICY IN CVD:
FOCUS ON LIPID MANAGEMENT
THE FACTS
Chairs: D.A. Wood (London, UK)
M. Volpe (Rome, Italy)
Hour:
Abstract
Number Ref.:
8.30 - 8.40
INTRODUCTORY REMARKS
D.A. Wood (London, UK)
–
8.40 - 8.55
THE ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE IN
THE EUROPEAN UNION
J. Leal (Oxford, UK)
83
8.55 - 9.10
CARDIOVASCULAR RISK REDUCTION IN WHOLE POPULATIONS:
ACHIEVEMENTS AND CHALLENGES
J. Critchley, F. Young, D.R. Whiting, N.C. Undwin, S. Capewell
(Newcastle upon Tyne and Liverpool, UK)
84
9.10 - 9.25
CARDIOVASCULAR PREVENTION: A CALL-TO-ACTION TO REDUCE
DISEASE BURDEN
85
THE BARRIERS
Chairs: D.A. Wood (London, UK)
24
9.25 - 9.40
CLINICAL EVIDENCE IN LIPID MANAGEMENT
86
9.40 - 9.55
BARRIERS AND INCENTIVES TO IMPROVING CVD PREVENTION
R. Hobbs (Birmingham, UK)
87
9.55 - 10.45
PANEL DISCUSSION with the following Discussants:
A.L. Catapano (Milan, Italy) - J. Critchley (Newcastle upon Tyne, UK) R. Hobbs (Birmingham, UK) - J. Leal (Oxford, UK) - R. Paoletti (Milan, Italy) M. Volpe (Rome, Italy) - D.A. Wood (London, UK)
Q & A from the floor
–
10.45 - 11.15
Coffee Break
11.15 - 13.00
Saturday, OCTOBER 25, 2008
ROOM A
Plenary Session
BRIDGING SCIENCE AND HEALTH POLICY IN CVD:
FOCUS ON LIPID MANAGEMENT
THE POLICY
Chairs: A. Brady (Glasgow, UK)
I.M. Graham (Dublin, Ireland)
Abstract
Number Ref.:
11.15 - 11.30
COST-EFFECTIVENESS OF LIPID-LOWERING - IMPLICATIONS OF
THE CHANGING ECONOMIC LANDSCAPE
P. Lindgren (Stockholm, Sweden)
88
11.30 - 11.45
CAN BETTER DRUG TREATMENT IMPROVE LONG-RUN FINANCIAL
SUSTAINABILITY OF NHS IN ITALY? THE CASE OF STATINS
V. Atella, F. Bellotti, F. D’Amico (Rome, Italy)
89
11.45 - 12.00
SETTING LEGISLATIVE AND ADMINISTRATIVE POLICY OBJECTIVES AT
EUROPEAN, NATIONAL, AND REGIONAL LEVELS
D. Vanuzzo (Udine, Italy)
427
12.00 - 12.50
PANEL DISCUSSION with the following Discussants:
V. Atella (Rome, Italy) - A. Brady (Glasgow, UK) I.M. Graham (Dublin, Ireland) - P. Lindgren (Stockholm, Sweden) G. Milillo (Rome, Italy) - D. Vanuzzo (Udine, Italy)
Q & A from the floor
–
12.50 - 13.00
SUMMING UP
I.M. Graham (Dublin, Ireland)
–
13.00
End of the Session
SATURDAY
Hour:
25
Palazzo del Casino’ Wednesday, OCTOBER 22 - Thursday, OCTOBER 23 afternoon (14.00)
1 - 15
GROUP A
Posters marked with YIA are competing for the Young Investigator Awards.
Poster Session
EPIDEMIOLOGY OF CARDIOVASCULAR RISK FACTORS
POSTER DISPLAY: for the duration of 11/2 days (Wednesday, October 22 from 9.00 to 18.30 and on Thursday,
October 23 from 8.30 to 14.00). Participants may view the posters displayed during these hours.
POSTER DISCUSSION: one
of the
from
from
from
authors will be available at the poster site as follows:
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
26
Abstract
Number Ref.:
1
HIGH PREVALENCE OF DYSLIPIDEMIA IN HEALTHY SLOVAK PEOPLE
M. Caprnda, A. Dukat, J. Lietava, J.G. Fodor (Bratislava, Slovak Republic
and Ottawa, ON, Canada)
90
2
CHANGES IN CHOLESTEROL LEVELS OVER TIME IN YOUNG ADULTS
M.H. Sayers, D. Bolgiano, S. Eason (Bedford, MA, Fort Worth, TX, Seattle, WA
and Dallas, TX, USA)
91
3
PREVALENCE OF MULTIPLE VS. ISOLATED LIPID DISORDERS IN A
SAMPLE OF SWISS ADULTS
T. Szucs, Y. Tomonaga, A. Roediger, V. Sazonov, B.M. Ambegaonkar (Zurich and
Glattbrugg, Switzerland and New Jersey, NJ, USA)
92
4
ASSOCIATION OF TOTAL CHOLESTEROL AND OTHER CARDIOVASCULAR
RISK FACTORS
A. Lejnieks, A. Kalvelis, G. Bahs, I. Stukena, U. Teibe, A.V. Putnina (Riga, Latvia)
93
5
CORRELATION OF OBESITY INDICATORS WITH OTHER CARDIOVASCULAR
RISK FACTORS
A. Lejnieks, A. Kalvelis, G. Bahs, I. Stukena, U. Teibe, A.V. Putnina (Riga, Latvia)
94
6
RISK OF OBESITY AND ATHEROSCLEROSIS DEPENDING ON THE AGE
P. Hlubik, H. Stritecka, J. Hlubik (Hradec Kralove and Prague, Czech Republic)
95
7
SPECTRUM AND PREVALENCE OF PROTHROMBOTIC SINGLE NUCLEOTIDE
POLYMORPHISM PROFILES IN THE GREEK CYPRIOT POPULATION
S. Xenophontos, M. Hadjivassiliou, N. Ayrton, A. Karagrigoriou, M. Pantziaris,
A.N.Nicolaides, M.A. Cariolou (Nicosia, Cyprus)
96
8
DEMOGRAPHIC VARIABLES AND ENVIRONMENTAL FACTORS ON
HYPERTENSION IN ISLAND LEMNOS GREECE POPULATION
S. Pagoni, C. Voulgari, S. Paximadas (Athens, Greece)
97
98
10
THE EPIMIL COHORT FOLLOW-UP : EFFICIENCY OF MEASURES LEADING TO
LIFESTYLE MODIFICATIONS IN METABOLIC SYNDROME
L. Bordier, C. Garcia, H. Mayaudon, F. Ceppa, O. Dupuy, J.P. Le Berre,
B. Bauduceau (Saint-Mandé, France)
99
11
FREQUENCY OF SEVERE VALVULAR DISEASE CAUSED BY MEDIASTINAL
RADIATION AMONG PATIENTS UNDERGOING VALVE SURGERY IN A
COMMUNITY HOSPITAL
K.A. Copeland, V.R. Hosmane, M.K. Banbury, J.F. Strasser, A.J. Doorey
(Newark, NJ, USA)
100
12
CORONARY ARTERY DISEASE IN YOUNG: RISK AND CLINICAL PROFILE
IN A NORTH INDIAN POPULATION
S. Dwivedi, A. Aggarwal, P. Kumar (Delhi, India)
101
13
CALCULATION OF 10-YEAR CORONARY HEART DISEASE RISK
USING MULTIPLE RISK FACTORS
B. Ezenwaka, E. Nwagbara, D. Seales, F. Okali, S. Hussaini, B. Raja,
A. Jones-LeClointe (St Augustine and Tobago, Trinidad - Tobago)
102
14
FOCUS: MULTIPLE BIOMARKERS FOR THE PREDICTION OF FIRST
MAJOR CARDIOVASCULAR EVENTS AND DEATH: COSTS AND BENEFITS
S. Bianco, A. Bloise, A. De Stefano, A. Monorchio, D. Ugliano, P. Cuccurullo,
M. Cafiero (Naples, Italy)
103
15
DETERMINATION OF CARDIOVASCULAR RISK APPLICABLE WORLDWIDE
C. Cricelli, J.M. Gaziano, J. Angello, C. Brotons, S. Engelen, M. Fisher,
M. Gryszkiewicz, A. Johns, T. Pearson, G. Tognoni (Harvard, MA and Morriston,
FL, USA)
104
WEDNESDAY
COSMO: LOW MEDICATION ADHERENCE AND USE OF LIFESTYLE
MODIFICATIONS AND ALTERNATIVE THERAPIES AMONG
HYPERTENSIVE OLDER ADULTS
M. Krousel-Wood, E. Stanley, D. Morisky, P. Muntner, L. Webber (New Orleans, LA,
Los Angeles, CA and New York, NY, USA)
THURSDAY
9
27
16 - 32
GROUP A
Poster Session
ESTABLISHED AND NEW EMERGING RISK FACTORS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
28
Abstract
Number Ref.:
16
DO WE NEED SPECIAL PREVENTION PROGRAMS ALSO IN A GENERAL
HEALTH-SYSTEM?
M. Hochleitner, A. Bader (Innsbruck, Austria)
105
17
RELATIONSHIP BETWEEN SLEEP APNEA-HYPOPNEA INDEX AND SERUM
MYELOPEROXIDASE MODIFIED LDL
K. Zouaoui Boudjeltia, A. Van Meerhaeghe, M. Dyzma, B. Farhaut, V. Nuyens,
P. Van Antwerpen, J. Ducobu, M. Vanhaeverbeek, D. Brohee, M. Kerkhofs
(Montigny-le-Tilleul and Brussels, Belgium)
106
18
EVALUATION OF A NEW, HIGH SENSITIVE, RAPID TROPONIN I ASSAY
(PATHFAST) IN ACUTE CORONARY SYNDROME PATIENTS OF THE
ATHEROGENE-STUDY
D. Peetz, S. Blankenberg (Mainz, Germany)
107
19
RELATIONSHIP BETWEEN SUBOPTIMAL SELENIUM STATUS AND
SUBCLINICAL HYPOTHYROIDISM IN SAUDI MALES WITHOUT
CORONARY HEART DISEASE
E. Alissa, K. Alshali, G. Ferns (Jeedah, Saudi Arabia and Guildford, UK)
108
20
ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF
FLOW-MEDIATED VASODILATION IN ASYMPTOMATIC, MARKED,
NEVER-TREATED HYPERCHOLESTEROLEMIA
L. Vladimirova-Kitova, D. Terzieva, N. Mateva (Plovdiv, Bulgaria)
109
21
PLASMA ASYMMETRIC DIMETHYLARGININE (ADMA) IS A PREDICTOR OF
INCIDENT CARDIOVASCULAR EVENTS AND MORTALITY IN HIGH AND
LOW RISK POPULATIONS
R. Boeger (Hamburg, Germany)
110
22
COMPARISON OF ADIPOKINES BETWEEN HEALTHY PERSONS WITH
POSITIVE AND NEGATIVE FAMILY HISTORY OF METABOLIC SYNDROME
AND TYPE 2 DIABETES MELLITUS
M. Gajdos, Z. Krivosikova, V. Fedelesova, V. Mongiellova, A. Oksa, K. Gazdikova
(Bratislava, Slovak Republic)
111
112
24
YIA
PERCEIVED MENTAL STRESS AS METABOLIC STRESS IN ELDERLY PEOPLE?
V. Palazzetti, M. Bove, A.F.G. Cicero, I. Georgoulis, G. Guerra, E. Grandi,
A.V. Gaddi (Bologna, Italy)
113
25
METABOLIC SYNDROME IN OBESE CHILDREN: DIET AND EXERCISE WORKS!
J. Hobkirk, S. Carroll, P. Pemberton, P. Gately, J. Barth, R. King (Leeds and
Manchester, UK)
114
26
YIA
CORONARY ARTERY DISEASE AND PERIODONTITIS: IS A CONTRIBUTING
FACTOR? ANALYSIS OF CARDIOVASCULAR RISK MARKER
A. Monteiro, M. Jardini, S. Alves, A. Neto, M. Gidlund (São Paulo and São José
dos Campos, Brazil)
115
27
PREDICTORS OF ACUTE CARDIAC EVENTS IN CORONARY HEART DISEASE
PATIENTS WITH AND WITHOUT CHRONIC INFECTION
T. Kvantaliani, N.S.H. Pargalava, P.A. Tsiklauri (Tbilisi, Georgia)
116
28
FACTORS RELATED TO LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS
WITH PERSISTENT ATRIAL FIBRILLATION
I. Aliakseyeuskaya, I. Karnialiuk, Y. Persidskikh, T. Sevruk, I. Ustinova (Minsk,
Belarus and Belgorod, Russia)
117
29
ATRIAL FIBRILLATION IS A STRONG AND INDEPENDENT PREDICTOR OF
DEATH AND CORONARY EVENTS IN ANGIOGRAPHIED CORONARY PATIENTS
T. Marte, C.H. Saely, F. Schmid, L. Koch, H. Drexel (Feldkirch, Austria and Triesen,
Liechtenstein)
118
30
DO IMAGING BIOMARKERS PROVIDE THE TOOLS WE NEED IN CHD RISK
ASSESSMENT AND CLINICAL TRIALS?
E. De Groot, J.J.P. Kastelein (Amsterdam, The Netherlands)
119
31
LOW LEVELS OF ANTIBODIES AGAINST PHOSPHORYLCHOLINE PREDICT
DEVELOPMENT OF HUMAN CARDIOVASCULAR DISEASE, ESPECIALLY
STROKE IN MEN
J. Frostegard (Huddinge, Sweden)
120
32
LEFT VENTRICULAR EJECTION FRACTION, THE CORONARY ANGIOGRAPHIC
STATE, AND CARDIOVASCULAR RISK IN ANGIOGRAPHIED CORONARY
PATIENTS
C.H. Saely, S. Aczel, T. Marte, P. Rein, A. Vonbank, W. Benzer, H. Drexel (Feldkirch,
Austria and Triesen, Liechtenstein)
121
WEDNESDAY
LEPTIN: ADIPONECTIN RATIO IS AN INDEPENDENT PREDICTOR OF
INTIMA-MEDIA THICKNESS OF THE COMMON CAROTID ARTERY
G. Norata, S. Raselli, L. Grigore, K. Garlaschelli, E. Dozio, P. Magni, A. Catapano
(Milan and Cinisello Balsamo, Italy)
THURSDAY
23
YIA
29
33 - 53
GROUP A
Poster Session
MULTIPLE RISK FACTORS AND BIOMARKERS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
30
Abstract
Number Ref.:
33
RISK FACTORS ASSOCIATED WITH CORONARY ATHEROSCLEROSIS
IN YOUNG MEN
S. Pokrovsky, M. Ezhov, O. Afanasieva, E. Trukhacheva, A. Lyakishev
(Moscow, Russia)
122
34
MYOCARDIAL INFARCTION PATIENTS SHOWED ALTERED LIPOPROTEIN
COMPOSITIONS COMPARED WITH ANGINA PECTORIS PATIENTS
K. Cho, D. Shin, S. Baek, J. Kim (Gyeongsan and Daegu, South Korea)
123
35
CHANGES IN STRUCTURE-FUNCTIONAL CHARACTERISTICS OF
ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
M. Kruchinina, S. Kurilovich, A. Gromov, A. Rabko, V. Generalov, T. Bakirov,
V. Ricter, D. Semenov (Novosibirsk, Russia)
124
36
PLASMA PROTEOMICS IDENTIFIES SPECIFIC SET OF PROTEIN(S) ASSOCIATED
WITH ACS
M. Khullar, A. Sharma, Y.P. Sharma, K.K. Talwar (Chandigarh, India)
125
37
CLINICAL ACCURACY OF SOLUBLE TWEAK IN THE PREDICTION OF
CORONARY ARTERY DISEASE
Z. Jelic-Ivanovic, N. Bujisic, S. Spasic, V. Spasojevic-Kalimanovska
(Belgrade, Serbia)
126
38
ALANINE AMINOTRANSFERASE AND GAMMA GLUTAMYL TRANSFERASE
ARE ASSOCIATED WITH THE METABOLIC SYNDROME BUT NOT WITH
ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS
C.H. Saely, A. Vonbank, P. Rein, S. Beer, M. Woess, S. Aczel, V. Jankovic, C. Boehnel,
L. Risch, H. Drexel (Feldkirch, Austria and Triesen, Liechtenstein)
127
39
NO SYNTHESIS IMPAIRMENT AND HOMOCYSTEINE IN ACUTE CORONARY
DISEASE
I. Squellerio, F. Veglia, G. Marenzi, F. Minardi, M. Amato, E. Tremoli, V. Cavalca
(Milan, Italy)
128
40
HYPOADIPONECTINEMIA AND INCREASED C-REACTIVE PROTEIN RELATED
TO THE PROGRESSION OF ACUTE CORONARY SYNDROME
E. Paltseva, A. Rodina, D. Andreev, E. Ponomar, D. Gusev, S. Severin, A. Syrkin
(Moscow, Russia)
129
130
42
ISCHEMIA MODIFIED ALBUMIN AND HIGH-SENSITIVITY C-REACTIVE
PROTEIN IN CORONARY ATHEROSCLEROSIS
K. Kazanis, M. Dalamaga, C. Nounopoulos, A.S. Manolis, I. Antonellis, G. Jullien,
A. Dionyssiou-Asteriou (Athens, Greece)
131
43
INTERACTIONS OF GENETIC MARKERS OF INFLAMMATION AND MULTIPLE
RISK FACTORS IN CAD (CORONARY ARTERY DISEASE)
C. Boiocchi, C. Falcone, S. Bozzini, A. Pirotta, M. Cuccia (Pavia, Italy)
132
44
YIA
PREDICTIVE VALUE OF CORONARY ARTERY STENOSES AND C-REACTIVE
PROTEIN LEVELS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski (Oviedo, Guadalajara,
Alicante, Spain and London, UK)
133
45
OXIDATIVE STRESS IN PATIENTS SUBJECTED TO CABG SURGERY AS
ASSESSED BY GLOBAL INDEX (OXY-SCORE)
F. Veglia, I. Squellerio, E. Sisillo, A. Parolari, F. Minardi, E. Tremoli,
V. Cavalca (Milan, Italy)
134
46
NT-PROBNP, BUT NOT BNP, IS INCREASED IN PATIENTS WITH SEVERE OBESITY
R. Marius, M. Popescu, A. Toadere (Oradea, Romania)
135
47
B-TYPE NATRIURETIC PEPTIDE CONCENTRATIONS IN ONE ELITE POTHOLER
DURING AN IMMERSION IN A SIPHON PLACED ON THE BOTTOM OF A
CAVE OF 350 M DEPTH
E. Stenner, P. Grassi, W. Micheli, G. Delbello, B. Biasioli (Trieste, Italy)
136
48
CARDIAC AUTONOMIC NERVOUS RESPONSE TO EXTREME AND AMATEUR
POTHOLING PERFORMED IN SOLITARY
E. Stenner, A. Accardo, T. Princi (Trieste, Italy)
137
49
YIA
SERUM IGFBP-1: AN IMPROVEMENT OVER HOMA2 AND QUICKI IN THE
ASSESSMENT OF INSULIN SENSITIVITY SCREENING FOR NON-DIABETIC
SUBJECTS
A. Borai, C. Livingstone, H. Zarif, G. Ferns (Guildford, UK and Jeddah, Saudi Arabia)
138
50
YIA
A COMPARATIVE STUDY OF INSULIN RESISTANCE BETWEEN SAUDI AND
CAUCASIAN POPULATIONS ACROSS ALL GLYCAEMIC CATEGORIES USING
IGFBP-1 AND OTHER INDICES
A. Borai, C. Livingstone, H. Zarif, S. Mehata, M. Kholeif, M. Abdelaal, H. Ghamdi,
G. Ferns (Guildford, UK and Jeddah, Saudi Arabia)
139
51
CHRONIC VENOUS INSUFFICIENCY IS ASSOCIATED WITH ELEVATED
LEVEL OF CIRCULATING MICROPARTICLES
A. Georgescu, N. Alexandru, D. Popov, M. Amuzescu, M. Nemecz, C. Zamfir,
H. Maniu, A. Badila (Bucharest, Romania)
140
52
THE ANTIVASOCONSTRICTOR EFFECT OF RESVERATROL IN RAT
PORTAL VEIN
D. Protic, H. Heinle, J. Cvejic, M. Prostran, Lj. Gojkovic Bukarica (Belgrade,
Serbia and Tubingen, Germany)
141
53
CHANGES OF LIPID LEVELS AFTER ADMINISTRATION
EZETIMIBE/SIMVASTATIN
S. Paximadas, S. Pagoni, C. Voulgari (Athens, Greece)
142
WEDNESDAY
VALUES OF C-REACTIVE PROTEIN ALONG WITH BNP INCREASE WHEN
ACUTE PULMONARY CORD OCCURS AT A NUMBER OF 60 PATIENTS
L. Lazar, A. Lazar, M. Rus, F. Tarlea, F. Marcu (Oradea, Romania)
THURSDAY
41
31
54 - 84
GROUP A
Poster Session
DYSLIPIDEMIA
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
32
Abstract
Number Ref.:
54
CORRELATIONS OF HUMAN APOLIPOPROTEIN AV WITH BLOOD LIPID
AND MECHANISM OF TNF-α DOWN-REGULATING APOLIPOPROTEIN AV
EXPRESSION
S. Zhao, S. Hu, M. Hu (Changsha, China)
143
55
REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY BY
INSULIN AND STERIODS IN MODEL CELL CULTURE SYSTEM
G. Ramakrishnan, N.C. Chandra (New Delhi, India)
144
56
LIVER X RECEPTOR AGONIST T0901317 INCREASES CHOLESTEROL
EXCRETION FROM THE BRAIN IN C57/BL6 MICE BY UP-REGULATING
NPC1 EXPRESSION
X. Ou, Z.J. Zhou, J.H. Zou, X.M. Bi, Z.J. Huang, Q.Y. Zhang, Y.T. Tang, X.H. Zhou,
Z.H. Wu, C.K. Tang (Shaoguan, Hengyang, China)
145
57
YIA
DEVELOPMENT OF DIFFERENTIAL PLASMA CHOLESTEROL DIAGNOSIS
USING A COMPUTATIONAL MODEL
D.B. van Schalkwijk, K. van Bochove, L.M. Havekes, B. van Ommen, A. Freidig
(Zeist and Leiden, The Netherlands)
146
58
THE DISTURBANCE OF POSTPRANDIAL TRIGLYCERIDE ELIMINATION THE RISK FACTOR OF CORONARY HEART DISEASE (CHD) IN WOMEN
WITH POLYCYSTIC OVARIES SYNDROME
T. Zykova, A. Strelkova, K. Balandina, L. Uledeva (Arkhangelsk, Russia)
147
59
SMALL DENSE LIPOPROTEINS AMONG NEW DIAGNOSED PATIENTS WITH
CARDIOVASCULAR DISEASES
A. Dukat, S. Oravec, M. Caprnda, I. Vacula, P. Gavornik (Bratislava, Slovak Republic)
148
60
MAGNITUDE OF DYSLIPIDEMIA AND ITS ASSOCIATION WITH MICRO
AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DIABETES:
A HOSPITAL BASED STUDY FROM BIKANER (NORTH WEST INDIA)
R. Agrawal, P. Sharma, S. Jain, N. Mohta, A. Kochar, D.K. Kochar (Bikaner, India)
149
61
PREDICTIVE VALUE OF LIPID PROFILE IN PATIENTS WITH ACUTE
CORONARY SYNDROME- A TAIWANESE COHORT STUDY
K. Wang, C. Ting (Taichung, Taiwan)
150
151
63
QUESTIONARY OF PERCEPTION OVER CLINICAL APPROACHES IN
DYSLIPEMIA. CHOLESTEROL SPAIN STUDY
M. Villaescusa Pedemonte, A. Martinez Pastor, J.A. Alarcón Gonzalez,
M. Leal Hernández, R. Soler Garcia, M. Gomez Ruiz (Murcia, Spain)
152
64
REASONS FOR NON-COMPLIANCE WITH LIPID LOWERING MEDICATION
P. Kardas (Lodz, Poland)
153
65
THE EFFECTS OF MULTIPLE LIPID GOAL ATTAINMENT ON CARDIOVASCULAR
EVENTS AND COSTS
S. Webb, R.J. Simko, M.J. Cziraky, R. Quimbo, S. Sarawate (Abbott Park, IL and
Wilmington, DE, USA)
154
66
INSUFFICIENT DOSES OF STATINS AS THE CAUSE OF INADEQUATE
CONTROL OF HYPERCHOLESTEROLAEMIA IN POLAND. RESULTS OF THE
3ST-POL STUDY
M. Naruszewicz, A. Mamcarz, K. Filipiak, J. Siebert (Warsaw and Gdansk, Poland)
155
67
LIPID-LOWERING DRUGS FOR PREVENTION AND TREATMENT OF
CORONARY HEART DISEASE
B. Georgiev, N. Gotcheva, V. Baytcheva, I. Ivanov, M. Hazan (Sofia, Bulgaria)
156
68
A MODEL-BASED ANALYSIS OF THE EFFECTS OF INTENSIFYING
LIPID-ALTERING
R. Simko, B. Zhang, M. Friedman, S. Charland, R. Burge (Abbott Park, IL,
Waltham, MA and Denver, CO, USA)
157
69
EFFECTS OF INTENSIFYING LIPID-ALTERING THERAPY ON CHD EVENTS IN A
SECONDARY PREVENTION POPULATION WITH HIGH NON-HDL CHOLESTEROL
R. Simko, J. Menzin, B. Zhang, S. Charland, R. Burge (Abbott Park, IL, Waltham,
MA and Denver, CO, USA)
158
70
EFFECTS OF PRAVASTATIN AND ATORVASTATIN ON THE HDL CHOLESTEROL
AND GLUCOSE METABOLISM IN PATIENTS WITH HYPERCHOLESTEROLEMIA
AND GLUCOSE INTOLERANCE
J. Sasaki, M. Aeta (Fukuoka and Nichinan, Japan)
159
71
AORTIC STIFFNESS AND INFLAMMATORY MARKER ARE DECREASED IN
PATIENTS WITH ACUTE CORONARY SYNDROME BY USING HMG CO-A
REDUCTASE INHIBITORS
J. Kim, K. Jeong, S. Lee, Y. Chai, K. Lee, S. Park (Daejeon, South Korea)
160
72
EFFICACY AND SAFETY OF INTERMITTENT REGIMEN ON COMBINED USE
OF FENOFIBRATE AND STATINS IN PATIENTS WITH UNSTABLE ANGINA
A. Shek, R. Kurbanov, S. Aminov (Tashkent, Uzbekistan)
161
73
EFFFECT OF TREATMENT WITH RIMONABANT, ALONE OR COMBINED WITH
FENOFIBRATE OR EZETIMIBE, ON METABOLIC PARAMETERS IN OBESE
DYSLIPIDEMIC PATIENTS
M. Florentin, E.N. Liberopoulos, C.V. Rizos, V. Tsimihodimos, C. Derdemezis,
M.S. Elisaf (Ioannina, Greece)
162
74
USE OF EZETIMIBE IN PATIENTS WITH UNSTABLE ANGINA AND INTOLERANCE
OF STATINS
A. Shek, R. Kurbanov, S. Aminov, M. Mavlyanova (Tashkent, Uzbekistan)
163
WEDNESDAY
LIPID PREDICTORS OF CARDIOVASCULAR EVENTS IN STATIN-TREATED
CORONARY PATIENTS WITH DIABETES MELLITUS
C.H. Drexel, S. Aczel, T. Marte, A. Vonbank, C.H. Saely (Feldkirch, Austria and Triesen,
Liechtenstein)
THURSDAY
62
33
34
75
EFFECTS OF DEMOGRAPHIC AND BASELINE LIPID/METABOLIC FACTORS ON
EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) IN TYPE 2 DIABETES
(T2DM) PATIENTS
R. Goldberg, J. Guyton, T. Mazzone, R. Weinstock, A. Polis, J. Tomassini, A. Tershakovec
(Miami, FL, Durham, NC, Chicago, IL, Syracuse, NY and N. Wales, PA, USA)
164
76
EZETIMIBE/SIMVASTATIN COMPARED WITH ATORVASTATIN OR ROSUVASTATIN
IN LOWERING BOTH LDL-C AND NON-HDL-C, (TOTAL-C/HDL-C), APO B,
(APO B/APO A-1), OR CRP
A.L. Catapano, M.H. Davidson, N. Abate, C.M. Ballantyne, X. Xu, J. Lin, E. Rosenberg,
A.M. Tershakovec (Milan, Italy, Chicago, IL, Dallas, TX, Houston, TX and N. Wales, PA, USA)
165
77
CRP AND LDL-C RESPONSE TO EZETIMIBE MONOTHERAPY AND ADDED-ON
TO BASELINE STATIN THERAPY
C. Ballantyne, T. Pearson, E. Veltri, A. Shah, S. Bird, J. Lin, E. Rosenberg, A. Tershakovec
(Houston, TX, Rochester, NY, Kenilworth, NJ and N. Wales, PA, USA)
166
78
EFFICACY AND SAFETY OF COMBINATION NIACIN EXTENDED-RELEASE
AND SIMVASTATIN (NER/S) COMPARED TO ATORVASTATIN (AT) IN SUBJECTS
WITH MIXED DYSLIPIDEMIA
R. Thakkar, W. Insull, J. Basile, A. Vo, P. Jiang, R. Padley (Abbott Park, IL, Houston, TX,
Charleston, SC and Long Beach, CA, USA)
167
79
RATES OF DRUG DISCONTINUATION DUE TO FLUSHING ARE GENERALLY
LESS THAN 6% DURING LIPID THERAPY WITH PROPRIETARY NIACIN
EXTENDED-RELEASE FORMULATIONS
R. Thakkar, E. Brinton, A. Vo, M. Kashyap, R. Padley, J. Salon, P. Jiang
(Abbott Park, IL, Salt Lake City, UT and Long Beach, CA, USA)
168
80
HISTORY OF ASPIRIN USE PRIOR TO INITIATION OF COMBINATION NIACIN
EXTENDED-RELEASE & SIMVASTATIN THERAPY REDUCES FLUSHING-RELATED
DISCONTINUATION RATES
R. Padley, E. Brinton, A. Vo, M. Kashyap, R. Thakkar, R. Parreno
(Abbott Park, IL, Salt Lake City, UT and Long Beach, CA, USA)
169
81
ATTAINMENT OF LIPID TARGETS AFTER NIACIN EXTENDED RELEASE/SIMVASTATIN
(NER/S) OR ATORVASTATIN (AT) TREATMENT IN PATIENTS WITH MIXED
DYSLIPIDEMIA
W. Insull, J. Basile, A. Vo, P. Jiang, R. Thakkar, R. Padley (Houston, TX, Charleston,
SC, Long Beach CA and Abbott Park, IL, USA)
170
82
COMBINATION NIACIN EXTENDED-RELEASE AND SIMVASTATIN (NER/S)
TREATMENT FOR 12 WEEKS REDUCED CALCULATED CARDIOVASCULAR
RISK MORE THAN ATORVASTATIN (AT)
W. Insull, J. Basile, A. Vo, D. Yang, R. Thakkar, R. Padley (Houston, TX, Charleston,
SC, Long Beach, CA and Abbott Park, IL, USA)
171
83
COMBINATION THERAPY FOR MIXED DYSLIPIDEMIA AND ITS EFFECTS ON
MULTIPLE LIPIDS: NIACIN EXTENDED RELEASE + STATIN VERSUS
EZETIMIBE + STATIN
H. Superko, J. McKenney, P. Jiang, R. Thakkar, R. Padley (Atlanta, GA, Richmond, VA
and Abbott Park, IL, USA)
172
84
EFFECT OF BASELINE CHARACTERISTICS ON LIPOPROTEIN(A) REDUCTION
FOLLOWING TREATMENT WITH COMBINATION NIACIN EXTENDED-RELEASE
AND SIMVASTATIN
H. Superko, R. Thakkar, C. Lovell, R. Padley (Atlanta, GA and Abbott Park, IL, USA)
173
85 - 119
WEDNESDAY
GROUP A
Poster Session
ATHEROSCLEROSIS AND THROMBOSIS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
Abstract
Number Ref.:
85
EFFECTS OF PROTEIN KINASE C ACTIVITY ON ADHESION REACTION OF
ENDOTHELIAL CELLS WITH MONOCYTES
Z.Q. Wang, L.H. Li, W.X. Zhao, J. Cui, W. Su, X. Dong (Xinxiang, China)
174
86
YIA
PRO-ANGIOGENIC ACTIVITY OF HDL3 AND SPHINGOSINE 1-PHOSPHATE
REQUIRES THE SYNERGIC ACTIVATION OF CLASS IB AND CLASS II
PHOSPHATIDYLINOSITOL 3-KINASES
G. Tibolla, G.D. Norata, R. Piñeiro, T. Maffucci, M. Falasca, A.L. Catapano
(Milan and Cinisello Balsamo, Italy and London, UK)
175
87
YIA
EFFECT OF HDL SIZE AND PHOSPHOLIPID CONTENT ON CELLULAR
CHOLESTEROL EFFLUX
G. Stomeo, E. Favari, L. Calabresi, M.P. Adorni, G. Franceschini, W. Jessup, F. Bernini
(Parma, Milan, Italy and Sydney, Australia)
176
88
IDENTIFICATION OF FUNCTIONAL DOMAINS IN APOLIPOPROTEIN AI INVOLVED
IN EFFLUX OF CHOLESTEROL ATP-BINDING CASSETTE A1 MEDIATED USING
MONOCLONAL ANTIBODIES
P. Uboldi, A. Pirillo, L. Imbrici, S. Marcovina, A.L. Catapano (Milan, Italy and Seattle, WA, USA)
177
89
YIA
POTENTIAL MECHANISM OF PROBUCOL-MEDIATED CUTANEOUS XANTHOMA
REDUCTION: IN VITRO STUDIES
S. Costa, M.P. Adorni, E. Favari, I. Zanotti, A. Granata, A. Corsini, A. Ronda, R. Gatti,
F. Bernini (Parma and Milan, Italy)
178
90
EXPRESSION OF CAVEOLIN 1 IN HYPERLIPIDEMIC HAMSTERS AND
ENDOTHELIAL DERIVED FOAM CELLS
E. Uyy, L. Ivan, R. Haraba, F. Antohe (Bucharest, Romania)
179
91
YIA
EFFECTS OF OXLDL ON THE HUMAN DENDRITIC CELL (DC) PHENOTYPE AND
RECEPTION CAPACITY
A. Monteiro, A. Azevedo, J. Barbuto, M. Gidlund (São Paulo, Brazil)
180
92
YIA
EFFECTS OF ESTRADIOL IN HLA-DR AND CD11C EXPRESSION AND
PHAGOCYTIC ACTIVITY BY HUMAN MONOCYTE-DERIVED DENDRITIC
CELLS TREATED WITH OXLDL
A. Azevedo, A. Monteiro, M. Gidlund, J. Barbuto (São Paulo, Brazil)
181
THURSDAY
35
36
93
TADALAFIL REDUCES ENDOTHELIAL CELLS INFLAMMATORY RESPONSE
INDUCED BY MYELOPEROXIDASE MODIFIED LDL (MOX-LDL)
K. Zouaoui Boudjeltia, T. Roumeguere, A. Rousseau, V. Nuyens, P. Van Antwerpen,
J. Ducobu, M. Vanhaeverbeek, D. Brohee, E. Wespes (Montigny-le-Tilleul, Brussels
and Charleroi, Belgium)
182
94
15-LIPOXYGENASE-MODIFIED HDL3 FAIL TO INHIBIT THE TNF-A-INDUCED
INFLAMMATORY RESPONSE IN HUMAN ENDOTHELIAL CELLS
A. Pirillo, P. Uboldi, C. Bolego, H. Kuhn, A.L. Catapano (Milan and Padua, Italy
and Berlin, Germany)
183
95
COPPER- BUT NOT HOCL-MODIFIED LOW DENSITY LIPOPROTEINS
ACCUMULATE HIF-1α PROTEIN IN THP-1 MACROPHAGES UNDER NORMOXIA
H. Laggner, S. Schreier, M. Moser, H. Goldenberg (Vienna, Austria)
184
96
ACTIVE MYELOPEROXIDASE IS DETECTED IN CAROTID ATHEROSCLEROTIC
LESION BY A NEW METHOD OF MEASUREMENT AND CORRELATES WITH
TOTAL LEVEL OF THE ENZYME
O. Gach, T. Frank, S. Derochette, G. Deby-Dupont, S. Vanbelle, L. Pierard, V. Legrand
(Liege, Belgium)
185
97
GENERATION OF HYDROGEN PEROXIDE BY NEUTROPHILS AND OXIDATIVE
LIPOPROTEIN MODIFICATION OF BLOOD FROM PATIENTS WITH UNSTABLE
ANGINA
I. Buko, I.V. Gorudko, L.Z. Polonetsky, S.N. Cherenkevich (Minsk, Belarus)
186
98
YIA
NITRIC OXIDE INHIBITION ENHANCES CYCLOOXYGENASE-2 INDUCTION
IN SMOOTH MUSCLE CELLS THROUGH MODULATION OF PHOSPHORYLATION
SIGNALLING EVENTS
B. Lamon, A. Gotto, D. Hajjar (New York, NY, USA)
187
99
FIBRILLAR COLLAGEN INHIBITS CHOLESTEROL BIOSYNTHESIS IN HUMAN
AORTIC SMOOTH MUSCLE CELLS
N. Ferri, E. Roncalli, L. Arnaboldi, A. Corsini (Milan, Italy)
188
100
YIA
EFFECT OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A ON LIPID
METABOLISM, TNF-ALPHA PRODUCTION AND SMOOTH MUSCLE CELL
PROLIFERATION
A. De Francesco, S. Bellosta, B. Viviani, F. Gilardi, M. Canavesi, N. Mitro, E. Scotti,
C. Godio, A. Corsini, M. Crestani (Milan, Italy)
189
101
SERUM ATHEROGENICITY REDUCTION AS A TOOL FOR ATHEROSCLEROSIS
PREVENTION AND TREATMENT
I. Sobenin, A. Orekhov (Moscow, Russia)
190
102
YIA
THE FIRST REPORT OF THE TREATMENT OF TRANSPLANT CORONARY
ARTERY DISEASE WITH DSA LIPID APHERESIS
R. Sosland, S. Gollub, P. Moriarty (Kansas City, KS, USA)
191
103
ARTERIAL PULSE AGAINST ATHEROSCLEROSIS
M. Beraia, G. Nebieridze (Tbilisi, Georgia)
192
104
FINGER-PRICK TESTING AT THE POINT-OF-CARE WITH SUPERIOR
ANALYTICAL PERFORMANCE USING MAGNETIC PARTICLE LABELS
N. Kahya, W. Dittmer, T. Evers, R. Kamps, P. de Kievit, W. Hardeman, J. Vissers,
J. de Beer, D. Dekkers, M. Martens (Eindhoven and Wijchen, The Netherlands)
193
105
ASSOCIATION BETWEEN LDL SUBCLASSES AND CAROTID INTIMA-MEDIA
THICKNESS IN CORONARY ARTERY DISEASE
S. Alabakovska, D. Labudovic, K. Tosheska, S. Jovanova, M. Alabakovski, B. Todorova
(Skopje, Macedonia)
194
195
107
BENEFICIAL EFFECT OF PREINFARCTION ANGINA ON VENTRICULAR
ARRHYTHMIAS IN PATIENTS AFTER PRIMARY ANGIOPLASTY
E. Lykasova, Y. Pak, V. Todosiychuk, V. Kuznetsov (Tyumen, Russia)
196
108
THE MIAMI STUDY (MARKERS OF INFLAMMATION AND ATORVASTATIN
EFFECT IN PREVIOUS MYOCARDIAL INFARCTION): RESULTS OF A
PROSPECTIVE, MULTICENTER STUDY
B. Porta, D. Baldassarre, M. Camera, M. Amato, M. Arquati, E. Tremoli, M. Cortellaro,
F. Perego (Milan, Italy)
197
109
BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS
FROM HUMAN ABDOMINAL AORTIC ANEURYSM
R. Ballerio, F. Boschetti, R. Spirito, S. Bellosta, A. De Francesco, M. Canavesi,
E. Di Martino, E. Tremoli, M. Camera (Milan, Italy and Pittsburgh, PA, USA)
198
110
YIA
HEAT SHOCK PROTEIN AND ANTIBODY RESPONSE TO CHLAMYDIA
PNEUMONIAE IN CORONARY ATHEROTHROMBOSIS
I. Burazor, A. Vojdani, M. Burazor (Nis, Serbia, and Los Angeles, CA, USA)
199
111
DETERMINATION OF THE PLATELET SENSITIVITY TO ANTIPLATELET
THERAPY AND THE ROLE OF OTHER BLOOD CELLS IN IT
L. Buryachkovskaya, I. Uchitel, A. Sumarokov, E. Popov (Moscow, Russia)
200
112
GPIIB ILE843SER GENOTYPE INFLUENCES ANTI-PLATELET EFFECTS
OF ASPIRIN
M. Brambilla, K. Gertow, P. Bogani, M. Camera, F. Veglia, M.C. Nava, D. Villa,
E. Tremoli, J.P. Werba (Milan, Italy)
201
113
MECHANISM OF THROMBOSIS INITIALIZATION WITH ATHEROSCLEROSIS;
MATHEMATICAL MODEL
M. Khanin, N. Malysh (Moscow, Russia)
202
114
MATHEMATICAL MODELING OF ACTIVATION DYNAMICS OF BIOCHEMICAL
SYSTEMS AS A METHOD OF SEEKING FOR OPTIMAL TREATMENT STRATEGIES
M. Khanin, N. Malysh (Moscow, Russia)
203
115
LABORATORY METHODS FOR ASSESSING COAGULATION AND PLATELET
AGGREGATION INDUCED BY THE PHYSIOLOGICAL RELEVANT ACTIVATOR
COLLAGEN/TISSUE FACTOR
G. Cvirn, J. Kutschera, T. Wagner, U. Ferstl, G. Juergens, M. Koestenberger (Graz, Austria)
204
116
FIBRIN SPECIFICITY CONFERRED ON THE PLASMINOGEN/PLASMIN SYSTEM
BY FREE FATTY ACIDS
K. Kolev, A. Tanka-Salamon, R. Machovich (Budapest, Hungary)
205
117
LEFT VENTRICULAR ANEURYSM AND ENDOTHELIUM-DEPENDENT
HEMOSTASIS IN PATIENTS WITH CHRONIC HEART FAILURE
K. Khmelnitskaya, E.V. Shlyakhto, M.Y. Sitnikova (Saint-Petersburg, Russia)
206
THE INFLUENCE OF COMBINED STREPTOKINASE AND ALPROSTADYL ON
THROMBOLYSIS ON REPERFUSION AND HAEMOSTASIS INDICES DYNAMICS
IN MYOCARDIAL INFARCTION
L. Polonetsky, V. Mironchik, S. Latyshev, T. Denisevich, O. Truhan (Minsk, Belarus)
207
PLATELETS RELATED TO THROMBOSIS AND FIBRINOLYSIS
S. Sarkar (Boston, MA, USA)
208
118
119
WEDNESDAY
ULTRASONOGRAPHIC FEATURES OF THE CAROTID ARTERIES AND RISK
FACTORS FOR STROKE IN PATIENTS UNDERGOING OPEN HEART SURGERY
M. Menih (Maribor, Slovenia)
THURSDAY
106
37
120 - 145
GROUP A
Poster Session
METABOLIC SYNDROME AND CARDIOMETABOLIC RISK
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
38
Abstract
Number Ref.:
120
ALGORITHM FOR DEFINITION OF METABOLIC SYNDROME BY TREATMENT
MODALITY
R. Feinman, E. Fine, J. Volek (Brooklyn, NY, Bronx, NY and Storrs, CT, USA)
209
121
METABOLIC SYNDROME (MS) IS USEFUL IN IDENTIFYING STRATEGIES OF
CARDIOVASCULAR PREVENTION? IN WHAT POPULATIONS?
E. Capuano, V. Capuano, T. D’Arminio, I. Bellacosa, F. Franculli
(Mercato San Severino, Italy)
436
122
YIA
MEASUREMENT OF TRIGLYCERIDES IN CAPILLARY BLOOD: VALIDATION IN
COMPARISON TO BLOOD MEASUREMENT
A. Alegría, A. Cordero, J. Moreno, M. Rodriguez, E. Alegria (Pamplona, Spain)
210
123
LIVER LIPID PROFILING IN THE CHOLESTEROL-FED RABBIT MODEL OF FATTY
LIVER DISEASE
L. Arnaboldi, A. Balsamo, D. Sartirana, A. Corsini, R. Baetta (Milan, Italy)
211
124
METABOLIC SYNDROME IN THE CZECH POPULATION
M. Tomeckova, H. Grünfeldova, J. Peleska, P. Hanus, M. Sedova
(Prague and Caslav, Czech Republic)
212
125
THE PREVALENCE OF THE METABOLIC SYNDROME IN TYPE 2 DIABETIC
PATIENTS IN TWO CARIBBEAN ISLANDS
C. Ezenwaka, E. Nwagbara, D. Seales, F. Okali, S. Hussaini, B. Raja (St Augustine
and Tobago, Trinidad - Tobago)
213
126
YIA
PREVALENCE OF METABOLIC SYNDROME AMONG CARDIOLOGY
PATIENTS IN BATUMI, GEORGIA
B. Gelaye, N. Dolidze, D. Enquobahrie, G. Chapidze, A. Fitzpatrick, M. Williams
(Seattle, WA, USA, Tbilisi, Georgia and Boston, MA, USA)
214
127
DETERMINANTS OF THE METABOLIC SYNDROME IN A MEDITERRANEAN
POPULATION: LARGE WAIST CIRCUMFERENCE IS THE BEST PREDICTOR
OF THE METABOLIC SYNDROME
G. Mombelli, A.M. Zanaboni, S. Gaito, C.R. Sirtori (Milan, Italy)
215
216
129
THE ROLE OF COMPONENTS OF METABOLIC SYNDROME ACCORDING
TO THE RESULTS OF TWO - EPIDEMIOLOGICAL AND CLINICAL - STUDIES
W. Piotrowski, M. Polakowska (Warsaw, Poland)
217
130
METABOLIC SYNDROME: CORRELATION OF BMI AND CENTRAL TYPE OBESITY
V. Nikolaou, I. Tsiafoutis, X. Crinos, I. Papadakis, L. Papadimitriou, E. Dimitriou,
A. Tsakiris (Athens, Greece)
218
131
RELATIONSHIP BETWEEN HOMA INDEX, GLYCOHEMOGLOBIN, METABOLIC
SYNDROME CRITERIA AND CORONARY ANGIOGRAPHY RESULTS IN
NON-DIABETIC PATIENTS
S. Ertek, M. Cesur, A.F. Cicero, M. Akcil, U. Avcioglu, M.E. Korkmaz (Ankara, Turkey
and Bologna, Italy)
219
132
PLASMA ADIPONECTIN CONCENTRATIONS AND ABNORMALITIES OF LEFT
VENTRICULAR FUNCTION IN PATIENTS WITH METABOLIC SYNDROME
L. Kedenko, V. Grin, I. Kedenko, B. Paulweber (Salzburg, Austria and Donetsk, Ukraine)
220
133
ENDOTHELIN-1, TNF-ALPHA AND VASOMOTOR DYSFUNCTION IN METABOLIC
SYNDROME PATIENTS WITH INSULIN RESISTANCE
P. Tretjakovs, A. Jurka, I. Bormane, I. Mikelsone, L. Balode, D. Reihmane, A. Stifts,
J.I. Aivars, V. Pirags (Riga, Latvia)
221
134
CORONARY ARTERY CALCIUM AND METABOLIC SYNDROME: IMPAIRED
FASTING GLUCOSE VERSUS NORMAL BLOOD GLUCOSE
G. Vincentelli, M.R. Pirro, P. Di Renzi, P. Pasqualetti, D. Maggi, F. Alegiani (Rome, Italy)
222
135
LIPID PEROXIDATION IN PATIENTS WITH METABOLIC SYNDROME: RELATION
TO DYSGLYCAEMIA
N. Kravchun, I. Karachencev, V. Poltorak, N. Krasova, M. Gorshunska, Z. Leshchenko,
A. Gladkin (Kharkiv, Ukraine)
223
136
YIA
SERUM INTERLEUKIN-16 LEVELS IN PATIENTS WITH METABOLIC SYNDROME
AND DIABETES MELLITUS
I. Kondratska, S. Melnichenko, B. Mankovsky, K. Zak (Kyiv, Ukraine)
224
137
SERUM URIC ACID IS ASSOCIATED WITH METABOLIC SYNDROME, BUT NOT
INDEPENDENTLY WITH ARTERIAL STIFFNESS IN KOREAN SUBJECTS
Y.K. Kim, S.H. Na, Y.S. Kim, M.Y. Rhee, M.M. Lee (Goyang, South Korea)
225
138
THYROID STIMULATING HORMONE AND COMPONENTS OF METABOLIC
SYNDROME AMONG OUTPATIENT CARDIOVASCULAR PATIENTS IN GEORGIA
N. Dolidze, B. Gelaye, D. Enquobahrie, G. Chapidze, M.A. Williams (Tbilisi, Georgia,
Seattle, WA and Boston, MA, USA)
226
139
CARDIO-METABOLIC COMPLICATIONS OF SUBCLINICAL
HYPOTHYROIDISM IN WOMEN WITH METABOLIC SYNDROME
V. Romanov, O. Mitchenko, I. Chulaevskaya, A. Logvinenko (Kiev, Ukraine)
227
140
THE LOWERING OF SMALL DENSE LDL IN PATIENTS WITH THE
METABOLIC SYNDROME BY SIMVASTATIN/EZETIMIBE VERSUS
FLUVASTATIN/FENOFIBRATE
S. Westphal, C. Abletshauser, K. Borucki, H. Klima, C. Luley (Magdeburg, Nuernberg
and Penzberg Germany)
228
WEDNESDAY
IMPORTANCE OF METABOLIC SYNDROME AS A RISK FACTOR OF
MYOCARDIAL INFARCTION
M. Tanaka (Fukuoka, Japan)
THURSDAY
128
39
40
141
YIA
EXPRESSION OF ADIPONECTIN RECEPTORS IN SUBJECTS WITH IMPAIRED
GLUCOSE HOMEOSTASIS - EFFECT OF ACUTE HYPERINSULINEAMIA AND
3-WEEK TELMISARTAN TREATMENT
E. Krusinova, K. Zidkova, P. Wohl, P. Mlejnek, L. Kazdova, M. Pravenec, T. Pelikanova
(Prague, Czech Republic)
229
142
CHANGES OF PLASMA LEPTIN LEVELS AND CARDIOMETABOLIC RISK
FACTORS DURING THE WEIGHT LOSS WITH ORLISTAT IN COMBINATION WITH
HYPOCALORIC DIET
E. Stokic (Novi Sad, Serbia)
230
143
ANTIHYPERTENSIVE TREATMENT WITH BETA-BLOCKERS IN THE METABOLIC
SYNDROME
A.M. Carella, G. Antonucci, M. Conte, M. Di Pumpo, E. Antonucci (San Severo, Italy)
231
144
ADULT TREATMENT PANEL III METABOLIC SYNDROME CRITERIA MORE
STRONGLY THAN INTERNATIONAL DIABETES FEDERATION CRITERIA
PREDICT THE INCIDENCE OF TYPE 2 DIABETES IN ANGIOGRAPHIED
CORONARY PATIENTS
C.H. Saely, A. Vonbank, P. Rein, S. Beer, S. Aczel, T. Marte, H. Drexel
232
145
YIA
METABOLIC SYNDROME AND CORONARY HEART DISEASE RISK
CHARACTERISTICS IN SEVERE AND PERSISTENTLY MENTALLY ILL
S. Kaushik, R. Shrivastava, A. Khan, S. Kaushik, J.P. Lindenmayer
(New York, NY and Shreveport, LA, USA)
233
146 - 153
WEDNESDAY
GROUP A
Poster Session
PREVENTION OF MULTIPLE RISK FACTORS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
Abstract
Number Ref.:
146
YIA
DIETARY VITAMINS INTAKE ON CZECH FORCES SOLDIERS
H. Stritecka, H. Hlubik, J. Psutka (Hradec Kralove, Czech Republic)
234
147
LONGITUDINAL FOLLOW UP (15 YEARS) STUDY OF THE TREND OF
NUTRITION OF THE 1% RANDOM SAMPLE OF POPULATION OF A
DISTRICT OF CENTRAL BOHEMIA
V. Adamkova, P. Suchanek, V. Lanska, J. Stochlova, R. Cifkova (Prague and Ceske
Budejovice, Czech Republic)
235
148
YIA
PROGRESSION OF CEREBRAL DAMAGE IN PATIENTS WITH SEVERE
ARTERIAL HYPERTENSION ON ANTIHYPERTENSIVE AND STATIN THERAPY
G. Radchenko, Y.U. Sirenko (Kyiv, Ukraine)
236
149
DEVELOPMENT OF A QUESTIONNAIRE DESIGNED TO MEASURE ADHERENCE
TO SECONDARY CVD PREVENTION STRATEGIES IN POST-MI PATIENTS:
THE ACT PILOT STUDY
A. Zaninelli, D. Schwappach (Florence, Italy and Zurich, Switzerland)
237
150
MULTIDISCIPLINARY SELF-MANAGEMENT OF RISK FACTORS FOR HEART
FAILURE
C. Smith (Kansas City, MO, USA)
238
151
PHARMACOLOGICAL AND NON PHARMACOLOGICAL RECOMMENDATIONS
GIVEN TO ACUTE CORONARY SYNDROMES PATIENTS - COMPARISON OF
UNIVERSITY AND DISTRICT HOSPITALS
A. Serafin, K.J. Filipiak, G. Opolski (Warsaw, Poland)
239
152
YIA
AFTER PTCA: IS THERE JUSTIFIED THE INITIATION OF A
COMPREHENSIVE CARDIOVASCULAR REHABILITATION PROGRAM?
S. Mancas, C.A. Sarau, D.M. Duda-Seiman, V.A. Ionescu, P. Dehelean, S. Urseanu,
L. Craciun (Timisoara, Romania)
240
153
VARIABLE RESPONSES IN POSTPRANDIAL LIPOPROTEIN AND
INFLAMMATORY RESPONSES IN THE METABOLIC SYNDROME, AND
RESPONSE TO FENOFIBRATE THERAPY
R. Rosenson, I. Helenowski, C. Tangney (Ann Arbor, MI and Chicago, IL, USA)
241
THURSDAY
41
154 - 155
GROUP A
Poster Session
ANTIATHEROSCLEROTIC DRUGS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
42
Abstract
Number Ref.:
154
WARNING: GREEN TEA MAY AFFECT SIMVASTATIN TOLERABILITY
P.J. Werba, M. Giroli, V. Cavalca, M.C. Nava, E. Tremoli (Milan, Italy)
242
155
SEPARATED AND COMBINED STATIN - FIBRATE THERAPY EFFECTS ON
VARIOUS ATHEROTHROMBOTIC RISK FACTORS, INCLUDING PHOSPHOLIPASE
A2 IN PATIENTS WITH CORONARY HEART DISEASE
Z. Fras, J. Osredkar, D. Latific Jasnic, N. Ruzic Medvescek, M. Mulej, M.F. Kenda
(Ljubljana and Jesenice, Slovenia)
243
156 - 163
WEDNESDAY
GROUP A
Poster Session
TREATMENT OF MULTIPLE RISK FACTORS
of the
from
from
from
12.30
to 14.00
15.45
to 16.30
12.30
to 14.00
Poster Board
No.:
Abstract
Number Ref.:
156
IS THERE A LINK BETWEEN THE EVOLUTION OF CARDIOVASCULAR
RISK AND PSYCHOSOCIAL FACTORS?
L. Goyer, R. Dufour, J. Dechamplain, C. Janelle, C. Blais, C. Labbe, P. Larochelle
(Montreal, QC, Canada)
244
157
IMPROVING CARDIOVASCULAR HEALTH IN PRIMARY PREVENTION: THE
EDUCOEUR INTERDISCIPLINARY RANDOMIZED CONTROLLED TRIAL
L. Goyer, R. Dufour, J. de Champlain, C. Blais, C. Labbe, C. Janelle, P. Larochelle
(Montreal, QC, Canada)
245
158
SLEEP DISORDERS IN CHRONIC HEART FAILURE
F. Lari, G. Bragagni, N. Di Battista (Bologna and Faenza, Italy)
246
159
ACUTE CHANGES OF CIRCULATING OXIDATIVE STRESS MARKERS IN
PATIENTS UNDERGOING REGULAR APHERESIS: A COMPARISON OF FOUR
DIFFERENT TECHNIQUES
S. Kopprasch, J. Grässler, S.R. Bornstein, P.E.H. Schwarz, S. Tselmin, A. Frind,
I. Poberschin, U. Julius (Dresden, Germany)
247
160
EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT
DEGREE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR G
ACTIVATION ON METABOLIC PARAMETERS
C.V. Rizos, E.N. Liberopoulos, M. Florentin, H.J. Milionis, G. Liamis, M.S. Elisaf
(Ioannina, Greece)
248
161
INFLUENCE OF NEOLIPIDRA ON SERUM LEVELS OF LIPOPROTEIN (a) AND
HOMOCYSTEINE IN HYPERCHOLESTEROLEMIC PATIENTS WITH CORONARY
HEART DISEASE
M. Boncheva, D. Dimov, S. Tomcheva (Varna and Sofia, Bulgaria)
249
162
GROWTH HORMONE (GH) REDUCES ATHEROGENIC RISKS IN PATIENTS WITH
GH DEFICIENCY AND TURNER SYNDROME
H. Kohno, A. Sasaki (Fukuoka, Japan)
250
163
PROVINOLTM IMPROVES HIGHER BRAIN REGULATIONS IN NORMOTENSIVE
SUBJECTS
F. Jagla, O. Pechanova (Bratislava, Slovak Republic)
251
THURSDAY
43
Palazzo del Casinò Friday, OCTOBER 24 - Saturday, OCTOBER 25 afternoon (13.00)
1-9
GROUP B
Poster Session
OBESITY
POSTER DISPLAY: for the duration of 11/2 days (Friday, October 24 from 9.00 to 18.30 and on Saturday,
POSTER DISCUSSION: one of the authors will be available at the poster site as follows:
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
Saturday October 25:
from 10.45
to 11.15
Poster Board
No.:
44
Abstract
Number Ref.:
1
YIA
ANTIOBESE EFFECTS OF SEAWEED ETHANOL EXTRACT CONTAINING
FUCOXANTHIN IN THE C57BL/6J MICE
S. Jeon, M. Woo, H. Kim, G. Do, Y. Shin, M. Choi (Daegu and Jinju, South Korea)
252
2
COFFEE CONSUMPTION IS INVERSELY ASSOCIATED WITH PLASMA
ADIPONECTIN
C. Lee, J. Mok, C. Park, K. Lee, S. Kim, C. Kim, S. Oh, S. Kim, S. Lee, H. Lee
(Guri, Bucheon, Incheon and Seoul, South Korea)
253
3
ASSOCIATION OF SLEEP DURATION WITH BODY MASS INDEX AND WAIST
CIRCUMFERENCE
J. Najafian, Z. Siadat, N. Mohamadifard, G. Sarr, M. Ramazani (Isfahan and Arak, Iran)
254
4
BODY MASS INDEX AND WAIST CIRCUMFERENCE AS PREDICTORS OF THE
INCIDENCE OF TYPE 2 DIABETES AMONG ANGIOGRAPHIED CORONARY
PATIENTS
C.H. Saely, P. Rein, S. Beer, A. Vonbank, T. Marte, S. Aczel, H. Drexel (Feldkirch,
255
5
RISK OF CARDIOVASCULAR DISEASE IN HEALTHY INDIVIDUALS IS CLOSELY
RELATED WITH INCREASED PLASMA LEVELS OF RETINOL BINDING PROTEIN 4
AND VISCERAL ADIPOSE TISSUE
C. Park, S. Oh, Y. Yoon, J. Ko (Seoul and Gyeonggi-Do, South Korea)
256
6
OBESITY, STNFR- I AND ACE GENETIC POLYMORPHISM IN HEART FAILURE
PATIENTS
D. Zdrenghea, D. Pop, G. Bodisz, D. Petrovai, B. Borz (Cluj-Napoca, Romania)
257
7
NON PHARMACOLOGICAL INTERVENTION FOR TREATMENT OF OBESE
SUBJECTS
D. Dobreva, K. Krahtova, M. Protich (Sofia, Bulgaria)
258
8
IMPACT OF WEIGHT CHANGE ON INTIMA MEDIA THICKNESS OF CAROTID
ARTERIES AND ENDOTHELIAL FUNCTION IN OBESE AND OVERWEIGHT
HYPERTENSIVE SUBJECTS
K. Chagunava, G. Lomtatidze, T. Kurtanidze (Tbilisi, Georgia)
259
9
THE IMPACT OF THE GUIDELINES FOR MANAGEMENT OF OBESITY IN
ACUTE CORONARY SYNDROMES
R. Dourado, D. Durão (Ponta Delgada and Santarém, Portugal)
260
10 - 45
GROUP B
Poster Session
DIABETES
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Abstract
Number Ref.:
HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF THE AQUEOUS EXTRACT
OF TERMINALIA SUPERBA IN ALLOXAN DIABETIC RATS
E. Momo Noumessing, G. Dongmo Fomekong, J. Enyong Oben (Yaoundé, Cameroon)
261
11
YIA
ANTIDIABETIC EFFECTS OF RESVERATROL IN C57BL/KSJ-DB/DB MICE
G. Do, H. Park, H. Kim, S. Jeon, M. Choi (Daegu, South Korea)
262
12
THE EFFECTS OF EARLY TREATMENT WITH INSULIN GLARGINE ON
METABOLIC MARKERS IN OBESE TYPE 2 DIABETES ANIMAL MODEL
J. Mok, C. Park, K. Lee, S. Kim, C. Kim, C. Lee (Bucheon, Seoul, Incheon, and
Guri, South Korea)
263
13
EDTA PROTECT HUMAN’S PANCREATIC B-CELLS OF DEATH CAUSED BY
8-OXYQUINALDIN, A DIABETOGENIC METABOLITE OF TRYPTOPHAN
A.G. Meyramova, G.G. Meyramov, A.A. Kikimbaeva, J.G. Meyramova (Karaganda,
Kazakhstan)
264
14
DEATH OF HUMAN’S B-CELLS CAUSED BY 5-META(HYDROXYPHENYLAZO)-8OXYQUINOLIN AND ITS PREVENTION
G.G. Meyramov, A.G. Meyramova, G.T. Tusupbekova, J.G. Meyramova,
O.N. DuPont-Meyramova (Karaganda, Kazakhstan)
265
15
GLUTATHIONE ANTIOXIDANT SYSTEM IN PATIENTS WITH DIABETES MELLITUS
L.S. Kolesnichenko, T.P. Bardymova, E.S. Sergeeva, M.P. Sergeeva, N.V. Verlan,
I.V. Belousova (Irkutsk, Russia)
266
16
L. Sokolova Djokic, S. Martinovic, B. Prosenica (Sombor, Serbia)
267
17
YIA
ESTIMATION OF CARDIOVASCULAR RISK IN A LOCAL POPULATION OF
DIABETIC PATIENTS
E. Pellegrini, M.S. Simonini, M. Maurantonio, I.M. Giannico, R. D’Amico,
D. Ganazzi, L. Carulli, P. Loria, M. Bertolotti, N. Carulli (Modena, Italy)
268
FRIDAY
10
YIA
SATURDAY
Poster Board
No.:
45
46
18
OBESITY AND DIABETES MELLITUS TYPE 2: PREVALENCE AND ASSOCIATION
WITH OTHER RISK FACTORS FOR CARDIOVASCULAR COMPLICATIONS
J. Kovacevska, B. Aleksov, E. Jakimovska (Dusseldorf, Germany, Skopje,
Macedonia and Paris, France)
269
19
YIA
MANAGEMENT OF DIABETES MELLITUS IN PRIMARY CARE: SITUATION IN
LITHUANIA
A. Domeikiene, L. Valius, L. Gedminas (Kaunas, Lithuania)
270
20
ETHNIC ASPECTS OF DIABETES MELLITUS OF TYPE 1 IN PATIENTS OF BURYAT
POPULATION
T. Bardymova, I. Dedov, L. Kolesnikova (Irkutsk and Moscow, Russia)
271
21
YIA
CARDIOMETABOLIC RISK FACTORS IN WOMEN WITH TYPE 2 DIABETES
I. Burazor, M. Brazor, M. Krstic, N. Burazor, Z. Burazor, J. Glasnovic, S. Nagorni,
S. Antic, M. Pesic, G. Cvetanovic (Nis, Serbia)
272
22
HORMONAL-METABOLIC PROFILES OF DYSLIPIDAEMIAS IN NON-OBESE
TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSIS
V. Anestiadi (Chisinau, Moldova)
273
23
GENDER-SPECIFIC RELATIONSHIP BETWEEN CIRCULATING LEPTIN AND
INSULIN RESISTANCE PARAMETERS IN TYPE 2 DIABETIC PATIENTS WITH
METABOLIC SYNDROME
M. Gorshunska, N. Krasova, I. Karachencev, E. Jansen, N. Kravchun, V. Poltorak
(Kharkiv, Ukraine and Bilthoven, The Netherlands)
274
24
YIA
THE RELATIONSHIP BETWEEN SOLUBLE RECEPTOR FOR ADVANCED
GLYCATION END-PRODUCTS AND PRO/ANTIATHEROGENIC PARAMETERS IN
OBESE TYPE 2 DIABETIC PATIENTS
M. Gorshunska, N. Krasova, I. Karachencev, E. Jansen, N. Kravchun, V. Poltorak
275
25
HIGH PLASMA C-REACTIVE PROTEIN IS RELATED TO LOW PARAOXONASE-I
ACTIVITY INDEPENDENTLY OF HIGH LEPTIN AND LOW ADIPONECTIN IN
TYPE 2 DIABETES
R.P.F. Dullaart, R. de Vries, W.J. Sluiter, H.A.M. Voorbij (Gröningen and Utrecht,
The Netherlands)
276
26
SERUM TOTAL HOMOCYSTEINE LEVELS ARE ASSOCIATED WITH NT-PROBNP
IN PATIENTS WITH TYPE 2 DIABETES
B. Idzior-Walus, M. Walus-Miarka, B. Katra, D. Fedak, E. Wozniakiewicz, J. Sieradzki
(Krakow, Poland)
277
27
IMPAIRED GLUCOSE TOLERANCE STRONGLY AND SIGNIFICANTLY INCREASES
THE RISK OF FUTURE VASCULAR EVENTS AMONG ANGIOGRAPHIED
CORONARY PATIENTS
H. Sourij, C.H. Saely, S. Aczel, H. Jahnel, R. Zweiker, P. Langer, T. Marte, W. Benzer,
T.C. Wascher, H. Drexel (Feldkirch, Graz, Austria and Triesen, Liechtenstein)
278
28
PREDICTION MODEL FOR HIGH GLYCATED HEMOGLOBIN CONCENTRATION
AMONG ETHNIC CHINESE
K. Chien, H. Hsu, B. Lee, H. Lin, Y. Lee, M. Chen (Taipei, Taiwan)
279
29
A NOVEL LABORATORY-BASED APPROACH TO SUPPORT PATIENTS WITH
DIABETES: HEMOGLOBIN A1C TESTING COMPLIANCE WITH CANADIAN
DIABETES ASSOCIATION GUIDELINE
P. Ganske, G. Hoag (Victoria, BC, Canada)
280
30
CONTROL OF RISK FACTORS IN HEART FAILURE DIABETIC MELLITUS TYPE II
PATIENTS
K. Vitlianovaz, T. Donova, S. Tsonev (Sofia, Bulgaria)
281
282
32
YIA
CLINICAL PREDICTORS OF ULCERS’ HEALING OF LOW EXTREMITIES IN
PATIENTS WITH DIABETIC FOOT SYNDROME (DFS)
T.A. Zykova, R. Seljelid, S.N. Zykova, K.A. Balandina, A.V. Strelkova (Arkhangelsk,
Russia and Tromso, Norway)
283
33
TYPE 2 DIABETES BUT NOT THE CORONARY ANGIOGRAPHIC STATE IS AN
INDEPENDENT DETERMINANT OF IMPAIRED MOBILITY IN ANGIOGRAPHIED
CORONARY PATIENTS
C.H. Saely, T. Dyballa, P. Rein, S. Beer, A. Vonbank, H. Drexel (Feldkirch, Austria and
Triesen, Liechtenstein)
284
34
YIA
FIVE YEAR PROGNOSIS IN PATIENTS, WHO WERE TREATED IN SPECIALIZED
HYPERTENSIVE UNIT, WITH DIABETES MELLITUS OR INCREASED SERUM
GLUCOSE LEVEL
G. Radchenko, Yu. Sirenko (Kyiv, Ukraine)
285
35
ANTIHYPERTENSIVE THERAPY EFFICIENCY IS IMPACT ON THE
CARDIOVASCULAR COMPLICATIONS FREQUENCY AT TYPE 2 DIABETES
PATIENTS WITH METABOLIC SYNDROME
O. Zemlyanitsyna, N. Kravchun, T. Grinchenko, T. Levchenko, T. Tikhonova
(Kharkov, Ukraine)
286
36
EFFECT OF A SINGLE BOUT OF MODERATE EXERCISE ON GLUCOSE
UPTAKE IN TYPE 2 DIABETES MELLITUS
H. Adachi, H. Kan, J. Murakami, T. Ohno, M. Oguri, S. Oshima (Maebashi, Japan)
287
37
EFFECTS OF MEDITERRANEAN-STYLE DIET ON OXIDATIVE STRESS AND
LOW-GRADE INFLAMMATION IN TYPE 2 DIABETIC PATIENTS
N. Kravchun, M. Gorshunska, I. Karachencev, N. Krasova, E. Jansen, V. Poltorak
288
38
YIA
BLOOD GLUCOSE-LOWERING EFFECTS OF CHUNGKUKJANG AND RED
GINSENG-CHUNGKUKJANG IN MILD HYPERGLYCEMIC SUBJECTS
S. Shin, J. Kwon, Y. Jeong, S. Jeon, H. Kim, J. Choi, G. Do, M. Choi (Daegu, South Korea)
289
39
EFFECT OF THYROXIN AND STATIN THERAPY ON LIPID METABOLISM IN
TYPE 2 DIABETIC PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM
G.R. Kurashvili, R. Kurashvili, L. Tsutskiridze, E. Shelestova (Tbilisi, Georgia)
290
40
POSITIVE EFFECTS OF REPLACEMENT OF INSULIN TREATMENT BY ORAL
ANTIDIABETICS ON SOME RISK FACTORS OF CARDIOVASCULAR DISEASES
IN OBESE TYPE 2 DIABETICS
M. Szabó, P. Peliskova, M. Matous, E. Novotna, M. Kvapil (Prague, Czech Republic)
291
41
EFFECT OF ANGIOTENSIN-II-RECEPTOR BLOCKERS ON DEVELOPMENT OF
DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES
L. Tsutskiridze, R. Kurashvili, G. Kurashvili, E. Shelestova, M. Dundua,
M. Nishnianidze, E. Skhiladze, T. Gvaladze (Tbilisi, Georgia)
292
42
SITAGLIPTIN DECREASES C-REACTIVE PROTEIN, MONOCYTE CHEMOTACTIC
PROTEIN-1, MYELOPEROXIDASE ACTIVITY AND INTERLEUKIN-6 IN DIABETICS
WITH ATHEROSCLEROSIS
L. Tan, S. Tan (Yucaipa, CA, USA)
293
FRIDAY
PREVALENCE AND PROGNOSTIC VALUE OF DIABETES IN PATIENTS
UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
A. De Monte, A. Perkan, G. Vitrella, S. Rakar, L. Cattin, G. Sinagra (Trieste, Italy)
SATURDAY
31
47
48
43
THE EFFECT OF A LOW GLYCEMIC INDEX DIET ON MARKERS OF
CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES
C.W.C. Kendall, A.R. Josse, J.M.W. Wong, J. Sievenpiper, D.J.A. Jenkins
(Toronto, ON, Canada)
294
44
FRUCTOSE’S EFFECT ON LIPIDS DEPENDS ON THE REFERENCE
CARBOHYDRATE, DOSE, AND FOLLOW-UP IN TYPE 2 DIABETES: A
META-ANALYSIS OF CONTROLLED TRIALS
J.L. Sievenpiper, A.J. Carleton, H.Y. Jiang, R.J. De Souza, C.W. Kendall,
D.J. Jenkins (Toronto, ON, Canada and Boston, MA, USA)
295
45
PULSES AS PART OF HIGH-FIBRE INTERVENTIONS FOR GLYCEMIC
CONTROL: A META-ANALYSIS OF CONTROLLED TRIALS
J.L. Sievenpiper, C.W. Kendall, R.P. Bazinet, J.M. Wong, A. Esfahani,
D.J Jenkins (Toronto, ON, Canada)
296
46 - 62
GROUP B
Poster Session
HYPERTENSION
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
46
THE NOVEL GASEOUS VASORELAXANT HYDROGEN SULFIDE INHIBITS
ANGIOTENSIN-CONVERTING ENZYME (ACE) ACTIVITY OF ENDOTHELIAL
CELLS
H. Laggner, M. Hermann, H. Esterbauer, M. Muellner, M. Exner, B.M.K. Gmeiner,
S. Kapiotis (Vienna, Austria)
297
47
NITRIC OXIDE - ITS PERIPHERAL AND CENTRAL EFFECTS
O. Pechanova (Bratislava, Slovak Republic)
298
48
THE COMPARABLE EFFECT OF L-NAME AND SALT DIET ON BLOOD
PRESSURE AND NITRIC OXIDE ACTIVITY IN THE HEART AND AORTA
O. Pechanova, S. Vrankova, L. Jendekova, F. Jagla (Bratislava, Slovak Republic)
299
49
MODULATION OF OXIDATIVE STRESS MARKERS BY ESTRADIOL IN
PREECLAMPSIA AND PROLONGATED PREGNANCY
S. Markovic, G. Babic, N. Djordjevic, B. Ognjanovic, A. Stajn, R. Zikic, Z. Saicic
(Kragujevac and Belgrade, Serbia)
300
50
ACTIVITY OF THE ANTIOXIDANT ENZYMES AND MARKERS OF OXIDATIVE
STRESS IN THE BLOOD OF PATIENTS WITH ARTERIAL HYPERTENSION
A. Dimitrova, S. Tisheva, A. Russeva, T. Betova, I. Gencheva, D. Strashimirov
(Pleven, Bulgaria)
301
51
YIA
MEASURES OF ADIPOSITY, PLASMA LIPIDS AND BIOMARKERS AMONG
HYPERTENSIVES IN GEORGIA
B. Gelaye, N. Dolidze, D. Enquobahrie, G. Chapidze, M. Williams (Seattle, WA,
Boston, MA, USA and Tbilisi, Georgia)
302
52
CLINICAL IMPLICATIONS OF WHITE-COAT EFFECT AMONG PATIENTS
ATTENDING AT A LIPID CLINIC
M. Bo, M. Comba, A. Canade, A. Brescianini, L. Corsinovi, M.A. Astengo, A. Sona,
G. Fonte, L. Pricop, V. Chiusano, I. Sciarrillo (Turin, Italy)
434
53
THE CORRELATION BETWEEN ARTERIAL STIFFNESS AND LEFT VENTRICULAR
DIASTOLIC FUNCTION IN THE PATIENTS WITH HYPERTENSION
L. Agoston-Coldea, T. Mocan, R. Pais, D.L. Dumitrascu (Cluj-Napoca, Romania)
303
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
49
50
54
RISK FACTORS IN CARDIOVASCULAR DISEASES
S. Martinovic, L. Sokolova Djokic, B. Prosenica (Sombor, Serbia)
304
55
RISK FACTORS IN THE PATIENTS WITH ARTERIAL HYPERTENSION AND
CEREBROVASCULAR COMPLICATIONS
A. Khodjaev, M. Shakirov, N. Salimova, N. Mahkamova, F. Sarmanov
(Tashkent, Uzbekistan)
305
56
PREVALENCE AND TREATMENT OF HYPERTENSION IN POLISH POPULATION
M. Polakowska, W. Piotrowski, A. Tykarski, B. Wyrzykowski, M. Kwasniewska,
A. Pajak, M. Tendera (Warsaw, Poland)
306
57
THE TREATMENT OF ESSENTIAL HYPERTENSION IN CHILDREN AND
ADOLESCENTS
R. Manasia, C. Lazea, D. Colcear (Cluj-Napoca, Romania)
307
58
THE ROLE OF BLOOD PRESSURE WHEN TREATING ACUTE
CORONARY SYNDROMES
D. Durão, R. Dourado (Santarém and Ponta Delgada, Portugal)
308
59
MANAGEMENT OF 427 EPISODES OF DECOMPENSATED CHRONIC
HEART FAILURE ATTENDED BY A HOSPITAL-AT-HOME TEAM
J. Guillamont-Salvador, M. Sopena-Vallejo, I. Bonilla-Aguilar, C. Davila-Lara
(Hospitalet Llobregat, Spain)
309
60
TELEMETRIC CONTROLLED TITRATION OF HIGH DOSE IRBESARTAN IN
UNADEQUATELY TREATED HYPERTENSION
E. Schulz, L. Neumann, A. Schwarz, N. Fischer, A. Wolf, U. Korth, M.H. Weber
(Goettingen and Stolberg, Germany)
310
61
COMPARISON OF EFFICACY AND TOLERABILITY OF ANGIOTENSIN TYPE 1
RECEPTORS BLOCKERS IN PATIENTS WITH ESSENTIAL HYPERTENSION
T. Morozova, T. Andrushishina (Moscow, Russia)
311
62
YIA
EFFECTS OF ESTRADIOL ON ANTIOXIDATIVE ENZYME ACTIVITIES IN
ERYTHROCYTE IN WOMEN WITH PREECLAMPSIA
N. Djordjevic, G. Babic, S. Markovic, B. Ognjanovic, A. Stajn, R. Zikic, Z. Saicic
(Kragujevac and Belgrade, Serbia)
312
63 - 67
GROUP B
Poster Session
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
63
PROTEIN AND GENE EXPRESSION OF HIGH MOBILITY GROUP BOX 1 IN
HYPERLIPIDEMIC MODELS
R. Haraba, L. Ivan, V. Suica, F. Antohe (Bucharest, Romania)
313
64
ACTIVATED PLATELETS INTERNALIZE VIRUSES IN PATIENTS WITH
INFLAMMATORY DILATED CARDIOMYOPATHY.
E. Gupalo, L. Buryachkovskaya, A. Sumarokov (Moscow, Russia)
314
65
THE METABOLIC SYNDROME, ANGIOGRAPHICALLY DETERMINED STABLE
CORONARY ARTERY DISEASE, AND SUBCLINICAL INFLAMMATION
S. Beer, P. Rein, C.H. Saely, A. Vonbank, H. Drexel (Feldkirch, Austria and Triesen,
Liechtenstein)
315
66
DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS IN ACUTE VIRAL
MYOCARDITIS IN CHILDREN
C. Lazea, R. Manasia, P. Grigorescu-Sido, C. Lazar, C.L. Denes (Cluj-Napoca, Romania)
316
67
YIA
A CASE OF INTRAPERICARDIAL INJECTION OF LORNOXICAM IN PATIENTS
WITH POSTPERICARDIOTOMY SYNDROME
N. Lomakin, A. Gruzdev, D. Privalov (Moscow, Russia)
317
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
51
68 - 70
GROUP B
Poster Session
HEART AND OTHER ORGANS
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
52
Abstract
Number Ref.:
68
A COMPARISON OF CARDIAC INVOLVEMENT IN CHRONIC HEPATITIS
VERSUS HEPATIC CIRRHOSIS
L.C. Dima Cozma, D. Radulescu, C. Dascalu, C. Ghiciuc, C. Lupusoru, G.I. Pandele
(Iasi, Romania)
318
69
PLAQUES IN THE COMMON CAROTID ARTERY ARE INDEPENDENT
PREDICTORS OF ANGIOGRAPHICALLY DETERMINED CORONARY
ATHEROSCLEROSIS
P. Rein, T. Kathrein, A. Vonbank, C.H. Saely, S. Beer, H. Drexel (Feldkirch, Austria
and Triesen, Liechtenstein)
319
70
EFFECT OF GLYCEMIC CONTROL ON CARDIAC DIASTOLIC FUNCTION IN
PATIENTS WITH ISCHEMIC HEART DISEASE
H. Kan, H. Adachi, J. Murakami, H. Hoshizaki, S. Oshima (Maebashi, Japan)
320
71 - 76
GROUP B
Poster Session
STROKE
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Abstract
Number Ref.:
HOMOCYSTEINE AND ACUTE CEREBROVASCULAR EVENTS
B. Zazzaro, G. Cascone, E. Valvo, R. Risicato, E. Vasques, C. Arcoraci,
M. Stornello (Siracusa, Italy)
321
72
CORRELATION BETWEEN LIPIDS, INFLAMMATORY MARKERS, SOME
322
PARAMETERS OF HEMEOSTASIS AND CAROTID ARTERIES
ATHEROSCLEROTIC LESIONS IN PATIENTS WITH STROKE
M. Akhvlediani, E. Vorobiova, M. Emukhvari, N. Sharasidze, D. Berulava (Tbilisi, Georgia)
73
ETHNIC DIFFERENCES IN ISCHEMIC STROKE HOSPITAL PRESENTATION
AMONG WOMEN
M. Smith, L. Morgenstern, L. Lisabeth (Ann Arbor, MI, USA)
323
74
NADROPARIN FOR STROKE PREVENTION AFTER CARDIOVERSION IN
PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
I. Korneluk, Y. Persidskikh, I. Alekseevskaja, O. Sugaeva, I. Ustinova (Belgorod and
Minsk, Belarus)
324
75
EARLY EFFECT OF STATIN ON INFLAMMATORY MARKERS IN ACUTE
ISCHEMIC STROKE
Y. Kim, E. Kim (Seoul and Busan, South Korea)
325
76
MULTIPLE LIPID FRACTION TARGET LEVEL AND ISCHEMIC STROKE EVENTS
S. Webb, R. Quimbo, M. Cziraky, S. Balu, R. Simko (Abbott Park, IL and Wilmington,
DE, USA)
326
FRIDAY
71
SATURDAY
Poster Board
No.:
53
77 - 86
GROUP B
Poster Session
RENAL DISEASES
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
54
Abstract
Number Ref.:
77
THE DIAGNOSIS OF RENAL ARTERY STENOSIS - AN EVERPRESENT
PROBLEM
R. Motoc, C. Motoc, M.I. Laszlo, I. Silivastru, L. Cozlea (Targu Mures, Romania)
327
78
VENTRICULAR ARRHYTHMIAS AND AUTONOMIC NEUROPATHY IN
HEMODIALYSIS PATIENTS
M. Krotin, B. Todic, B. Milovanovic, A. Djokovic, M. Zaja (Belgrade, Serbia)
328
79
ALBUMINURIA, THE GLOMERULAR FILTRATION RATE, AND
P. Rein, C.H. Saely, L. Risch, S. Beer, A. Vonbank, U. Neyer, H. Drexel (Feldkirch,
329
80
DECREASING KIDNEY FUNCTION PREDICTS VASCULAR EVENTS
INDEPENDENTLY FROM THE GLOMERULAR FILTRATION RATE AT
BASELINE: A PROSPECTIVE COHORT STUDY
P. Rein, C.H. Saely, L. Risch, T. Marte, S. Aczel, S. Beer, U. Neyer, H. Drexel
330
81
DETERMINANTS OF SHORT- AND LONG-TERM SURVIVAL IN PREVALENT
W. Mantovani, V. Bedogna, S. Tardivo, A. Poli, N. Tessitore (Verona, Italy)
331
82
IMPACT OF NUTRITIONAL ADVICE ON DYSLIPIDEMIA AND LIPID
PEROXIDATION IN CHRONIC RENAL FAILURE PATIENTS
K. Mekki, A. Boukaddoum, N. Bekada-Bouzidi, A. Kaddous, M. Bouchenak
(Oran, Algeria)
332
83
THE EFFECT OF N-3 FATTY ACIDS ON HOMOCYSTEINE LEVELS IN
HYPERHOMOCYSTEINAEMIC PATIENTS UNDERGOING CHRONIC
HEMODIALYSIS
L. Rasmussen, M. Svensson, E.B. Schmidt, J.H. Christensen (Aalborg, Denmark)
333
334
85
EFFECT OF NANDROLONE DECANOATE ON THE SERUM LEVELS OF
LIPOPROTEIN(A) AND TRIGLYCERIDES IN HEMODIALYSIS PATIENTS
N. Rashtchizadeh, A. Ghorbanihaghjo, H. Argani, M. Rohbaninoubar, A. Vatankhah
(Tabriz, Iran)
335
86
NEPHROPROTECTIVE ROLE OF COMBINED VALSARTAN - FLUVASTATIN
THERAPY IN CRF PATIENTS
L. Di Lullo, R. Addesse, C. Comegna, C. Galderisi, G.R. Iannacci, F. Floccari,
P. Polito (Tivoli, Italy)
336
FRIDAY
THE EFFECT OF ZINC SUPPLEMENTATION ON PARAOXONASE ACTIVITY IN
A. Ghorbanihaghjo, N. Rashtchizadeh, H. Argani, M. Rohbaninoubar, J. Safa,
A. Vatankhah, B. Rahimi (Tabriz, Iran)
SATURDAY
84
55
87 - 93
GROUP B
Poster Session
PERIPHERAL VASCULAR DISEASE
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
56
Abstract
Number Ref.:
87
ANKLE-BRACHIAL INDEX IS AN INDEPENDENT PREDICTOR OF
P. Rein, T. Kathrein, A. Vonbank, S. Beer, C.H. Saely, H. Drexel (Feldkirch, Austria
337
88
IMPLICATIONS OF ROUTINELY MEASURING ANKLE-BRACHIAL INDEX (ABI)
AMONG PATIENTS ATTENDING AT A LIPID CLINIC
M. Bo, A. Sona, M. Comba, A. Brescianini, L. Corsinovi, M. Zanocchi, G. Fonte,
M.A. Astengo, A. Canade, L. Pricop, V. Chiusano, I. Sciarrillo (Turin, Italy)
435
89
HIGH PREVALENCE OF ABNORMAL GLUCOSE METABOLISM IN PATIENTS
WITH SONOGRAPHICALLY DIAGNOSED PERIPHERAL ARTERIAL DISEASE
P. Rein, S. Beer, T. Kathrein, C.H. Saely, A. Vonbank, H. Drexel (Feldkirch, Austria
338
90
CAROTID ENDARTERECTOMY OR STENTING: WHAT INFLUENCES THE
CHOICE FOR INTERVENTION?
R. Shrivastava, P. Venkatesh, V. Jeevanantham, V. Rajaram, N. Tandon (Shreveport,
LA and Winston-Salem, NC, USA)
339
91
CLINICAL FEASIBILITY AND ANGIOGRAPHIC FOLLOW-UP OF ENDOVASCULAR
STENT-GRAFT FOR TYPE B DISSECTION (STANTFORD). EXPERIENCE OF A
SINGLE CENTER IN BRAZIL
A. Daige, R. de Barros Wanderley, M. Wanderley Júnior, I. Kury Nunes, R. Favero,
C. Albernaz (Campo Grande, Brazil)
340
92
CORRELATIONS BETWEEN HYPERHOMOCYSTEINEMIA, EARLY
ATHEROSCLEROSIS AND DEEP VENOUS THROMBOSIS
C. Hotoleanu, M. Dronca, E. Dronca, M.L. Rusu (Cluj-Napoca, Romania)
341
93
EXAMINATION OF 14 PULMONARY ARTERY EMBOLISM AND VEIN
THROMBUS SYNDROME EXAMPLES IN RECENT 4YEARS
Y. Minagawa (Kuji, Japan)
342
94 - 97
GROUP B
Poster Session
RHEUMATIC DISEASE
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
94
INTIMA MEDIA THICKNESS OF CAROTID ARTERIES IN PATIENTS
WITH SYSTEMIC LUPUS ERYTHEMATOSUS ACCORDING TO PRESENCE
OF ANTIPHOSPHOLIPID SYNDROME
M. Krotin, L.J. Stojanovic, A. Djokovic, V. Bisenic (Belgrade, Serbia)
343
95
PREVENTION, PHYSICAL EXERCISE
M. Hochleitner, A. Bader (Innsbruck, Austria)
344
96
HOW TO DO PREVENTION IN IMMIGRANT WOMEN - IS LANGUAGE A REAL
BARRIER?
A. Bader, M. Hochleitner (Innsbruck, Austria)
345
97
ARRHYTHMIA PREVALENCE IN PATIENTS WITH SYSTEMIC LUPUS
ERYTHEMATOSUS
A. Djokovic, M. Krotin, L.J. Stojanovic, R. Pokrajac, B. Milovanovic (Belgrade, Serbia)
346
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
57
98 - 100
GROUP B
Poster Session
HIV AND CARDIOVASCULAR RISK
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
58
Abstract
Number Ref.:
98
CARDIOVASCULAR AND BIOCHEMICAL STATUS IN NEWLY DIAGNOSED
HIV-1(SUBTYPE C) BLACK SOUTH-AFRICANS.
J. Van Rooyen, C.M.T. Fourie, H.W. Huisman, R. Schutte, N.T. Malan, L. Malan,
A. Kruger, A.E. Schutte (Potchefstroom, South Africa)
347
99
DYSLIPIDEMIA AND LIPODYSTROPHY IN NEWLY DIAGNOSED HIV-1
(SUBTYPE C) BLACK SOUTH AFRICANS
C. Fourie, J.M. van Rooyen, H.W. Huisman, R. Schutte, N.T. Malan, L. Malan,
A. Kruger, A.E. Schutte (Potchefstroom, South Africa)
348
100
ELEVATED C-REACTIVE PROTEIN IS ASSOCIATED WITH CAROTID
LESIONS, BUT NOT WITH MEAN CAROTID INTIMA-MEDIA THICKNESS, IN
HIV-INFECTED AND HIV-UNINFECTED WOMEN
R. Kaplan, L. Benning, J. Lazar, W.A. Meyer, P.C. Tien, A.R. Sharrett, K. Anastos,
H.N. Hodis (Bronx, NY, Baltimore, MD, Brooklyn, NY, San Francisco and Los Angeles,
CA, USA)
349
101 - 114
GROUP B
Poster Session
GENETICS
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Abstract
Number Ref.:
LIPID EXCHANGE DISTURBANCES IN NEONATES AND HEREDITARY
PREDISPOSE TO ATHEROSCLEROSIS
K. Nadaraia, N. Kipshidze, M. Khelaia, A. Jabauri, M. Gudushauri (Tbilisi, Georgia)
350
102
LIPID PROFILE AND ANTHROPOMETRIC PARAMETERS IN GIRLS WITH
TURNER SYNDROME
A. Tabor, M. Schlegel-Zawadzka, J. Starzyk (Krakow, Poland)
351
103
APOLIPOPROTEIN E POLYMORPHISM AS A RISK FACTOR FOR MYOCARDIAL
INFARCTION IN YOUNG EGYPTIAN ADULTS
O. Leheta, E. Abdallah, M. ElShabrawy, G. Nasr (Ismailia, Egypt)
352
104
YIA
APOLIPOPROTEIN E GENE POLYMORPHISM AND OBESITY STATUS IN
MIDDLE-AGED MEN WITH CORONARY HEART DISEASE
G. Kolovou, K. Anagnostopoulou, P. Kostakou,V. Giannakopoulou, I. Vasiliadis,
C. Mihas, O. Diakoumakou, M. Stamatelatou, D.P. Mikhailidis, D.V. Cokkinos
(Athens, Greece and London, UK)
353
105
SINGLE NUCLEOTIDE POLYMORPHISMS IN PPAR-DELTA AND PPARGC1A IN
RELATION TO METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS
Z. Krivosikova, D. Kuba, Z. Dzupinkva, M. Gajdos, J. Tirpakova, V. Fedelesova,
V. Mongiellova, A. Oksa, K. Gazdikova (Bratislava, Slovak Republic)
354
106
YIA
-308 G/A TNF-ALFA AND I/D ACE POLYMORPHISMS AS GENETIC RISK
FACTORS FOR METABOLIC SYNDROME
N. Kondratova, G. Roytberg, A. Tikhonravov (Moscow, Russia)
355
107
T1264G CD36 GENE POLYMORPHISM ASSOCIATION WITH METABOLIC
SYNDROME IN KYRGYZ DISLIPIDEMIC MEN
O. Lunegova, A. Bairamukova, M. Pavlenko, A. Noruzbaeva, A. Kerimkulova, Z.H.
Isakova, E. Yusupova, A. Aldashev, M. Mirrakhimov (Bishkek, Kyrgyzstan)
356
108
ESSENTIAL HYPERTENSION AND ITS NATURAL SELECTION IN MODERN
CONDITIONS
O. Khizhnyak, S. Shtandel, Y. Karachentsev, I. Barilyak, I. Snegurskaya,
D. Miloslavsky (Kharkov and Kiev, Ukraine)
357
FRIDAY
101
SATURDAY
Poster Board
No.:
59
60
109
MUTATIONS IN HOMOCYSTEINE METABOLISM CONFER HIGH RISK OF
VASCULAR EVENTS IN RUSSIAN PATIENTS WITH STABLE CORONARY
ARTERY DISEASE
A. Komarov, O. Shakhmatova, D. Stambolsky, D. Rebrikov, A. Deev, E. Panchenko
(Moscow, Russia)
358
110
YIA
ROLE OF P22PHOX, ENDOTHELIAL NO SYNTHASE AND PAI-1 GENE
POLYMORPHISMS IN THE EARLY DEVELOPMENT OF ARTERIAL
HYPERTENSION AND CORONARY HEART DISEASE
E. Andreenko, L. Samokhodskaya, A. Ershova, S. Boytsov (Moscow, Russia)
359
111
Q192R POLYMORPHISM AND ACTIVITY OF PARAOXONASE 1 IN HIGH
CARDIOVASCULAR RISK SUBJECTS ON HYPOLIPIDEMIC DRUGS
T. Domagala, S. Dziedzina, S. Polanski, A. Szczeklik (Krakow, Poland)
360
112
YIA
POLYMORPHISMS IN STATIN METABOLISM PATHWAY GENES PREDICT
STATIN MEDIATED LDL CHOLESTEROL LOWERING IN CORONARY ARTERY
DISEASE PATIENTS
A. Poduri, A. Bahl, Y.P. Sharma, M. Khullar (Chandigarh, India)
361
113
ASSOCIATION BETWEEN VARIANTS IN THE GENES FOR LEPTIN, LEPTIN
RECEPTOR AND PROOPIOMELANOCORTIN WITH CHRONIC HEART FAILURE
IN THE CZECH POPULATION
A. Vasku, J. Bienertova Vasku, L. Spinarova, P. Bienert (Brno, Czech Republic)
362
114
ASSOCIATION BETWEEN GENETIC VARIANTS ON THE CHROMOSOMAL LOCI
9P21.3, 6Q25.1, AND 2Q36.3 AND ANGIOGRAPHICALLY DETERMINED
CORONARY ARTERY DISEASE
A. Muendlein, C.H. Saely, G. Sonderegger, S. Rhomberg, S. Loacker, P. Rein,
S. Beer, A. Vonbank, T. Winder, H. Drexel (Feldkirch, Austria and Triesen, Liechtenstein)
363
115 - 124
GROUP B
Poster Session
SPECIAL POPULATIONS
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Abstract
Number Ref.:
FACTOR ANALYSIS OF CARDIOVASCULAR RISK FACTORS AMONG
SCHOOL CHILDREN IN SERBIA
S. Spasic, D. Dzelajlija, N. Bogavac-Stanojevic, Z. Jelic-Ivanovic,
V. Spasojevic-Kalimanovska (Belgrade, Serbia)
364
116
YIA
OBESITY, OVERWEIGHT AND DIETARY HABITS OF SCHOOL CHILDREN
H. Stritecka, P. Hlúbik (Hradec Kralove, Czech Republic)
365
117
OBESITY, INSUFFICIENT PHYSICAL ACTIVITY AND SMOKING AS
CARDIOVASCULAR RISK FACTORS IN YOUNG WOMEN
D. Stojanovic, J. Jelenkovic, B. Miladinovic, D. Joksimovic Stevanovic (Nis, Serbia)
366
118
NON-INVASIVE TESTS OF EARLY ATHEROSCLEROSIS AND
CARDIOVASCULAR RISK FACTORS IN POPULATION-BASED COHORT OF
YOUNG POLICE OFFICERS
T. Domagala, K. Kotula-Horowitz, M. Kaszuba, B. Krzyzanowski, A. Szczeklik
(Krakow, Poland)
367
119
YIA
SPORT RELATED HYPERHOMOCYSTEINEMIA: ADAPTATION TO MUSCULAR
DEMAND TO BE NOTICED FOR CARDIOVASCULAR RISK
A. Spaccamiglio, L. Grasso, A. Angeli, F. Pigozzi, P. Borrione (Turin and Rome, Italy)
368
120
RISK FACTORS OF CARDIOVASCULAR DISEASE AND LIFESTYLE IN FIRST
GRADERS: A FIVE-YEAR FOLLOW UP IN THE PEP FAMILY HEART STUDY
G. Haas, E. Liepold, P. Schwandt (Muenchen, Germany)
369
121
PRIORITY POPULATIONS FOR STROKE MORTALITY RISK IN LOWER
APPALACHIA
T. Aldrich, J. Savoy, V. Yalamanchali, K. Cole (Johnson City, TN, USA)
370
122
CVD RISK FACTORS AND LIFESTYLE IN THE ELDERLY - A THREE-YEAR
FOLLOW UP: THE PEP FAMILY HEART STUDY
P. Schwandt, T. Bertsch, K. Gallert, E. Liepold, G.M. Haas (Muenchen and
Nuernberg, Germany)
371
FRIDAY
115
SATURDAY
Poster Board
No.:
61
62
123
YIA
THE CARDIOPROTECTIVE EFFECT OF PREINFARCTION ANGINA IS
LOST IN ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION
Y. Pak (Tyumen, Russia)
372
124
YIA
DEGERATIVE AORTIC VALVE STENOSIS - MOST COMMON IN THE ELDERLY
MEANING OF INTIMA-MEDIA THICKNESS INDEX
K. Koleva, M. Klisurski, P. Stamenova, N. Zlatareva, A. Gourev (Sofia, Bulgaria)
373
125 - 131
GROUP B
Poster Session
GENDER PERSPECTIVES IN CARDIOVASCULAR RISK FACTORS
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Abstract
Number Ref.:
CHANGES OF SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH
FACTOR AND NITRIC OXIDE BY ESTROGEN THERAPY IN NORMOTENSIVE
AND HYPERTENSIVE OVARIECTOMIZED RATS
M. Khazaei, M. Nematbakhsh, J.L. Mobarakeh (Isfahan and Tehran, Iran)
374
126
LOW-ENERGY DENSE DIETS BY ADDING FRUITS REDUCE WEIGHT AND
ENERGY INTAKE OF WOMEN AND REDUCE CARDIOVASCULAR RISKS
M.C. de Oliveira, M. de Paula, E. Sombra, E. Morais, F.M. Rod Costa,
M. De Fátima Pereira, S.R.D. Menezes, A. Silva de Almeida, A. Pessoa Ferreira,
A. de Oliveira Abtibol, M.C. de Arruda, S.M. Mundim, A. Pinho Rodrigues
(Rio de Janeiro, Brazil)
375
127
EFFECTS OF GENDER AND MENOPAUSAL STATUS ON SMALL DENSE LOW
DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN B
CONCENTRATIONS
V. Spasojevic-Kalimanovska, A. Zeljkovic, J. Vekic, Z. Jelic-Ivanovic, S. Spasic,
L. Memon (Belgrade, Serbia)
376
128
INCREASED HIGH SENSITIVE C-REACTIVE PROTEIN IS DETERMINED BY
HIGHER PLASMA LEPTIN IN WOMEN
R.P.F. Dullaart, W.J. Sluiter (Groningen, The Netherlands)
377
129
HOMOCYSTEINE CONCENTRATIONS IN NEONATES FROM THE MERIDA
COHORT. INFLUENCE OF CORTISOL AND GH LEVELS
F. Sánchez-Muniz, S. Bastida, E. Gesteiro (Madrid, Mérida and Badajos, Spain)
378
130
RISK FACTORS, CLINICAL AND ANGIOGRAPHIC PARTICULARITIES OF
CORONARY HEART DISEASE IN PERI AND POSTMENOPAUSAL WOMEN
C. Motoc, R. Motoc, M.I. Laszlo, I. Tilea, I. Silivastru, M. Ursu, L. Cozlea
(Targu Mures, Romania)
379
131
MULTIPLE RISK FACTORS AND ACUTE CORONARY SYNDROMES: THERE
ARE GENDER DIFFERENCES?
R. Dourado, D. Durão (Ponta Delgada and Santarém, Portugal)
380
FRIDAY
125
YIA
SATURDAY
Poster Board
No.:
63
132 - 136
GROUP B
Poster Session
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
64
Abstract
Number Ref.:
132
A POTENTIAL MODEL TO EXAMINE THE EFFECTS OF TOBACCO SMOKE
ON VASCULAR ENDOTHELIAL CELLS
E. Bishop, I.M. Fearon, M. Gaca (Southampton, UK)
381
133
SMOKING BEHAVIOR, SENSATION SEEKING AND RISK PERCEPTIONS IN
ADOLESCENTS
S. Ristic, M. Uljarevic, M. Nesic (Nis, Serbia)
382
134
TOBACCO SMOKING IN POLISH POPULATION - RESULTS FROM THE
WOBASZ STUDY
M. Polakowska, W. Piotrowski (Warsaw, Poland)
383
135
YIA
‘SMOKING’ A CARDIOVASCULAR RISK FACTOR’: ROLE OF AUDIOVISUAL
MEDIA TO PREVENT IT IN A SELECTED AREA IN THE CAPITALCITY (DHAKA)
OF BANGLADESH
N. Khurshid, J. Naznin, S. Alam (Dhaka, Bangladesh)
384
136
SMOKING CESSATION AND WEIGHT GAIN
H. Cena, R. Niniano, A. Tesone, G. Turconi, C. Roggi, I. Cerveri (Pavia, Italy)
385
137 - 151
GROUP B
Poster Session
ATHEROSCLEROSIS AND NUTRITION
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
137
YIA
ORAL ADMINISTRATION OF L-ASPARTATE PLUS L-GLUTAMATE PREVENTS
AORTIC FATTY STREAKS DEVELOPMENT AND ATTENUATES LIVER DAMAGE
IN CHOLESTEROL-FED RABBIT
A. Yanni, G. Agrogiannis, T. Nomikos, E. Fragopoulou, A. Pantopoulou, S. Antonopoulou,
D. Perrea (Athens, Greece)
386
138
ANTHOCYANIN SUPPLEMENTATION IMPROVED SERUM LDL-C, HDL-C
LEVELS AND ENHANCED CAPACITY OF CELLULAR CHOLESTEROL EFFLUX
TO SERUM IN DYSLIPIDEMIC SUBJECTS
W. Ling (Guangzhou, China)
387
139
THE EFFECT OF CHRONIC L-ARGININE ADMINISTRATION ON SERUM LIPID
PROFILE IN NORMAL AND HIGH CHOLESTEROL FED MALE RABBITS
M. Khazaei, J.L. Mobarakeh, A. Rahimi (Isfahan and Tehran, Iran)
388
140
DIFFERENT GALENIC FORMULATIONS OF FLUVASTATIN HAVE EQUAL
LIPID-LOWERING ACTION BUT DIFFER IN REDUCING LIPEMIA-INDUCED
ENDOTHELIAL DYSFUNCTION
S. Westphal, C. Abletshauser, C. Luley (Magdeburg and Nuernberg, Germany)
389
141
HYPOCHOLESTEROLEMIC AND ANTIOXIDATIVE EFFECTS OF HESPERETIN
AND ITS METABOLITES IN THE SYRIAN GOLDEN HAMSTERS
H. Kim, S. Jeon, G. Do, M. Woo, M. Choi (Daegu, South Korea)
390
142
BENEFICIAL EFFECT OF SARDINE PROTEINS ON TISSUES LIPID
PEROXIDATION AND ANTIOXIDANT DEFENSE ENZYMES IN
HYPERCHOLESTEROLEMIC RATS
M. Lamri-Senhadji, S. Hamza Reguig, S. Louala, S. Bouderbala, A. Boualga,
M. Bouchenak (Oran, Algeria)
391
143
YIA
THE INFLUENCE OF CLA ISOMERS ON THE CATALASE ACTIVITY AND ROS
GENERATION IN MACROPHAGES
M. Rybicka, E. Stachowska, D. Chlubek (Szczecin, Poland)
392
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
65
66
144
EFFECT OF DIETARY CHANGES ON PLASMA TRIGLYCERIDES AFTER A
FAT LOAD WITH OR WITHOUT ALCOHOL AND AN ALMOST COMPLETE
ABSTINENCE FROM FAT: THE DAY AFTER
I. Georgoulis, M. Giovannini, M. Bove, A.F.G. Cicero, A.V. Gaddi (Bologna, Italy)
393
145
RESEARCH OF THE THERAPEUTICS ACTION OF THE SOYBEAN FLAVONOID
SUPPLEMENT IN THE PATIENTS WITH METABOLIC SYNDROME
V. Kapetivadze, R.I.T. Tabukashvili, Z.G.G. Grigorashvili, K.M.T. Tchaava,
I.G.K. Kapetivadze, N.D.G. Gegeshidze (Tbilisi, Georgia)
394
146
CAN A HUMAN EVOLUTION BASED DIET, COMBINED WITH SIMPLE
SUPPLEMENTS, REVERSE THE METABOLIC SYNDROME?
S. Gundry, W. Ehrman (Palm Springs, CA, USA)
395
147
FISH PROTEIN VS CASEIN ON BLOOD PRESSURE, GLYCEMIA, LIPIDEMIA
AND REDOX STATUS, IN SHR AND STREPTOZOTOCIN-INDUCED DIABETIC
SHR RATS
M. Bouchenak, F.O. Boukortt, D. Ait-yahia, J. Prost (Oran, Algeria and Dijon, France)
396
148
APOLIPOPROTEIN E DETERMINES THE HEPATIC TRANSCRIPTIONAL PROFILE
OF DIETARY MASLINIC ACID IN MICE
J. Osada, N. Guillen, S. Acín, J.C. Surra, C. Arnal, A. García-Granados, P. Muniesa,
V. Ruiz-Gutiérrez (Zaragoza, Granada, Seville and Madrid, Spain)
397
149
WALNUT-ENRICHED MEAT CONSUMPTION IMPROVES THE THROMBOGENIC
STATUS IN INDIVIDUALS AT HIGH CHD RISK. A CROSS-OVER,
PLACEBO-CONTROLLED STUDY
F. Sánchez-Muniz, S. Bastida, A. Canales, M. Nus, J. Librelotto, J. Benedí
(Madrid, Spain)
398
150
THE EFFECT OF A LOW CARBOHYDRATE WEIGHT REDUCING PLANT BASED
DIET ON APOLIPOPROTEINS AND BLOOD PRESSURE
J.M.W. Wong, C.W.C. Kendall, A. Esfahani, V.W.Y. Ng, K.A. Greaves, G. Paul, D.J.A.
Jenkins (Toronto, ON, Canada and St. Louis, MO, USA)
399
151
BARLEY PROTEIN AND OXIDIZED LOW DENSITY LIPOPROTEIN
J.M.W. Wong, K. Srichaikul, N. Fozdar, A.R. Josse, C.W.C. Kendall, D.J.A. Jenkins
(Toronto, ON, Canada)
400
152 - 162
GROUP B
Poster Session
NON-PHARMACOLOGICAL APPROACHES AND INTERVENTION
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
152
ANTIHYPERTENSIVE EFFECTS OF HIGH POTASSIUM INTAKE IN YOUNG
AND ADULT SALT HYPERTENSIVE DAHL RATS
J. Zicha, Z. Dobesova, J. Kunes (Prague, Czech Republic)
401
153
THE EFFECTS OF AQUEOUS AND ETHANOL EXTRACTS OF ALLIUM SATIVUM
ON THE ISOLATED HEART ATRIA OF RAT
M. Radenkovic, S. Brankovic, D. Kitic, S. Veljkovic, V. Ivetic, M. Nesic (Nis, Serbia)
402
154
ATHEROGENIC LIPID MODIFICATIONS AS A RESULT OF A SINGLE SESSION
OF SUBMAXIMAL EXERCISE IN APPARENTLY HEALTHY INDIVIDUALS
Z. Caparevic, N. Kostic, S. Ilic, J. Radojkovic, B. Pencic, M. Dekleva, V. Celic,
L.J. Konstantinovic (Belgrade, Serbia)
403
155
FEASIBILITY AND EFFICACY OF A PHYSICAL EXERCISE PROGRAM IN
PATIENTS WITH TYPE 2 DIABETES IN A PUBLIC OUTPATIENT CLINIC
P. Auletta, G. Annuzzi (Frattamaggiore and Naples, Italy)
404
156
REDUCTION OF CARDIOVASCULAR DISEASE RISK FACTORS USING YAN XIN
QIGONG EXTERNAL QI TREATMENT - A PILOT STUDY
X. Yan, H. Shen, W. Zhang, D. Hu, J. Wang, X. Wu, M.C. Tsai (Chongqing, China,
New York, NY, Houston, TX and Boston, MA, USA)
405
157
THE EFFECT OF PALATINOSE ON MULTIPLE RISK FACTORS IN
CARDIOVASCULAR DISEASES IN CHINESE
M. Mori, J. Wen Xu, H. Mori, Z. Sixiu, W. Wentao, G. Hongwei, Y. Yamori (Nishinomiya,
Japan and Shanghai, China)
406
158
PREVENTIVE EFFECT OF PALATINOSE ON THE RISK OF LIFESTYLE - RELATED
DISEASE
H. Mori, M. Mori, Y. Yamori (Nishinomiya, Japan)
407
159
YIA
HYPOTENSIVE AND NEGATIVE CHRONOTROPIC AND INOTROPIC
EFFECTS OF THE AQUEOUS AND ETHANOL EXTRACT FROM PARSLEY
LEAVES (PETROSELINUM CRISPUM)
S. Brankovic, S. Djosev, D. Kitic, M. Radenkovic, S. Veljkovic, M. Nesic, D. Pavlovic
(Nis, Serbia)
408
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
67
68
160
HUMOR, AS ADJUNCT THERAPY IN DIABETIC CARE, ATTENUATES
CATECHOLAMINES, INFLAMMATORY MARKERS, C-REACTIVE PROTEIN, AND
MYOCARDIAL INFARCTION OCCURRENCE
S.A. Tan, L.G. Tan, L.S. Berk (Yucaipa, CA, USA)
409
161
PACEMAKER DERIVED MINUTE VENTILATION IMPROVING OUTCOMES WITH
CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS - THE MOVE STUDY
J. Adams, W.A. Bradley, J.R. Adams, B.L. Strunk, M.L. Baer, A.K. Kao, D.C. Sperling,
R.T. Sperling, M.P. Wexman, J. Sklar, J. Young, B. Keeffe, K.N. Gershengorn, M. Nisam
(San Francisco, CA, USA)
410
162
BODY WEIGHT TELEMETRY IN HEMODIALYSIS PATIENTS REDUCES
SYSTOLIC BLOOD PRESSURE, INTERDIALYTIC WEIGHT GAIN AND
ULTRAFILTRATION
E. Schulz, F. Wagner, N. Fischer, A. Schwarz, A. Wolf, U. Korth, M.H. Weber
(Goettingen and Stolberg, Germany)
411
163 - 168
GROUP B
Poster Session
HEALTH ECONOMICS
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
163
PERSISTENCE AND ADHERENCE TO HYPOLIPEMIC THERAPY IN REAL
PRACTICE: RESULTS OF A LARGE ADMINISTRATIVE DATABASE.
L.G. Mantovani, C. Fornari, F. Madotto, V. Chiodini, G. Veronesi, M. Ferrario,
G. Cesana (Naples, Monza and Varese, Italy)
412
164
YIA
EDUCATIONAL PREVENTIVE TECHNOLOGY FOR PATIENTS WITH
HYPERTENSION (CLINIC EFFICIENCY AND COST-EFFECTIVENESS ANALYSIS)
A. Kontsevaya, A. Kalinina (Moscow, Russia)
413
165
COST -UTILITY ANALYSIS OF A NATIONAL PROJECT TO REDUCE
HYPERTENSION IN ISRAEL
D. Gavish, H. Yosefy, G. Ginsberg, R. Viskoper, D. Dicker (Holon, Ashkelon,
Jerusalem and Petach Tikva, Israel)
414
166
THE ECONOMIC VALUE OF BETTER RISK PREDICTION: A PROJECTION
FROM THE CHD POLICY MODEL
M. Pletcher, L. Lazar, K. Bibbins-Domingo, A. Moran, N. Rodondi, P. Coxson,
J. Lightwood, L. Williams, L. Goldman (San Francisco, CA, New York, NY, Boston,
MA, USA and Lausanne, Switzerland)
415
167
MEDICARE POLICIES: TRANSLATING RESEARCH ON INFORMATION
TECHNOLOGY TREATMENT OF TYPE 2 DIABETES AND HYPERTENSION
AMONG OLDER ADULTS TO POLICY
C.C. Quinn (Baltimore, MD, USA)
416
168
MOBILE PHONE DIABETES MANAGEMENT: IMPACT ON PHYSICIAN
PRESCRIBING BEHAVIOR FOR PATIENTS WITH COMORBID HEART
DISEASE
C.C. Quinn (Baltimore, MD, USA)
417
FRIDAY
Abstract
Number Ref.:
SATURDAY
Poster Board
No.:
69
169 - 170
GROUP B
Poster Session
GUIDELINES FOR PRACTICE
Friday, October 24:
from 13.00
to 14.00
Friday, October 24:
from 16.00
to 16.30
from 10.45
to 11.15
Poster Board
No.:
70
Abstract
Number Ref.:
169
FOLLOW-UP PROGRAMME FOR PATIENTS WITH CORONARY ARTERY
DISEASE (CAD) - THE WAY TO IMPLEMENT GUIDELINES IN PRACTICE
I. Mintale, I. Zake, A. Erglis (Riga, Latvia)
418
170
DRUG CHOICES IN THE TREATMENT OF PATIENTS WITH CORONARY
HEART DISEASE IN BULGARIA
B. Georgiev, N. Gotcheva, V. Baytcheva, A. Genov, M. Hazan (Sofia, Bulgaria)
419
Index of Abstract Contributors
(The numbers refer to the Abstract Number)
-AAbate, N. ........................................................................165
Abdallah, E. ..................................................................352
Abdelaal, M. ..................................................................139
Abletshauser, C. ................................................228, 389
Accardo, A. ....................................................................137
Acin, S. ..............................................................................78
Acín, S. ............................................................................397
Aczel, S. ..................................44, 121, 151, 232, 255,
278, 330
Adachi, H. ............................................................287, 320
Adamkova, V. ..............................................................235
Adams, J. ........................................................................410
Addesse, R. ....................................................................336
Adorni, M.P. ........................................................176, 178
Aeta, M. ..........................................................................159
Afanasieva, O. ..............................................................122
Aggarwal, A. ................................................................101
Agoston-Coldea, L. ....................................................303
Agrawal, R. ....................................................................149
Agrogiannis, G. ............................................................386
Ahnhström, J. ..................................................................58
Ait-yahia, D. ..................................................................396
Aivars, J.I. ......................................................................221
Akcil, M. ........................................................................219
Akhvlediani, M. ..........................................................322
Alabakovska, S. ..........................................................194
Alabakovski, M. ..........................................................194
Alam, S. ..........................................................................384
Alarcón Gonzalez, J.A. ............................................152
Albernaz, C. ..................................................................340
Aldashev, A. ..................................................................356
Aldrich, T. ......................................................................370
Alegiani, F. ....................................................................222
Alegria, E. ......................................................................210
Alegría, A. ......................................................................210
Alekseevskaja, I. ..........................................................324
Aleksov, B. ....................................................................269
Alexandru, N.................................................................140
Al-Hani, A. ......................................................................75
Aliakseyeuskaya, I. ....................................................117
Alissa, E. ........................................................................108
Alshali, K. ......................................................................108
Alter, P. ..............................................................................29
Alves, S. ..........................................................................115
Amato, M. ............................................................128, 197
Ambegaonkar, B.M. ......................................................92
Aminov, S. ..........................................................161, 163
Amuzescu, M. ..............................................................140
Anagnostopoulou, K. ................................................353
Anand, I. ........................................................................440
Anastos, K. ....................................................................349
Andreenko, E. ..............................................................359
Andreev, D. ....................................................................129
Andrushishina, T. ........................................................311
Anestiadi, V. ..................................................................273
Angeli, A. ......................................................................368
Angello, J. ......................................................................104
Anker, S.D. ....................................................................440
Annuzzi, G. ....................................................................404
Antic, S. ..........................................................................272
Antohe, F. ............................................................179, 313
Antonellis, I. ..................................................................131
Antonopoulou, S. ................................................51, 386
Antonucci, E. ................................................................231
Antonucci, G. ................................................................231
Anzivino, C. ....................................................................62
Arbones-Mainar, J.M. ..................................................78
Arcoraci, C. ..................................................................321
Argani, H. ............................................................334, 335
Arnaboldi, L. ..............................................64, 188, 211
Arnal, C. ..................................................................78, 397
Arnsdorf, M. ....................................................................75
Arquati, M. ............................................................48, 197
Arroyo-Espliguero, R.........................................31, 133
Astengo, M.A. ....................................................434, 435
Atella, V. ............................................................................89
Auletta, P. ......................................................................404
Avanzas, P...............................................................31, 133
Avcioglu, U. ..................................................................219
Axler, O. ............................................................................58
Ayrton, N. ........................................................................96
Azevedo, A. ........................................................180, 181
-BBabic, G. ..............................................................300, 312
Bader, A. ....................................................105, 344, 345
Badila, A. ........................................................................140
Baek, S. ..........................................................................123
Baetta, R. ........................................................................211
Bahl, A.............................................................................361
Bahs, G.......................................................................93, 94
Bairamukov, A. ............................................................356
Bakirov, T. ......................................................................124
Bakris, G. ..........................................................................75
Balandina, K. ................................................................147
Balandina, K.A.............................................................283
Balcou-Debussche, M. ................................................13
Baldassarre, D. ............................................................197
Ballantyne, C.M...........................................................165
The numbers refer to the Abstract Number.
71
Ballantyne, C. ..............................................................166
Ballerio, R. ....................................................................198
Balode, L. ......................................................................221
Balsamo, A. ....................................................................211
Balu, S. ............................................................................326
Banbury, M.K. ..............................................................100
Banfi, C. ............................................................................59
Barbieri, S.S.....................................................................41
Barbuto, J. ............................................................180, 181
Barcella, S. ......................................................................59
Bardymova, T.P. ..........................................................266
Bardymova, T. ..............................................................271
Barilyak, I. ....................................................................357
Barth, J. ..........................................................................114
Basile, J.......................................................167, 170, 171
Bastida, S. ............................................................378, 398
Basu, S. ..............................................................................55
Bauduceau, B. ................................................................99
Bauer, D. ..........................................................................16
Bays, H. ............................................................................23
Baytcheva, V. ......................................................156, 419
Bazinet, R.P. ..................................................................296
Bedogna, V. ....................................................................331
Beer, S. ............................20, 44, 127, 232, 255, 284,
315, 319, 329, 330, 337, 338, 363
Bekada-Bouzidi, N. ....................................................332
Bellacosa, I. ..................................................................436
Bellosta, S. ..................................................60, 189, 198
Belotti, F. ..........................................................................89
Belousova, I.V. ............................................................266
Benedí, J. ........................................................................398
Benning, L. ....................................................................349
Benzer, W. ............................................................121, 278
Beraia, M. ......................................................................192
Berk, L.S. ................................................................33, 409
Bernini, F. ............................................................176, 178
Bertolotti, M. ........................................................62, 268
Bertsch, T. ..............................................................36, 371
Berulava, D. ..................................................................322
Betova, T.........................................................................301
Bi, X.M. ..........................................................................145
Bianco, S. ......................................................................103
Biasioli, B. ....................................................................136
Bibbins-Domingo, K. ................................................415
Bienert, P. ......................................................................362
Bienertova Vasku, J. ..................................................362
Bird, S. ............................................................................166
Bisenic, V. ......................................................................343
Bishop, E. ......................................................................381
Black, H.............................................................................75
Blais, C. ................................................................244, 245
Blankenberg, S. ............................................................107
Blauw, G. ..........................................................................37
Bliddal, H. ........................................................................25
Bloise, A. ........................................................................103
Bo, M. ....................................................................434, 435
Bodisz, G. ......................................................................257
Boeger, R. ......................................................................110
Boehnel, C. ......................................................................20
Bogani, P.........................................................................201
Bogavac-Stanojevic, N. ............................................364
Boiocchi, C. ..................................................................132
Bolego, C. ......................................................................183
Bolgiano, D. ....................................................................91
Boncheva, M. ................................................................249
Bond, D. ............................................................................17
Bongo, A.S. ......................................................................18
Bonilla-Aguilar, I. ......................................................309
Borai, A. ................................................................138, 139
Bordier, L. ........................................................................99
Borghi, C. ......................................................................425
Bormane, I. ....................................................................221
Bornstein, S.R. ............................................................247
Borrione, P. ....................................................................368
Borucki, K. ....................................................................228
Borz, B. ..........................................................................257
Boschetti, F. ..................................................................198
Boualga, A. ....................................................................391
Bouchenak, M. ........................................332, 391, 396
Bouderbala, S. ..............................................................391
Boukaddoum, A. ..........................................................332
Boukortt, F.O. ..............................................................396
Bove, M. ..............................................................113, 393
Boytsov, S. ....................................................................359
Bozzini, S. ......................................................................132
Bragagni, G. ..................................................................246
Brambilla, M. ................................................................201
Brankovic, S. ......................................................402, 408
Brazor, M. ......................................................................272
Brescianini, A. ....................................................434, 435
Brinton, E. ............................................................168, 169
Brioschi, M. ....................................................................59
Brohee, D. ............................................................106, 182
Brotons, C. ....................................................................104
Brudi, P. ............................................................................63
Bruun, J. ............................................................................55
Bujisic, N. ......................................................................126
Buko, I. ............................................................................186
Burazor, I. ............................................................199, 272
Burazor, M. ....................................................................199
Burazor, N. ....................................................................272
Burazor, Z. ....................................................................272
72
Burge, R. ..............................................................157, 158
Burgmaier, M. ................................................................19
Buryachkovskaya, L. ......................................200, 314
Butler, J. ............................................................................16
-CCafiero, M. ....................................................................103
Cahill, P. ............................................................................61
Calabresi, L. ..................................................................176
Calder, P.C. ......................................................................82
Callebert, J. ......................................................................40
Camera, M. ................................................197, 198, 201
Canade, A. ............................................................434, 435
Canales, A. ....................................................................398
Canavesi, M. ................................................60, 189, 198
Caparevic, Z. ................................................................403
Capewell, S. ....................................................................84
Caprnda, M. ..........................................................90, 148
Capuano, E. ..................................................................436
Capuano, V. ....................................................................436
Carella, A.M. ................................................................231
Cariolou, M.A. ................................................................96
Carleton, A.J. ................................................................295
Carroll, S.........................................................................114
Carulli, L. ................................................................62, 268
Carulli, N. ..............................................................62, 268
Casazza, G. ......................................................................48
Cascone, G. ....................................................................321
Casscells, S.W. ..................................................................3
Catapano, A.L. ....8, 14, 86, 112, 165, 175, 177, 183
Cattin, L. ................................................................43, 282
Cavalca, V. ................................................129, 135, 242
Cebanu, M. ......................................................................50
Celic, V. ..........................................................................403
Cena, H. ..........................................................................385
Ceppa, F. ............................................................................99
Cerveri, I.........................................................................385
Cesana, G. ......................................................................412
Cesur, M. ........................................................................219
Chagunava, K. ..............................................................259
Chai, Y. ............................................................................160
Chait, A. ............................................................................68
Chandra, N.C. ..............................................................144
Chapidze, G. ......................................24, 214, 226, 302
Chapman, M.J...............................................................441
Charland, S. ........................................................157, 158
Chen, M. ........................................................................279
Cherenkevich, S.N. ....................................................186
Cheriyath, P. ....................................................................22
Chiariello, M. ..................................................................77
Chien, K. ........................................................................279
Chin-Dusting, J...............................................................30
Chiodini, V. ....................................................................412
Chironi, G. ........................................................................40
Chiusano, V. ........................................................434, 435
Chiurlia, E. ......................................................................73
Chlubek, D. ....................................................................392
Cho, K. ............................................................................123
Choi, J. ............................................................................289
Choi, M. ............................................252, 262, 289, 390
Christensen, R. ................................................................25
Christensen, J.H. ..........................................................333
Christenson, R. ............................................................440
Chulaevskaya, I. ..........................................................227
Cicero, A.F. ....................................................................219
Cicero, A.F.G. ....................................................113, 393
Cifkova, R. ....................................................................235
Clopton, P. ......................................................................440
Cokkinos, DV. ..............................................................353
Colcear, D. ....................................................................307
Cole, K. ..........................................................................370
Comba, M. ..........................................................434, 435
Comegna, C. ..................................................................336
Conte, M. ........................................................................231
Copeland, K.A. ............................................................100
Cordero, A. ....................................................................210
Cornuz, J. ..........................................................................16
Corsini, A. ........................10, 64, 178, 188, 189, 211
Corsinovi, L. ......................................................434, 435
Cortellaro, M. ........................................................48, 197
Costa, S. ..........................................................................178
Costanzo, P. ......................................................................77
Coxson, P. ......................................................................415
Cozlea, L. ............................................................327, 379
Craciun, L. ....................................................................240
Crea, F. ..............................................................................66
Crestani, M. ..................................................................189
Cricelli, C. ......................................................................104
Crinos, X. ......................................................................218
Critchley, J.A. ..................................................................84
Crosetti, M. ......................................................................64
Cuccia, M. ......................................................................132
Cuccurullo, P. ................................................................103
Cuchel, M. ........................................................................15
Cui, J. ..............................................................................174
Cullen, J.............................................................................61
Cvejic, J. ........................................................................141
Cvetanovic, G. ..............................................................272
Cvirn, G. ........................................................................204
Cziraky, M.J. ................................................................154
Cziraky, M. ....................................................................326
73
-DDahlbäck, B. ....................................................................58
Daige, A. ........................................................................340
Daida, H. ........................................................................426
Dalamaga, M.................................................................131
Dallinga-Thie, G.M. ....................................................56
Daniels, L.B. ................................................................440
D’Amico, F.......................................................................89
D’Amico, R. ..................................................................268
D’Arminio, T. ..............................................................436
Dascalu, C. ............................................................32, 318
Davidson, M.H. ....................................................69, 165
Davila-Lara, C. ............................................................309
de Arruda, M.C. ..........................................................375
De Backer, G.................................................................421
de Barros Wanderley, R. ..........................................340
De Caterina, R. ............................................................420
De Fátima Pereira, M. ..............................................375
De Feo, P. ..........................................................................52
De Francesco, A. ........................................60, 189, 198
De Groot, E. ..................................................................119
de Kievit, P. ..................................................................193
de Kievit, J. ....................................................................193
de la Llera-Moya, M. ..................................................15
De Monte, A. ........................................................43, 282
de Oliveira Abtibol, A. ..............................................375
De Oliveira Sarkis, M.C. ..........................................375
De Souza, R.J. ..............................................................295
De Stefano, A. ..............................................................103
de Vries, R. ....................................................................276
Debussche, X...................................................................13
Deby-Dupont, G. ........................................................185
Dechamplain, J...................................................244, 245
Dedov, I...........................................................................271
Deev, A. ..........................................................................358
Dehelean, P. ..................................................................240
Dekkers, D. ....................................................................193
Dekleva, M. ..................................................................403
Del Pino, M. ....................................................................40
Del Puppo, M. ................................................................62
Delbello, G. ..................................................................136
Denes, C.L. ....................................................................316
Denisevich, T. ..............................................................207
Derdemezis, C. ............................................................162
Derochette, S.................................................................185
Despres, J.-P.....................................................................47
Detopoulou, P. ................................................................51
Devlin, J. ..........................................................................37
Dhaliwal, S. ......................................................................21
Diakoumakou, O. ........................................................353
Di Battista, N. ..............................................................246
Dicker, D. ......................................................................414
Di Lullo, L. ....................................................................336
Dima Cozma, LC.................................................32, 318
Di Martino, E. ..............................................................198
Dimitriou, E...................................................................218
Dimitrova, A. ................................................................301
Dimov, D. ......................................................................249
Dionyssiou-Asteriou, A. ..........................................131
Di Pumpo, M. ..............................................................231
Di Renzi, P. ....................................................................222
Di Somma, S. ................................................................440
Dittmer, W. ....................................................................193
Djokovic, A. ..............................................328, 343, 346
Djordjevic, N. ....................................................300, 312
Djosev, S. ........................................................................408
Do, G. ................................................252, 262, 289, 390
Dobesova, Z. ................................................................401
Dobreva, D. ..................................................................258
Dolidze, N. ........................................24, 214, 226, 302
Domagala, T. ......................................................360, 367
Domeikiene, A. ............................................................270
Dong, X...........................................................................174
Dongmo Fomekong, G. ............................................261
Donova, T. ......................................................................281
Doorey, A.J. ..................................................................100
Dourado, R. ..............................................260, 308, 380
Dozio, E. ........................................................................112
Drexel, H. ....20, 44, 118, 121, 127, 151, 232, 255,
278, 284, 315, 319, 329, 330, 337, 338, 363
Dronca, M. ....................................................................341
Dronca, E. ......................................................................341
Duan, Y. ............................................................................22
Duão, D. ..........................................................................260
Duca, P.G. ........................................................................48
Ducobu, J. ............................................................106, 182
Duda-Seiman, D.M.....................................................240
Dufour, R. ............................................................244, 245
Dukat, A. ................................................................90, 148
Dullaart, R.P.F. ......................................2, 56, 276, 377
Dumitrascu, D.L. ........................................................303
Dundua, M. ....................................................................292
DuPont-Meyramova, O.N. ......................................265
Dupuy, O. ..........................................................................99
Durão, D. ..............................................................308, 380
Dwivedi, S. ....................................................................101
Dyballa, T. ......................................................................284
Dyzma, M. ....................................................................106
Dzelajlija, D. ................................................................364
Dziedzina, S. ................................................................360
Dzupinkva, Z. ..............................................................354
74
-EEason, S. ............................................................................91
Ebrahimi, R. ....................................................................39
Eckel, R.H. ......................................................................67
Ehnholm, C. ....................................................................58
Ehrman, W. ............................................................12, 395
Elisaf, M.S. ..........................................................162, 248
Ellrott, T. ..........................................................................79
ElShabrawy, M. ............................................................352
Emukhvari, M...............................................................322
Engelen, S. ....................................................................104
Enquobahrie, D. ..............................24, 214, 226, 302
Enyong Oben, J. ..........................................................261
Erglis, A. ........................................................................418
Ershova, A. ....................................................................359
Ertek, S. ..........................................................................219
Esfahani, A. ........................................................296, 399
Esterbauer, H.................................................................297
Evers, T. ..........................................................................193
Exner, M. ........................................................................297
Ezenwaka, C. ......................................................102, 213
Ezhov, M. ......................................................................122
-FFalasca, M. ....................................................................175
Falcone, C. ....................................................................132
Farhaut, B. ......................................................................106
Farnier, M.......................................................................428
Favari, E. ..............................................................176, 178
Favero, R. ......................................................................340
Fearon, I.M. ..................................................................381
Fedak, D. ........................................................................277
Fedelesova, V. ....................................................111, 354
Feinman, R. ..................................................................209
Ferns, G. ....................................................108, 138, 139
Ferrario, M. ....................................................................412
Ferraro, S. ........................................................................18
Ferri, N. ..........................................................................188
Ferstl, U. ........................................................................204
Filipiak, K. ....................................................................155
Filipiak, K.J. ..................................................................239
Filippatos, G. ................................................................440
Fine, E. ............................................................................209
Fischer, N. ............................................................310, 411
Fisher, M.........................................................................104
Fitzpatrick, A. ..............................................................214
Fleg, J.L. ............................................................................11
Floccari, F.......................................................................336
Florentin, M. ......................................................162, 248
Fodor, J.G. ........................................................................90
Fonte, G. ..............................................................434, 435
Foody, J. ............................................................................72
Ford, I. ................................................................................37
Fornari, C. ............................................................348, 412
Fourie, C.M.T. ..............................................................347
Fozdar, N. ..................................................................6, 400
Fragopoulou, E. ....................................................51, 386
Franceschini, G. ..........................................................176
Franculli, F. ....................................................................436
Frank, T. ..........................................................................185
Fras, Z. ............................................................................243
Fraser, N. ..........................................................................45
Freidig, A. ......................................................................146
Friedman, M. ................................................................157
Frikke-Schmidt, R. ........................................................58
Frind, A. ..........................................................................247
Frostegard, J. ................................................................120
Fruchart, J.-C. ..............................................................439
Fruttero, R. ......................................................................64
-GGabbi, C. ..........................................................................62
Gaca, M...........................................................................381
Gach, O. ..........................................................................185
Gaddi, A.V. ..........................................................113, 393
Gaito, S. ..........................................................................215
Gajdos, M. ............................................................111, 354
Galderisi, C. ..................................................................336
Gallert, K. ......................................................................371
Galli, C. ............................................................................81
Galli Kienle, M. ..............................................................62
Ganazzi, D. ....................................................................268
Ganske, P. ......................................................................280
García-Granados, A. ..................................................397
Garcia, C. ..........................................................................99
Garlanda, C. ....................................................................14
Garlaschelli, K. ............................................................112
Gasco, A. ..........................................................................64
Gately, P. ........................................................................114
Gatti, R. ..........................................................................178
Gavish, D. ......................................................................414
Gavornik, P. ..................................................................148
Gayet, C.............................................................................26
Gazdikova, K. ....................................................111, 354
Gaziano, J.M. ................................................................104
Gedminas, L. ................................................................270
Gegeshidze, N.D.G. ....................................................394
Gelaye, B. ..........................................24, 214, 226, 302
Gencheva, I. ..................................................................301
75
Generalov, V. ................................................................124
Genov, A. ........................................................................419
Georgescu, A. ................................................................140
Georgiev, B. ........................................................156, 419
Georgoulis, I. ......................................................113, 393
Georgiou, N. ...................................................................17
Gertow, K. ......................................................................201
Gesteiro, E. ....................................................................378
Ghamdi, H. ....................................................................139
Ghiciuc, C...............................................................32, 318
Ghorbanihaghjo, A. ..........................................334, 335
Giampaoli, S. ....................................................................7
Giannakopoulou, V. ....................................................353
Giannico, I.M. ..............................................................268
Gidlund, M. ..............................................115, 180, 181
Gilardi, F. ........................................................................189
Gillies, P. ..........................................................................53
Ginsberg, G. ..................................................................414
Ginsberg, H.N. ................................................................26
Giovannini, M. ............................................................393
Giroli, M. ........................................................................242
Gladkih, A. ....................................................................223
Glasnovic, J. ..................................................................272
Gmeiner, B.M.K. ........................................................297
Godio, C. ........................................................................189
Gojkovic Bukarica, Lj. ..............................................141
Goldberg, R. ..........................................................46, 164
Goldenberg, H. ............................................................184
Goldman, L. ..................................................................415
Gollub, S.........................................................................191
Gomez Ruiz, M. ..........................................................152
Gorshunska, M...............................223, 274, 275, 288
Gorudko, I.V. ................................................................186
Gotcheva, N. ......................................................156, 419
Gotto, A...........................................................................187
Goudev, A. ....................................................................373
Goyer, L. ..............................................................244, 245
Graessler, J. ....................................................................247
Granata, A. ....................................................................178
Grandi, E.........................................................................113
Grassi, P. ........................................................................136
Grasso, L. ......................................................................368
Greaves, K.A. ..............................................................399
Green, J.W. ......................................................................53
Griffin, M. ........................................................................17
Grigorashvili, Z.G.G. ................................................394
Grigore, L. ......................................................................112
Grigorescu-Sido, P. ....................................................316
Grin, V. ............................................................................220
Grinchenko, T. ..............................................................286
Gromov, A. ....................................................................124
Grünfeldova, H. ..........................................................212
Grundy, S.............................................................................4
Gruzdev, A. ....................................................................317
Gryszkiewicz, M. ........................................................104
Gudushauri, M. ............................................................350
Guerra, G. ......................................................................113
Guillamont-Salvador, J. ............................................309
Guillen, N. ..............................................................78, 397
Gulati, M. ..........................................................................75
Gundry, S. ..............................................................12, 395
Gupalo, E. ......................................................................314
Gusev, D. ........................................................................129
Gustafson, K. ..........................................................23, 45
Guyton, J. ................................................................46, 164
Gvaladze, T. ..................................................................292
-HHaas, G. ..................................................................38, 369
Haas, G.M. ............................................................36, 371
Hadjivassiliou, M. ........................................................96
Hajjar, D. ........................................................................187
Haj-Yahya, S. ..................................................................65
Hamza Reguig, S.........................................................391
Hanus, P. ........................................................................212
Haraba, R. ............................................................179, 313
Hardeman, W. ..............................................................193
Harris, T. ............................................................................16
Havekes, L.M. ..............................................................146
Havulinna, A. ..................................................................58
Hazan, M. ............................................................156, 419
Heinle, H. ......................................................................141
Helenowski, I. ..............................................................241
Henry, P. ............................................................................63
Hermann, M. ................................................................297
Hernandez-Ono, A.........................................................26
Hess, K. ............................................................................19
Hiro, T. ............................................................................426
Hlubik, H. ......................................................................234
Hlubik, J. ..........................................................................95
Hlubik, P. ................................................................95, 365
Hoag, G. ..........................................................................280
Hoang, A. ..........................................................................30
Hobbs, R. ..........................................................................87
Hobkirk, J. ......................................................................114
Hochleitner, M. ........................................105, 344, 345
Hodis, H.N. ....................................................................349
Hogan, C.........................................................................440
Hongwei, G. ..................................................................406
Hoshizaki, H. ................................................................320
Hosmane, V.R. ..............................................................100
76
Hotoleanu, C. ................................................................341
Howard, B.V. ........................................................11, 429
Howard, W.J.....................................................................11
Hsu, H. ............................................................................279
Hu, D. ..............................................................................405
Hu, M. ..............................................................................143
Hu, S. ..............................................................................143
Huang, Z.J. ....................................................................145
Huisman, H.W. ..................................................347, 348
Hussaini, S. ..........................................................102, 213
-IIakoubova, O. ..................................................................37
Iannacci, G.R. ..............................................................336
Idzior-walus, B. ............................................................277
Ilic, S. ..............................................................................403
Imbrici, L. ......................................................................177
Insull, W. ....................................................167, 170, 171
Ionescu, V.A. ................................................................240
Isakova, Z.H. ................................................................356
Ivan, L. ..................................................................179, 313
Ivanov, I. ........................................................................156
Ivetic, V. ..........................................................................402
-JJabauri, A. ......................................................................350
Jagla, F...................................................................251, 299
Jahnel, H. ........................................................................278
Jain, S. ............................................................................149
Jakimovska, E...............................................................269
Janelle, C. ............................................................244, 245
Jankovic, V. ......................................................................20
Jansen, E. ....................................................274, 275, 288
Jardini, M. ......................................................................115
Jauhiainen, M. ................................................................58
Jeevanantham, V. ........................................................339
Jelenkovic, J. ................................................................366
Jelic-Ivanovic, Z. ....................................126, 364, 376
Jendekova, L. ................................................................299
Jenkins, D.J. ........................................................295, 296
Jenkins, D.J.A. ....................................6, 294, 399, 400
Jeon, S. ..............................................252, 262, 289, 390
Jeong, K. ........................................................................160
Jeong, Y. ..........................................................................289
Jessup, W. ......................................................................176
Jiang, H.Y. ......................................................................295
Jiang, P. ............................................167, 168, 170, 172
Johns, A...........................................................................104
Johnson-Levonas, A.O.................................................63
Joksimovic Stevanovic, D. ......................................366
Jones, P. ............................................................................45
Jones-LeClointe, A. ....................................................102
Josse, A.R. ......................................................6, 294, 400
Josse, R.G. ..........................................................................6
Jovanova, S. ..................................................................194
Juergens, G. ..................................................................204
Jukema, J...........................................................................37
Julius, U. ........................................................................247
Jullien, G. ......................................................................131
Jurka, A. ..........................................................................221
-KKaddous, A. ..................................................................332
Kahya, N.........................................................................193
Kalinina, A. ....................................................................413
Kalvelis, A. ..............................................................93, 94
Kamps, R. ......................................................................193
Kan, H. ..................................................................287, 320
Kapetivadze, I.G.K. ....................................................394
Kapetivadze, V. ............................................................394
Kapiotis, S. ....................................................................297
Kaplan, R. ......................................................................349
Karachencev, I. ..............................223, 274, 275, 288
Karachentsev, Y. ..........................................................357
Karagrigoriou, A. ..........................................................96
Kardas, P. ........................................................................153
Karnialiuk, I. ................................................................117
Kashyap, M. ........................................................168, 169
Kaski, J.C. ..............................................................31, 133
Kastelein, J.J.P. ............................................................119
Kaszuba, M. ..................................................................367
Kathrein, T. ................................................319, 337, 338
Katra, B. ..........................................................................277
Kaushik, S. ....................................................................233
Kazanis, K. ....................................................................131
Kazdova, L. ..................................................................229
Kedenko, I. ....................................................................220
Kedenko, L. ..................................................................220
Kelly, M. ....................................................................23, 45
Kenda, M.F. ..................................................................243
Kendall, C.W.......................................................295, 296
Kendall, C.W.C. ..................................6, 294, 399, 400
Kerimkulova, A. ..........................................................356
Kerkhofs, M. ................................................................106
Khan, A. ..........................................................................233
Khanin, M. ..........................................................202, 203
Khazaei, M. ........................................................374, 388
Khelaia, M. ....................................................................350
Khizhnyak, O. ..............................................................357
77
Khmelnitskaya, K. ......................................................206
Khodjaev, A. ..................................................................305
Kholeif, M. ....................................................................139
Khullar, M. ..........................................................125, 361
Khurshid, N. ..................................................................384
Kikimbaeva, A.A. ........................................................264
Kim, C. ..................................................................253, 263
Kim, E. ............................................................................325
Kim, H. ............................................252, 262, 289, 390
Kim, J. ..................................................................123, 160
Kim, S. ..................................................................253, 263
Kim, Y. ............................................................................325
Kim, Y.K. ........................................................................225
Kim, Y.S. ........................................................................225
Kimura, K. ....................................................................426
Kimura, T. ......................................................................426
King, R. ..........................................................................114
Kipshidze, N. ................................................................350
Kitic, D. ................................................................402, 408
Klima, H. ........................................................................228
Klisurski, M...................................................................373
Ko, J. ................................................................................256
Koch, L. ..........................................................................118
Kochar, A. ......................................................................149
Kochar, D.K. ................................................................149
Koestenberger, M. ......................................................204
Kohno, H. ......................................................................250
Kolesnichenko, L.S. ..................................................266
Kolesnikova, L. ............................................................271
Kolev, K. ........................................................................205
Koleva, K. ......................................................................373
Kolovou, G. ..................................................................353
Komarov, A. ..................................................................358
Kondratova, N. ............................................................355
Kondratska, I.................................................................224
Konstantinovic, LJ. ....................................................403
Kontsevaya, A. ............................................................413
Kopprasch, S. ................................................................247
Korkmaz, M.E. ............................................................219
Korneluk, I. ....................................................................324
Korth, U. ..............................................................310, 411
Kostakou, P. ..................................................................353
Kostic, N.........................................................................403
Kotula-Horowitz, K. ..................................................367
Kovacevska, J. ..............................................................269
Krahtova, K. ..................................................................258
Krasova, N. ......................................223, 274, 275, 288
Kratzer, A. ........................................................................65
Kravchun, N. ........................223, 274, 275, 286, 288
Krikken, J.A.....................................................................56
Kris-Etherton, P.M. ......................................................53
Krivosikova, Z. ..................................................111, 354
Krotin, M. ..................................................328, 343, 346
Krousel-Wood, M. ........................................................98
Krstic, M.........................................................................272
Kruchinina, M. ............................................................124
Kruger, A. ............................................................347, 348
Krusinova, E. ................................................................229
Krzyzanowski, B. ........................................................367
Kuba, D. ..........................................................................354
Kuhn, H...........................................................................183
Kumar, P. ........................................................................101
Kunes, J...........................................................................401
Kurashvili, G.................................................................292
Kurashvili, G.R. ..........................................................290
Kurashvili, R. ......................................................290, 292
Kurbanov, R. ......................................................161, 163
Kurilovich, S. ................................................................124
Kurtanidze, T. ..............................................................259
Kury Nunes, I. ..............................................................340
Kutschera, J. ..................................................................204
Kuznetsov, V. ................................................................196
Kvantaliani, T. ..............................................................116
Kvapil, M. ......................................................................291
Kwasniewska, M. ........................................................306
Kwon, J. ..........................................................................289
-LLabbe, C. ..............................................................244, 245
Labudovic, D. ..............................................................194
Laggner, H. ..........................................................184, 297
Lamon, B. ......................................................................187
Lamri-Senhadji, M. ....................................................391
Landsberg, J. ................................................................440
Langer, P. ........................................................................278
Lanska, V. ......................................................................235
Lansky, A. ........................................................................39
Lari, F...............................................................................246
Larochelle, P. ......................................................244, 245
Laszlo, M.I. ........................................................327, 379
Latific Jasnic, D. ..........................................................243
Latyshev, S.....................................................................207
Launay, J.-M. ..................................................................40
La Vecchia, C. ................................................................71
Lawn, R. ..............................................................................9
Lazar, A. ..........................................................................130
Lazar, C. ..........................................................................316
Lazar, J. ..........................................................................349
Lazar, L. ................................................................130, 415
Lazea, C. ..............................................................307, 316
Lazzarato, L. ....................................................................64
78
Leal, J. ................................................................................83
Leal Hernández, M. ....................................................152
Le Berre, J.P.....................................................................99
Lee, B. ............................................................................279
Lee, C. ..................................................................253, 263
Lee, H. ............................................................................253
Lee, K. ........................................................160, 253, 263
Lee, M.M. ......................................................................225
Lee, S. ....................................................................160, 253
Lee, Y. ..............................................................................279
Legrand, V. ....................................................................185
Leheta, O. ......................................................................352
Leiter, L.A. ..........................................................................6
Lejnieks, A. ..............................................................93, 94
Leshchenko, Z. ............................................................223
Levchenko, T. ..............................................................286
Li, L.H. ............................................................................174
Liamis, G. ......................................................................248
Liao, D. ..............................................................................22
Libby, P. ..........................................................................422
Liberopoulos, E.N.............................................162, 248
Librelotto, J. ..................................................................398
Lichtenstein, A.H. ......................................................424
Liepold, E. ............................................36, 38, 369, 371
Lietava, J. ..........................................................................90
Lightwood, J. ................................................................415
Lim, S.T. ............................................................................63
Lin, H. ..............................................................................279
Lin, J. ....................................................................165, 166
Lincoff, A. ........................................................................39
Lindenmayer, J.P. ........................................................233
Lindgren, P. ......................................................................88
Ling, W. ..........................................................................387
Lisabeth, L. ....................................................................323
Liu, J. ..................................................................................22
Liu, W. ................................................................................61
Livingstone, C. ..................................................138, 139
Loacker, S. ....................................................................363
Logvinenko, A. ............................................................227
Lomakin, N. ..................................................................317
Lomtatidze, G. ..............................................................259
Loria, P. ..........................................................................268
Louala, S.........................................................................391
Lovell, C. ........................................................................173
Luley, C.................................................................228, 389
Lund, P. ..............................................................................55
Lunegova, O. ................................................................356
Lupi, A. ..............................................................................18
Lupusoru, C. ..........................................................32, 318
Lyakishev, A. ................................................................122
Lykasova, E. ..................................................................196
-MMachovich, R. ..............................................................205
Madjid, M. ..........................................................................3
Madotto, F. ....................................................................412
Maffucci, T. ..................................................................175
Maggi, D.........................................................................222
Magni, P. ........................................................................112
Mahkamova, N. ............................................................305
Maisch, B. ........................................................................29
Maisel, A. ......................................................................440
Malan, L. ..............................................................347, 348
Malan, N.T. ..........................................................347, 348
Malysh, N.............................................................202, 203
Mamcarz, A. ..................................................................155
Manasia, R. ..........................................................307, 316
Mancas, S. ......................................................................240
Mancia, G. ..........................................................................5
Mangge, H. ......................................................................65
Maniu, H.........................................................................140
Mankovsky, B. ..............................................................224
Manolis, A.S. ................................................................131
Mantovani, A. ..................................................................14
Mantovani, L.G. ..........................................................412
Mantovani, W. ..............................................................331
Marchesi, P. ......................................................................14
Marchie, A. ........................................................................6
Marciano, C. ....................................................................77
Marcovina, S.M. ................................................177, 423
Marcu, F. ........................................................................130
Marenzi, G. ....................................................................128
Marius, R. ......................................................................135
Markovic, S. ........................................................300, 312
Marques-Vidal, P. ..........................................................16
Marte, T. ..........44, 118, 121, 151, 232, 255, 278, 330
Martens, M. ..................................................................193
Martinovic, S. ....................................................267, 304
Marx, N. ............................................................................19
Massaad, R. ......................................................................63
Mateva, N. ......................................................................109
Matous, M. ....................................................................291
Maurantonio, M. ..........................................................268
Mavlyanova, M. ..........................................................163
Mayaudon, H. ..................................................................99
Matsuzaki, M. ..............................................................426
Mazzone, T. ............................................................46, 164
McCormick, S. ................................................................30
McKenney, J. ................................................................172
Mehata, S. ......................................................................139
Mehran, R. ........................................................................39
Mekki, K.........................................................................332
79
Melnichenko, S. ..........................................................224
Memon, L. ......................................................................376
Menezes, S.R.D. ..........................................................375
Menih, M. ......................................................................195
Menzin, J. ......................................................................158
Mete, M. ............................................................................11
Meyer, W.A. ..................................................................349
Meyramov, G.G. ................................................264, 265
Meyramova, A.G. ..............................................264, 265
Meyramova, J.G. ..............................................264, 265
Micheli, W. ....................................................................136
Mihas, C. ........................................................................353
Mikelsone, I...................................................................221
Mikhailidis, D.P. ..........................................................353
Miki, I. ............................................................................426
Miladinovic, B. ............................................................366
Milionis, H.J. ................................................................248
Miloslavsky, D. ............................................................357
Milovanovic, B. ................................................328, 346
Minagawa, Y. ................................................................342
Minardi, F. ............................................................128, 134
Minematsu, S. ..............................................................426
Mintale, I. ......................................................................418
Mironchik, V. ................................................................207
Mirrakhimov, M...........................................................356
Mitchenko, O. ..............................................................227
Mitro, N. ........................................................................189
Miyauchi, K...................................................................426
Mlejnek, P. ....................................................................229
Mobarakeh, J.I. ..................................................374, 388
Mocan, T. ........................................................................303
Möckel, M. ....................................................................440
Modena, M.G. ................................................................73
Mohamadifard, N. ......................................................254
Mohta, N.........................................................................149
Mok, J. ..................................................................253, 263
Mombelli, G. ................................................................215
Momo Noumessing, E...............................................261
Mongiellova, V. ..................................................111, 354
Monorchio, A. ..............................................................103
Monteiro, A. ..............................................115, 180, 181
Moon, B.............................................................................26
Morais, E. ......................................................................375
Moran, A.........................................................................415
Moreno, J. ......................................................................210
Morgenstern, L. ............................................................323
Mori, H. ................................................................406, 407
Mori, M. ................................................................406, 407
Moriarty, P. ....................................................................191
Morimoto, T. ................................................................426
Morisky, D. ......................................................................98
Morita, T. ..........................................................................42
Morozova, T. ................................................................311
Morrow, D. ......................................................................61
Moser, M. ......................................................................184
Motoc, C. ..............................................................327, 379
Motoc, R. ..............................................................327, 379
Muellner, M. ..................................................................297
Muendlein, A. ..............................................................363
Mukhamedova, N. ........................................................30
Mulej, M. ........................................................................243
Müller, C.........................................................................440
Mundim, S.M. ..............................................................375
Muniesa, P. ....................................................................397
Muntner, P.........................................................................98
Murakami, J. ......................................................287, 320
Murphy, A. ........................................................................30
Murphy, M. ......................................................................37
Myasoedova, V. ..............................................................57
-NNa, S.H. ..........................................................................225
Nadaraia, K. ..................................................................350
Nagorni, S. ....................................................................272
Najafian, J. ....................................................................254
Nakagawa, Y. ................................................................426
Nam, G. ............................................................................54
Naruszewicz, M. ..........................................................155
Nasr, G. ..........................................................................352
Nava, M.C. ..........................................................201, 242
Navarro, M.A. ................................................................78
Navis, G.J. ........................................................................56
Naznin, J. ........................................................................384
Neath, S.-X. ..................................................................440
Nebieridze, G. ..............................................................192
Nematbakhsh, M. ........................................................374
Nemecz, M. ..................................................................140
Nesic, M. ....................................................382, 402, 408
Neto, A. ..........................................................................115
Neumann, L. ..................................................................310
Newman, A. ....................................................................16
Neyer, U. ..............................................................329, 330
Ng, L. ..............................................................................440
Ng, V.W.Y.......................................................................399
Nguyen, T.H. ......................................................................6
Nicolaides, A. ..................................................................17
Nicolaides, A.N. ............................................................96
Nicolini, V.........................................................................64
Nikolaou, V. ..................................................................218
Niniano, R. ....................................................................385
Nishnianidze, M. ........................................................292
80
Nomikos, T. ............................................................51, 386
Norata, G.D. ................................................14, 112, 175
Noruzbaeva, A. ............................................................356
Nounopoulos, C. ..........................................................131
Novotna, E. ....................................................................291
Nowak, R. ......................................................................440
Nus, M. ............................................................................398
Nuyens, V. ............................................................106, 182
Nwagbara, E. ......................................................102, 213
-OOgnjanovic, B.....................................................300, 312
Oguri, M. ........................................................................287
Oh, S. ....................................................................253, 256
Ohno, T. ..........................................................................287
Okali, F. ................................................................102, 213
Oksa, A. ................................................................111, 354
Opolski, G. ....................................................................239
Oravec, S. ......................................................................148
Orekhov, A. ............................................................57, 190
Orman, I. ..........................................................................78
Osada, J. ..................................................................78, 397
Ose, L. ................................................................................34
Oshima, S. ............................................................287, 320
Osredkar, J. ....................................................................243
Ota, T. ................................................................................26
Otvos, J.D. ........................................................................11
Ou, X. ..............................................................................145
Ozaki, Y...........................................................................426
-PPadley, R. ..........167, 168, 169, 170, 171, 172, 173
Pagoni, S. ................................................................97, 142
Pais, R. ............................................................................303
Pajak, A. ..........................................................................306
Pak, Y. ....................................................................196, 372
Palazzetti, V. ..................................................................113
Paltseva, E. ....................................................................129
Panagiotakos, D. ............................................................51
Panayiotou, A. ................................................................17
Panchenko, E. ..............................................................358
Pandele, G.I. ..........................................................32, 318
Pankuweit, S. ..................................................................29
Pantopoulou, A. ............................................................386
Pantziaris, M. ..................................................................96
Papadakis, I. ..................................................................218
Papadimitriou, L. ........................................................218
Pargalava, N.SH...........................................................116
Park, C.........................................................253, 256, 263
Park, H.............................................................................262
Park, S. ............................................................................160
Parolari, A. ....................................................................134
Parreno, R. ....................................................................169
Pasqualetti, P. ................................................................222
Pastor, A.M. ..................................................................152
Patrono, C. ........................................................................28
Paul, G. ............................................................................399
Paulweber, B. ................................................................220
Pavlenko, M. ................................................................356
Pavlovic, D. ..................................................................408
Paximadas, S. ........................................................97, 142
Peacock, W.F. ................................................................440
Pearson, T. ............................................................104, 166
Pechanova, O. ..........................................251, 298, 299
Peetz, D. ..........................................................................107
Peleska, J. ......................................................................212
Pelikanova, T. ..............................................................229
Peliskova, P. ..................................................................291
Pellegrini, E. ..................................................................268
Pemberton, P. ................................................................114
Pencic, B.........................................................................403
Peoc’h, K. ........................................................................40
Perego, F. ................................................................48, 197
Perkan, A. ..............................................................43, 282
Perrea, D. ........................................................................386
Perrone-Filardi, P. ..........................................................77
Persidskikh, Y. ....................................................117, 324
Pesic, M. ........................................................................272
Pessoa Ferreira, A. ......................................................375
Petretta, M. ......................................................................77
Petrovai, D. ....................................................................257
Phillips, J.A. ....................................................................15
Pierard, L. ......................................................................185
Pigozzi, F. ......................................................................368
Pille, J. ................................................................................76
Piñeiro, R. ......................................................................175
Pines, A. ............................................................................74
Pinho Rodrigues, A. ..................................................375
Piotrowski, W. ..........................................217, 306, 383
Pirags, V. ........................................................................221
Pirillo, A. ..............................................................177, 183
Pirotta, A.........................................................................132
Pirro, M.R. ....................................................................222
Pi-Sunyer, F.X. ................................................................47
Pitsavos, C. ......................................................................51
Pletcher, M. ....................................................................415
Poberschin, I. ................................................................247
Poduri, A.........................................................................361
Pokrajac, R. ..................................................................346
Pokrovsky, S. ................................................................122
81
Polakowska, M. ......................................217, 306, 383
Polanski, S. ....................................................................360
Poli, A. ............................................................................331
Polis, A. ..................................................................46, 164
Polito, P. ..........................................................................336
Polonetsky, L. ..............................................................207
Polonetsky, L.Z. ..........................................................186
Poltorak, V. ......................................223, 274, 275, 288
Pomykaj, T. ......................................................................63
Ponikowski, P. ..............................................................440
Ponomar, E. ..................................................................129
Pop, D. ....................................................................50, 257
Popescu, M. ..................................................................135
Popov, D. ........................................................................140
Popov, E. ........................................................................200
Porta, B. ..................................................................48, 197
Prassl, R.............................................................................65
Pravenec, M...................................................................229
Pricop, L. ..............................................................434, 435
Princi, T. ..........................................................................137
Privalov, D. ....................................................................317
Procopciuc, L. ................................................................50
Prosenica, B. ......................................................267, 304
Prost, J. ............................................................................396
Prostran, M. ..................................................................141
Protic, D. ........................................................................141
Protich, M. ....................................................................258
Psutka, J. ........................................................................234
Putnina, A.V. ............................................................93, 94
-QQuiles, J. ..................................................................31, 133
Quimbo, R. ..........................................................154, 326
Quinn, C.C. ..........................................................416, 417
-RRabko, A. ........................................................................124
Radchenko, G. ....................................................236, 285
Radenkovic, M. ..................................................402, 408
Rader, D.J. ........................................................................15
Radojkovic, J. ..............................................................403
Radulescu, D. ........................................................32, 318
Raff, M...............................................................................55
Rahimi, A. ......................................................................388
Rahimi, B. ......................................................................334
Raja, B. ..................................................................102, 213
Rajaram, V. ....................................................................339
Rakar, S. ..........................................................................282
Ramakrishnan, G. ........................................................144
Ramazani, M. ................................................................254
Ranocchi, M. ................................................................434
Raselli, S. ........................................................................112
Rashtchizadeh, N. ............................................334, 335
Rasmussen, L. ..............................................................333
Ratner, RE. ......................................................................11
Rebrikov, D. ..................................................................358
Reckless, J.P.D. ..............................................................63
Redmond, E. ....................................................................61
Reihmane, D. ................................................................221
Rein, P.....................20, 44, 121, 127, 232, 255, 284,
315, 319, 329, 330, 337, 338, 363
Remaley, A. ......................................................................30
Remuzzi, G. ....................................................................27
Rendu, F. ..........................................................................40
Renesto, E.........................................................................48
Rhee, M.Y. ....................................................................225
Rhomberg, S. ................................................................363
Richards, A.M...............................................................440
Ricter, V. ........................................................................124
Risch, L. ................................................................329, 330
Risicato, R. ....................................................................321
Ristic, S. ..........................................................................382
Rizos, C.V. ..........................................................162, 248
Robertson, J. ....................................................................39
Robertson, M. ..................................................................37
Rod Costa, F.M. ..........................................................375
Roddier, M. ......................................................................13
Rodina, A. ......................................................................129
Rodondi, N. ............................................................16, 415
Rodriguez, M. ..............................................................210
Rodriguez-Colon, S. ....................................................22
Roediger, A. ....................................................................92
Roggi, C. ........................................................................385
Rohbaninoubar, M. ..........................................334, 335
Roman, M.J. ....................................................................11
Romanov, V. ..................................................................227
Roncalli, E. ....................................................................188
Ronda, A. ........................................................................178
Rosenberg, E. ......................................................165, 166
Rosenson, R.S. ..................................................241, 433
Rossi, L. ............................................................................18
Rossi, R. ............................................................................73
Rosso, R. ..........................................................................18
Roth, E. ..............................................................................45
Rothblat, G.H. ................................................................15
Roumeguere, T. ............................................................182
Rousseau, A. ..................................................................182
Rowland, C. ....................................................................37
Roytberg, G. ..................................................................355
82
Ruiz-Gutiérrez, V. ................................................78, 397
Rus, M. ............................................................................130
Russell, M. ........................................................................11
Russeva, A. ....................................................................301
Rusu, ML. ......................................................................341
Ruzic Medvescek, N. ................................................243
Rybicka, M. ..................................................................392
-SSaely, C.H. ................................20, 44, 118, 121, 127,
151, 232, 255, 278, 284, 315,
319, 329, 330, 337, 338, 363
Safa, J. ............................................................................334
Saicic, Z. ..............................................................300, 312
Saji, T. ................................................................................42
Saito, S. ..........................................................................426
Salimova, N. ..................................................................305
Salomaa, V. ......................................................................58
Salon, J. ..........................................................................168
Samokhodskaya, L. ....................................................359
Sánchez-Muniz, F. ............................................378, 398
Sansa, M. ..........................................................................18
Santagostino, M. ............................................................18
Sarau, C.A. ....................................................................240
Sarawate, S. ..................................................................154
Sarkar, S. ........................................................................208
Sarmanov, F. ..................................................................305
Sarr, G. ............................................................................254
Sartirana, D. ..................................................................211
Sasaki, A. ........................................................................250
Sasaki, J. ........................................................................159
Satterfield, S. ..................................................................16
Savoy, J. ..........................................................................370
Sayers, M.H. ...................................................................91
Sazonov, V. ......................................................................92
Scheen, A. ........................................................................47
Schlegel-Zawadzka, M. ............................................351
Schmid, F. ......................................................................118
Schmidt, E.B. ................................................................333
Schmidt, K. ......................................................................49
Schoeneberger, A. ..........................................................49
Schreier, S. ....................................................................184
Schulz, E. ..............................................................310, 411
Schutte, A.E.........................................................347, 348
Schutte, R. ............................................................347, 348
Schwandt, P. ........................................36, 38, 369, 371
Schwappach, D. ..........................................................237
Schwarz, P.E.H. ............................................................247
Schwarz, A. ..........................................................310, 411
Sciarrillo, I. ..........................................................434, 435
Scotti, E...........................................................................189
Seales, D. ..............................................................102, 213
Sedova, M. ....................................................................212
Segovia, J.C. ....................................................................78
Seljelid, R. ......................................................................283
Semenov, D. ..................................................................124
Serafin, A. ......................................................................239
Sergeeva, E.S. ..............................................................266
Sergeeva, M.P. ..............................................................266
Setze, C. ....................................................................23, 45
Severin, S. ......................................................................129
Sevruk, T. ........................................................................117
Shah, A. ..................................................................54, 166
Shakhmatova, O. ........................................................358
Shakirov, M. ..................................................................305
Sharasidze, N. ..............................................................322
Sharma, A. ......................................................................125
Sharma, P. ......................................................................149
Sharma, Y.P. ........................................................125, 361
Sharrett, A.R. ................................................................349
Shek, A. ................................................................161, 163
Shelestova, E. ....................................................290, 292
Shen, H. ..........................................................................405
Shepherd, J. ..............................................................35, 37
Shin, D.............................................................................123
Shin, S. ............................................................................289
Shin, Y. ............................................................................252
Shlyakhto, E.V. ............................................................206
Shrivastava, R.....................................................233, 339
Shtandel, S. ....................................................................357
Siadat, Z. ........................................................................254
Siebert, J. ........................................................................155
Sieradzki, J. ..................................................................277
Sievenpiper, J. ..............................................................294
Sievenpiper, J.L. ................................................295, 296
Silivastru, I. ........................................................327, 379
Silva de Almeida, A. ..................................................375
Simko, R. ....................................................157, 158, 326
Simko, R.J. ....................................................................154
Simon, A. ..........................................................................40
Simonini, M.S. ............................................................268
Sinagra, G. ..............................................................43, 282
Singer, W. ............................................................................6
Sinner, F.............................................................................65
Sirenko, Y.U. ......................................................236, 285
Sirtori, C.R. ............................................................70, 215
Sisillo, E. ........................................................................134
Sitar-Taut, A. ....................................................................50
Sitnikova, M.Y. ............................................................206
Sixiu, Z. ..........................................................................406
Skhiladze, E...................................................................292
83
Sleep, D. ....................................................................23, 45
Sluiter, W.J. ..........................................................276, 377
Smith, C. ........................................................................238
Smith, M. ........................................................................323
Snegurskaya, I. ............................................................357
Sobenin, I. ..............................................................57, 190
Sokolova Djokic, L. ........................................267, 304
Soler Garcia, R. ............................................................152
Sombra, E. ......................................................................375
Sona, A. ................................................................434, 435
Sonderegger, G.............................................................363
Sopena-Vallejo, M. ....................................................309
Sosland, R. ....................................................................191
Sourij, H. ........................................................................278
Spaccamiglio, A. ..........................................................368
Spasic, S. ....................................................126, 364, 376
Spasojevic-Kalimanovska, V. ............126, 364, 376
Spinarova, L. ................................................................362
Spirito, R. ......................................................................198
Squellerio, I. ........................................................128, 134
Srichaikul, K. ................................................................400
Stachowska, E. ............................................................392
Stajn, A. ................................................................300, 312
Stamatelatou, M. ..........................................................353
Stambolsky, D. ............................................................358
Stamenova, P. ................................................................373
Stanley, E. ........................................................................98
Starzyk, J. ......................................................................351
Stenner, E. ............................................................136, 137
Stifts, A. ..........................................................................221
Stizaker, R. ......................................................................30
Stochlova, J. ..................................................................235
Stojanovic, D. ..............................................................366
Stojanovic, L.J. ..................................................343, 346
Stokic, E. ........................................................................230
Stolzenbach, J. ................................................................23
Stomeo, G. ....................................................................176
Stone, G. ............................................................................39
Stornello, M...................................................................321
Straarup, E. ......................................................................55
Strashimirov, D. ..........................................................301
Strasser, J.F. ..................................................................100
Strelkova, A. ..................................................................147
Strelkova, A.V...............................................................283
Stritecka, H. ................................................95, 234, 365
Stukena, I. ................................................................93, 94
Su, W. ..............................................................................174
Suchanek, P. ..................................................................235
Sugaeva, O. ....................................................................324
Suica, V. ..........................................................................313
Sumarokov, A. ....................................................200, 314
Superko, H. ..........................................................172, 173
Surra, J.............................................................................397
Sutton-Tyrrell, K. ..........................................................16
Svensson, M. ................................................................333
Sviridov, D. ......................................................................30
Syrkin, A.........................................................................129
Szabó, M.........................................................................291
Szczeklik, A. ......................................................360, 367
Szucs, T. ............................................................................92
-TTabor, A...........................................................................351
Tabukashvili, R.I.T. ....................................................394
Talwar, KK. ..................................................................125
Tan, L. ..............................................................................293
Tan, L.G. ................................................................33, 409
Tan, S. ..............................................................................293
Tan, S.A...................................................................33, 409
Tanaka, M. ....................................................................216
Tandon, N. ......................................................................339
Tang, Y.T. ........................................................................145
Tang, C.K. ......................................................................145
Tangney, C. ....................................................................241
Tanka-Salamon, A. ......................................................205
Tanna, A. ..........................................................................64
Tardivo, S. ......................................................................331
Tarlea, F...........................................................................130
Tatebe, J.............................................................................42
Tavazzi, L.............................................................437, 438
Tchaava, K.M.T. ..........................................................394
Teibe, U. ....................................................................93, 94
Tendera, M. ....................................................................306
Terada, E. ..........................................................................42
Tershakovec, A. ..........................................46, 164, 166
Tershakovec, A.M. ......................................................165
Terzieva, D.....................................................................109
Tesone, A. ......................................................................385
Tessitore, N. ..................................................................331
Thakkar, R. ........167, 168, 169, 170, 171, 172, 173
Tholstrup, T. ....................................................................55
Tibolla, G. ......................................................................175
Tien, P.C. ........................................................................349
Tikhonova, T. ................................................................286
Tikhonravov, A.............................................................355
Tilea, I. ............................................................................379
Ting, C. ............................................................................150
Tirpakova, J. ..................................................................354
Tisheva, S. ......................................................................301
Toadere, A. ....................................................................135
Todic, B...........................................................................328
84
Todorova, B. ..................................................................194
Todosiychuk, V. ............................................................196
Tognoni, G. ....................................................................104
Tomassini, J. ..........................................................46, 164
Tomcheva, S. ................................................................249
Tomeckova, M. ............................................................212
Tomonaga, Y. ..................................................................92
Tong, C. ............................................................................37
Tosheska, K. ..................................................................194
Tremoli, E. ..........41, 59, 128, 134, 197, 198, 201, 242
Tretjakovs, P. ................................................................221
Truhan, O. ......................................................................207
Trukhacheva, E. ..........................................................122
Tsai, M.C. ......................................................................405
Tsakiris, A. ....................................................................218
Tselmin, S. ....................................................................247
Tsiafoutis, I. ..................................................................218
Tsiklauri, P,A. ................................................................116
Tsimihodimos, V. ........................................................162
Tsonev, S. ......................................................................281
Tsutskiridze, L. ..................................................290, 292
Turconi, G. ....................................................................385
Tusupbekova, G.T. ......................................................265
Tybjaerg-Hanssen, A. ..................................................58
Tykarski, A.....................................................................306
Tyllis, T. ............................................................................17
-UUboldi, P. ..............................................................177, 183
Uchitel, I. ........................................................................200
Ugliano, D. ....................................................................103
Uledeva, L. ....................................................................147
Uljarevic, M. ................................................................382
Umans, JG. ......................................................................11
Undwin, N.C. ..................................................................84
Urseanu, S. ....................................................................240
Ursu, M. ..........................................................................379
Ustinova, I. ..........................................................117, 324
Uyy, E. ............................................................................179
-VVacula, I. ........................................................................148
Valius, L. ........................................................................270
Valvo, E...........................................................................321
Van Antwerpen, P. ......................................................182
Vanbelle, S. ....................................................................185
Vanden Heuvel, J.P. ......................................................53
Vandormael, K. ..............................................................63
Van Gaal, L.F...................................................................47
Vanhaeverbeek, M. ..........................................106, 182
Van Meerhaeghe, A. ..................................................106
Van Meerhaeghe, P. ....................................................106
Van Rooyen, J. ..............................................................347
van Rooyen, J.M. ........................................................348
van Schalkwijk, B. ......................................................146
van Schalkwijk, D.B. ................................................146
van Schalkwijk, K.......................................................146
Vanuzzo, D. ..................................................................427
Vasan, S. ............................................................................54
Vasiliadis, I. ..................................................................353
Vasku, A. ........................................................................362
Vasques, E. ....................................................................321
Vatankhah, A. ......................................................334, 335
Veglia, F. ....................................................128, 134, 201
Vekic, J. ..........................................................................376
Veljkovic, S. ........................................................402, 408
Velliquette, R.A. ............................................................53
Veltri, E. ..........................................................................166
Venkatesh, P...................................................................339
Verlan, N.V. ..................................................................266
Veronesi, G. ..................................................................412
Villa, D. ..........................................................................201
Villaescusa Pedemonte, M.......................................152
Vincentelli, G. ..............................................................222
Visioli, F. ..........................................................................80
Viskoper, R. ..................................................................414
Vissers, J. ........................................................................193
Vitlianovaz, K. ..............................................................281
Vitrella, G. ..............................................................43, 282
Vittinghoff, E...................................................................16
Viviani, B. ......................................................................189
Vladimirova-Kitova, L. ............................................109
Vo, A. ......................................167, 168, 169, 170, 171
Vögele, C. ........................................................................79
Vojdani, A.......................................................................199
Volek, J. ..........................................................................209
Volpe, M. ..........................................................................85
Volpe, R. ............................................................................76
Volpi, E. ............................................................................64
Vonbank, A. ....................20, 44, 121, 127, 151, 232,
255, 284, 315, 319, 329, 337, 338, 363
Voorbij, H.A.M. ..........................................................276
Vorobiova, E. ................................................................322
Voulgari, C. ............................................................97, 142
Vrankova, S. ..................................................................299
-WWagner, F. ......................................................................411
Wagner, T. ......................................................................204
85
Wait, R. ..............................................................................59
Walcher, D. ......................................................................19
Walus-Miarka, M. ......................................................277
Wanderley Júnior, M. ................................................340
Wang, J. ..........................................................................405
Wang, K. ........................................................................150
Wang, Z.Q. ....................................................................174
Wascher, T.C. ................................................................278
Webb, S. ................................................................154, 326
Webber, L. ........................................................................98
Weber, M.H. ........................................................310, 411
Weinstock, R. ........................................................46, 164
Weissman, N.J. ................................................................11
Weksler, B.B. ..................................................................41
Welborn, T. ......................................................................21
Wen Xu, J. ......................................................................406
Wentao, W. ....................................................................406
Werba, J.P. ......................................................................201
Werba, P.J. ......................................................................242
Wespes, E. ......................................................................182
Westphal, S. ........................................................228, 389
Whiting, D.R. ..................................................................84
Williams, A.M. ............................................................226
Williams, L. ..................................................................415
Williams, M. ................................................24, 214, 302
Winder, T. ......................................................................363
Wohl, P. ..........................................................................229
Wolf, A. ................................................................310, 411
Wolf, P.A. ............................................................................1
Wolfe, M.L. ......................................................................15
Wong, J.M. ....................................................................296
Wong, J.M.W. ......................................6, 294, 399, 400
Woo, M. ................................................................252, 390
Wood, D.A. ....................................................................430
Woolard, K. ......................................................................30
Wozniakiewicz, E. ......................................................277
Wu, A.H.B. ....................................................................440
Wu, C. ................................................................................22
Wu, X. ..............................................................................405
Wu, Z.H. ........................................................................145
Wyrzykowski, B. ........................................................306
-XXenophontos, S. ............................................................96
Xu, X. ..............................................................................165
-Y-
Yalamanchali, V. ..........................................................370
Yamazaki, J. ....................................................................42
Yamori, Y. ............................................................406, 407
Yan, X. ............................................................................405
Yang, D. ..........................................................................171
Yanni, A. ........................................................................386
Yoon, Y. ..........................................................................256
Yosefy, H. ......................................................................414
Yoshino, G. ......................................................................42
Young, F. ..........................................................................84
Yusupova, E...................................................................356
-ZZacchi, E. ..........................................................................41
Zaja, M. ..........................................................................328
Zak, K. ............................................................................224
Zake, I. ............................................................................418
Zambon, A. ..........................................................431, 432
Zamfir, C. ......................................................................140
Zanaboni, A.M. ............................................................215
Zaninelli, A. ..................................................................237
Zanocchi, M. ................................................................435
Zanotti, I. ........................................................................178
Zarif, H. ................................................................138, 139
Zazzaro, B. ....................................................................321
Zdrenghea, D. ........................................................50, 257
Zeljkovic, A. ..................................................................376
Zemlyanitsyna, O. ......................................................286
Zhang, B. ..............................................................157, 158
Zhang, Q.Y. ....................................................................145
Zhang, W. ......................................................................405
Zhao, G. ............................................................................53
Zhao, S. ..........................................................................143
Zhao, Z.X. ......................................................................174
Zhou, X.H. ....................................................................145
Zhou, Z.J.........................................................................145
Zicha, J. ..........................................................................401
Zidkova, K. ....................................................................229
Zikic, R. ................................................................300, 312
Zimmer, A.........................................................................65
Zlatareva, N. ..................................................................373
Zocchi, L. ..........................................................................48
Zou, J.H. ........................................................................145
Zouaoui Boudjeltia, K. ....................................106, 182
Zweiker, R. ....................................................................278
Zykova, T. ......................................................................147
Zykova, T.A...................................................................283
Zykova, S.N. ................................................................283
Yamagishi, M. ..............................................................426
Yamaguchi, T. ..............................................................426
86
Note
87
Note
88
Note
89
Note
90
Legend
� Congress Venue
� San Marco Square
� Piazzale Roma
� S.M. Elisabetta Square
� Railway Station
� Grand Canal
(arrival of ferry boats from Downtown
Venice)
Lorenzini Foundation Symposium: 311
MRF 2008
FONDAZIONE GIOVANNI LORENZINI
MEDICAL SCIENCE FOUNDATION
Via A. Appiani 7 - 20121 Milan (Italy)
Phone: (+39) 02 29006267 - Fax: (+39) 02 29007018
E-mail: [email protected]
.
w
w
w
in
z
n
e
lor
ifo
n
o
i
t
a
und
.
mrf
/
g
r
o
2
htm
.
8
0
0
l

Final Program

Transcription

Similar documents

L`ombelico del mondo

Intimissimi has a great history behind it. The extraordinary

Installation of Scrolling Ceiling

Installation of Scrolling Banner CNFS00 1

Pictorial Modernism Art Deco

Leaving Cert Craft Exam-Poster Question By Ruth Graydon

The READ Design Studio Starter Pack features

BETWEEN THE COVERS RARE BOOKS

absolute online collectibles auction at wham

MNLA Plant Posters for garden centers and nurseries